<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD001914.pub3" GROUP_ID="CF" ID="510599082314374106" MERGED_FROM="" MODIFIED="2017-06-29 10:31:10 +0100" MODIFIED_BY="Nikki Jahnke" REVIEW_NO="0023" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="10.0">
<COVER_SHEET MODIFIED="2017-06-29 10:31:10 +0100" MODIFIED_BY="Nikki Jahnke">
<TITLE>Oral protein calorie supplementation for children with chronic disease</TITLE>
<CONTACT MODIFIED="2017-06-29 10:31:10 +0100" MODIFIED_BY="Nikki Jahnke"><PERSON ID="19850469889328789181100304190740" ROLE="AUTHOR"><FIRST_NAME>Damian</FIRST_NAME><MIDDLE_INITIALS>K</MIDDLE_INITIALS><LAST_NAME>Francis</LAST_NAME><EMAIL_1>damian.francis@uwimona.edu.jm</EMAIL_1><ADDRESS><DEPARTMENT>Epidemiology Research Unit</DEPARTMENT><ORGANISATION>Caribbean Institute for Health Research, The University of the West Indies, Mona</ORGANISATION><CITY>Kingston</CITY><COUNTRY CODE="JM">Jamaica</COUNTRY></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2017-06-29 10:31:10 +0100" MODIFIED_BY="Nikki Jahnke"><PERSON ID="19850469889328789181100304190740" ROLE="AUTHOR"><FIRST_NAME>Damian</FIRST_NAME><MIDDLE_INITIALS>K</MIDDLE_INITIALS><LAST_NAME>Francis</LAST_NAME><EMAIL_1>damian.francis@uwimona.edu.jm</EMAIL_1><ADDRESS><DEPARTMENT>Epidemiology Research Unit</DEPARTMENT><ORGANISATION>Caribbean Institute for Health Research, The University of the West Indies, Mona</ORGANISATION><CITY>Kingston</CITY><COUNTRY CODE="JM">Jamaica</COUNTRY></ADDRESS></PERSON><PERSON ID="z1309181112311576973682916318698" ROLE="AUTHOR"><FIRST_NAME>Joanne</FIRST_NAME><LAST_NAME>Smith</LAST_NAME><EMAIL_1>joanne.smith02@uwimona.edu.jm</EMAIL_1><ADDRESS><ORGANISATION>University of West Indies</ORGANISATION><CITY>Mona Kingston 7</CITY><COUNTRY CODE="JM">Jamaica</COUNTRY></ADDRESS></PERSON><PERSON ID="04959458368120864272110822111736" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Tawab</FIRST_NAME><LAST_NAME>Saljuqi</LAST_NAME><EMAIL_1>tawabsaljuqi@gmail.com</EMAIL_1><ADDRESS><ORGANISATION/><ADDRESS_1>1609 S Bentley Ave Apt #1</ADDRESS_1><CITY>Los Angeles</CITY><ZIP>CA 90025</ZIP><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1 424 208-3197</PHONE_1></ADDRESS></PERSON><PERSON ID="11831" ROLE="AUTHOR"><PREFIX>Mrs</PREFIX><FIRST_NAME>Ruth</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>Watling</LAST_NAME><POSITION>Chief Dietitian</POSITION><EMAIL_1>Ruth.Watling@alderhey.nhs.uk</EMAIL_1><ADDRESS><DEPARTMENT>Department of Nutrition and Dietetics</DEPARTMENT><ORGANISATION>Alder Hey Children's NHS Foundation Trust</ORGANISATION><ADDRESS_1>Eaton Road</ADDRESS_1><CITY>Liverpool</CITY><ZIP>L12 2AP</ZIP><REGION>Merseyside</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 151 252 5847</PHONE_1><FAX_1>+44 151 252 5494</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2015-05-20 11:31:32 +0100" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="20" MONTH="5" YEAR="2015"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="24" MONTH="2" YEAR="2015"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="22" MONTH="5" YEAR="2017"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2000"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="2000"/>
<LAST_CITATION_ISSUE ISSUE="6" YEAR="2017"/>
</DATES>
<WHATS_NEW MODIFIED="2017-06-29 10:31:10 +0100" MODIFIED_BY="Nikki Jahnke"><WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2017-06-29 10:31:10 +0100" MODIFIED_BY="Nikki Jahnke"><DATE DAY="29" MONTH="6" YEAR="2017"/><DESCRIPTION><P>Contact details updated.</P></DESCRIPTION></WHATS_NEW_ENTRY>


</WHATS_NEW>
<HISTORY MODIFIED="2017-06-29 10:31:10 +0100" MODIFIED_BY="Nikki Jahnke"><WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2017-06-29 10:31:10 +0100" MODIFIED_BY="Nikki Jahnke">
<DATE DAY="20" MONTH="5" YEAR="2015"/>
<DESCRIPTION>
<P>A new review team has taken on this review at the 2015 update.</P>
<P>Despite the inclusion of one new trial (in a different disease area than those trials previously included), the conclusions of the review have not changed.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY><WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2017-06-29 10:31:10 +0100" MODIFIED_BY="Nikki Jahnke">
<DATE DAY="20" MONTH="5" YEAR="2015"/>
<DESCRIPTION>
<P>Three new studies were identified in the latest searches; one of these has been included in the updated review (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>) and one has been excluded with reasons (<LINK REF="STD-Botr_x00e1_n-2011" TYPE="STUDY">Botrán 2011</LINK>). The third new study is still ongoing and the authors have been contacted to ascertain when the published data will be available (<LINK REF="STD-Cox-2014" TYPE="STUDY">Cox 2014</LINK>).</P>
<P>One reference that was previously listed as 'Awaiting classification' has now been included under the main (already included) study ID with confirmation of the paediatric data from the authors (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>). Five further studies that were previously listed as 'Awaiting classification' have now been excluded (<LINK REF="STD-Jain-2006" TYPE="STUDY">Jain 2006</LINK>; <LINK REF="STD-Johnson-2006" TYPE="STUDY">Johnson 2006</LINK>; <LINK REF="STD-Nielson-2007" TYPE="STUDY">Nielson 2007</LINK>; <LINK REF="STD-Powers-2006" TYPE="STUDY">Powers 2006</LINK>; <LINK REF="STD-Rollins-2007" TYPE="STUDY">Rollins 2007</LINK>). One study that was previously listed as 'Awaiting classification' has been identified as part of an already excluded study (<LINK REF="STD-Rickard-1989" TYPE="STUDY">Rickard 1989</LINK>).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-07-23 15:55:23 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="12" MONTH="8" YEAR="2009"/>
<DESCRIPTION>
<P>Contact details updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2015-02-03 20:34:53 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="10" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>17 new trials were identified in the latest searches: 12 new trials have been listed as excluded (<LINK REF="STD-Abdulhamid-2008" TYPE="STUDY">Abdulhamid 2008</LINK>; <LINK REF="STD-Bruzzese-2007" TYPE="STUDY">Bruzzese 2007</LINK>; <LINK REF="STD-Lloyd_x002d_Still-2006" TYPE="STUDY">Lloyd-Still 2006</LINK>; <LINK REF="STD-Manguso-2005" TYPE="STUDY">Manguso 2005</LINK>; <LINK REF="STD-Marques-2004" TYPE="STUDY">Marques 2004</LINK>; <LINK REF="STD-Ndekha-2005" TYPE="STUDY">Ndekha 2005</LINK>; <LINK REF="STD-Newby-2007" TYPE="STUDY">Newby 2007</LINK>; <LINK REF="STD-Oudshoorn-2007" TYPE="STUDY">Oudshoorn 2007</LINK>; <LINK REF="STD-Papas-2007" TYPE="STUDY">Papas 2007</LINK>; <LINK REF="STD-Soliman-2004" TYPE="STUDY">Soliman 2004</LINK>; <LINK REF="STD-Stark-2005" TYPE="STUDY">Stark 2005</LINK>; <LINK REF="STD-Teixido_x002d_Planas-2005" TYPE="STUDY">Teixido-Planas 2005</LINK>); five new trials have been listed as 'Awaiting classification' (Jain 2006a; Johnson 2006a; Nielson 2007a; Powers 2006a; Rollins 2007a). </P>
<P>One trial which was previously listed as ongoing has now been published in full and has been included in the review (<LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>); one additional reference to an already included trial has also been listed as 'Awaiting classification' until we are able to obtain and analyse data for paediatric participants only (Kalnins 2005).</P>
<P>We have obtained the published paper from one trial which was previously listed as 'Awaiting classifcation' and we have now judged this to be not eligible to be listed even as an excluded study.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-08-12 14:52:25 +0100" MODIFIED_BY="Nikki Jahnke">
<DATE DAY="10" MONTH="4" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-04-10 16:25:18 +0100" MODIFIED_BY="Nikki Jahnke">
<DATE DAY="14" MONTH="11" YEAR="2005"/>
<DESCRIPTION>
<P>A search was run in November 2004 and no new references were found which were eligible for inclusion in the review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-04-10 16:24:24 +0100" MODIFIED_BY="Nikki Jahnke">
<DATE DAY="27" MONTH="1" YEAR="2004"/>
<DESCRIPTION>
<P>A search was run in August 2003 and identified 13 new references. Not all of these were eligible for inclusion in the review, but two of the references (Lepage 2002; Pelekanos 1990) have been added to 'Excluded studies'.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-04-10 16:23:40 +0100" MODIFIED_BY="Nikki Jahnke">
<DATE DAY="16" MONTH="10" YEAR="2002"/>
<DESCRIPTION>
<P>An update of the review was completed in October 2002. No additional studies were found to be eligible for inclusion in the review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="21" MONTH="5" YEAR="1999"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2015-02-24 16:15:53 +0000" MODIFIED_BY="Nikki Jahnke">
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES MODIFIED="2015-02-24 16:15:53 +0000" MODIFIED_BY="Nikki Jahnke">
<SOURCE>
<NAME>North West NHS Executive R&amp;D Directorate Training Fellowship Scheme</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>British Dietetic Association General Education Trust</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2015-02-24 16:15:53 +0000" MODIFIED_BY="Nikki Jahnke">
<NAME>National Institute for Health Research</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>This systematic review was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Cystic Fibrosis and Genetic Disorders Group.</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2015-05-21 10:26:33 +0100" MODIFIED_BY="Nikki Jahnke">
<SUMMARY MODIFIED="2015-05-20 11:41:16 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-04-15 15:29:29 +0100" MODIFIED_BY="Nikki Jahnke">The use of oral protein calorie supplements in children with chronic disease</TITLE>
<SUMMARY_BODY MODIFIED="2015-05-20 11:41:16 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Background</B>
</P>
<P>A lack of growth and poor nutrition are common in children with chronic diseases like cystic fibrosis and paediatric cancer. This may be due to reduced appetite, poor absorption and the need for extra calories due to the disease. Oral protein calorie supplements, either as milk or juices, may improve nutritional status and help children gain weight. Side effects of taking these supplements include the risk that the protein and calories in the supplement end up replacing those from normal food and have a negative effect on eating behaviour and physical side effects (e.g. bloating, vomiting and diarrhoea).</P>
<P>
<B>Search date</B>
</P>
<P>The evidence is current to: 24 February 2015.</P>
<P>
<B>Study characteristics</B>
</P>
<P>We looked for trials of oral protein calorie supplements compared to usual treatment or no alternative treatment where the children took the supplements for at least one month. The review included four trials with 187 children; in three of these the children had cystic fibrosis and in one they had cancer. Studies lasted from three months to one year. We recorded the results and judged whether the trials were at risk of being biased based on the design or the way it was run. We looked at outcomes such as weight and height, calorie intake, behaviour and also side effects.</P>
<P>
<B>Key results</B>
</P>
<P>One study (with 58 children) showed increases in the total calories consumed at both six and 12 months. None of the other outcomes we looked at showed any difference between treatments. This is an updated version of the review, which found no conclusive evidence to support the use of oral protein supplements. We suggest that at least one high quality trial be conducted.Therefore, we suggest that these products are used sparingly and with caution.</P>
<P>
<B>Quality of the evidence</B>
</P>
<P>Overall the included studies had a low risk of bias, except for two studies in which it was possible that the organisers knew which treatment group in which the children would be placed. These issues are unlikely to change the results as knowing which treatment one receives is unlikely to affect the results of body measurements (e.g. weight, height outcomes). All planned outcomes were reported on, with the exception of one study that did not report on eating behaviour and lipase intake which were measured. The quality of the results for the eating behaviour assessment was questionable and many of the children did not return the food diaries from which the lipase intake could be calculated.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2015-05-20 11:39:07 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2015-05-20 11:34:17 +0100" MODIFIED_BY="[Empty name]">
<P>Poor growth and nutritional status are common in children with chronic diseases. Oral protein calorie supplements are used to improve nutritional status in these children. These expensive products may be associated with some adverse effects, e.g. the development of inappropriate eating behaviour patterns. This is a new update of a Cochrane review last updated in 2009.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To examine evidence that in children with chronic disease, oral protein calorie supplements alter daily nutrient intake, nutritional indices, survival and quality of life and are associated with adverse effects, e.g. diarrhoea, vomiting, reduced appetite, glucose intolerance, bloating and eating behaviour problems.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2015-02-24 16:14:12 +0000" MODIFIED_BY="Nikki Jahnke">
<P>Trials of oral protein calorie supplements in children with chronic diseases were identified through comprehensive electronic database searches, handsearching relevant journals and abstract books of conference proceedings. Companies marketing these products were also contacted.</P>
<P>Most recent search of the Group's Trials Register: 24 February 2015.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2008-11-11 11:33:09 +0000" MODIFIED_BY="Nikki Jahnke">
<P>Randomised or quasi-randomised controlled trials comparing oral protein calorie supplements for at least one month to increase calorie intake with existing conventional therapy (including advice on improving nutritional intake from food or no specific intervention) in children with chronic disease.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2015-02-17 13:29:53 +0000" MODIFIED_BY="Nikki Jahnke">
<P>We independently assessed the outcomes: indices of nutrition and growth; anthropometric measures of body composition; calorie and nutrient intake (total from oral protein calorie supplements and food); eating behaviour; compliance; quality of life; specific adverse effects; disease severity scores; and mortality; we also assessed the risk of bias in the included trials.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2015-05-20 11:39:07 +0100" MODIFIED_BY="[Empty name]">
<P>Four studies (187 children) met the inclusion criteria. Three studies were carried out in children with cystic fibrosis and one study included children with paediatric malignant disease. Overall there was a low risk of bias for blinding and incomplete outcome data.Two studies had a high risk of bias for allocation concealment. Few statistical differences were found in the outcomes we assessed between treatment and control groups, except change in total energy intake at six and 12 months, mean difference 304.86 kcal per day (95% confidence interval 5.62 to 604.10) and mean difference 265.70 kcal per day (95% confidence interval 42.94 to 485.46), respectively. However, these were based on the analysis of just 58 children in only one study. Only two chronic diseases were included in these analyses, cystic fibrosis and paediatric malignant disease. No other studies were identified which assessed the effectiveness of oral protein calorie supplements in children with other chronic diseases.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2014-11-04 22:16:18 +0000" MODIFIED_BY="[Empty name]">
<P>Oral protein calorie supplements are widely used to improve the nutritional status of children with a number of chronic diseases. We identified a small number of studies assessing these products in children with cystic fibrosis and paediatric malignant disease, but were unable to draw any conclusions based on the limited data extracted. We recommend a series of large, randomised controlled trials be undertaken investigating the use of these products in children with different chronic diseases. Until further data are available, we suggest these products are used with caution.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2015-05-20 13:03:12 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2015-05-20 11:42:21 +0100" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2015-05-20 11:42:21 +0100" MODIFIED_BY="[Empty name]">
<P>Inadequate gains in growth, due to poor nutritional intake, increased nutrient requirements during illness, and reduced appetite are frequently observed features in children with chronic diseases. This has been demonstrated in respiratory disease, chronic renal failure, neuromuscular disease and juvenile chronic arthritis (<LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>; <LINK REF="REF-Johansson-1986" TYPE="REFERENCE">Johansson 1986</LINK>). Studies also show a prevalence of both acute and chronic malnutrition of children in hospital of between 6% to over 30% in both developed and developing countries globally (<LINK REF="REF-Hendricks-1995" TYPE="REFERENCE">Hendricks 1995</LINK>; <LINK REF="REF-Hendrickse-1997" TYPE="REFERENCE">Hendrickse 1997</LINK>; <LINK REF="REF-Moy-1990" TYPE="REFERENCE">Moy 1990</LINK>; <LINK REF="REF-Pawellek-2008" TYPE="REFERENCE">Pawellek 2008</LINK>; <LINK REF="REF-Joosten-2010" TYPE="REFERENCE">Joosten 2010</LINK>; <LINK REF="REF-Spagnuolo-2013" TYPE="REFERENCE">Spagnuolo 2013</LINK>). Growth failure and poor nutritional status in chronic disease are multi-factorial in origin. Contributing factors include reduced dietary intake as a result of reduced appetite, malabsorption and increased nutritional requirements associated with some diseases. Poor nutritional status and sub-optimal growth can have a detrimental effect on both short- and long-term disease outcomes (<LINK REF="REF-Corey-1988" TYPE="REFERENCE">Corey 1988</LINK>; <LINK REF="REF-CPS-1994" TYPE="REFERENCE">CPS 1994</LINK>; <LINK REF="REF-Koscik-2004" TYPE="REFERENCE">Koscik 2004</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2008-04-15 15:32:00 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Prevention or correction of malnutrition is increasingly recognised as an important component of the management of chronic childhood disease. Several interventions are available to increase nutritional intake thereby improving nutritional status. These include dietetic advice to increase the nutritional content of the child's diet; provision of oral protein calorie supplements; and provision of additional nutrition in the form of tube feeding.</P>
</INTERVENTION>
<THEORY MODIFIED="2008-11-10 11:05:51 +0000" MODIFIED_BY="Nikki Jahnke">
<P>Oral protein calorie supplements in the form of either whole protein milk or juice drinks are used to increase the total daily protein and calorie intake in order to improve weight gain and nutritional status. These supplements also contain a range of micronutrients (vitamins and minerals) which may be of benefit to the malnourished child. Supplements which provide only calories with no additional nutrients are also available, however these are infrequently recommended for children with malnutrition as these children require supplementation of protein and other nutrients in addition to calories, rather than calories alone. Provided protein calorie supplements are taken in addition to normal dietary intake from food, then overall nutritional intake should be improved. However, it is possible that these products may replace some of the protein and calories taken as food and their potential effect on overall protein and calorie intake either reduced or eliminated. A further potential adverse consequence of replacing protein and calorie intake from normal food by protein and calories from these supplements may be to have a detrimental effect on eating behaviour which is particularly critical in toddlers and young children who are learning to develop normal eating behaviour. These products may also cause a number of other unpleasant symptoms, for example diarrhoea, vomiting, glucose intolerance and bloating. In addition, these products are expensive especially when compared calorie for calorie to food.</P>
</THEORY>
<IMPORTANCE MODIFIED="2015-05-20 11:30:33 +0100" MODIFIED_BY="[Empty name]">
<P>Given the potential benefits and harms described above it is important to evaluate the effectiveness of oral protein calorie supplements in children with chronic disease. This is an update of a Cochrane review last updated in 2009 (<LINK REF="REF-Poustie-2009" TYPE="REFERENCE">Poustie 2009</LINK>).</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2015-02-17 10:18:14 +0000" MODIFIED_BY="Nikki Jahnke">
<P>To examine the evidence that in children with chronic disease, oral protein calorie supplements:</P>
<OL>
<LI>alter nutritional indices, daily calorie, protein and other nutrient intake, survival and quality of life;</LI>
<LI>alter protein and calorie intake from normal food and affect overall nutrient intake;</LI>
<LI>are associated with adverse effects in children with chronic disease which are either important to the child or have long-term sequelae (these may include diarrhoea, vomiting, reduced appetite, glucose intolerance, bloating and eating behaviour problems).</LI>
</OL>
</OBJECTIVES>
<METHODS MODIFIED="2015-05-20 12:12:22 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2008-11-10 11:05:58 +0000" MODIFIED_BY="Nikki Jahnke">
<CRIT_STUDIES>
<P>Randomised controlled trials (RCTs) and quasi-randomised controlled trials, published or unpublished.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Children, aged between one year and 16 years, with any defined chronic disease i.e. a disease which requires medical intervention for a period of six months or more, or for the remainder of the person's lifetime. Children with malnutrition resulting from insufficient dietary intake without any causative disease, e.g. during famine, were excluded.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Protein calorie supplements administered orally, in any amount and given for a period of at least one month, compared with no intervention, routine nutritional advice or placebo. A period of at least one month has been selected as we are interested in the longer-term use of these products to improve nutritional status and growth. These products are sometimes provided in the short term to boost nutritional intake during a period when dietary intake is compromised, for example during an acute infection. Studies with an intervention period of less than one month will therefore be excluded. Oral protein calorie supplements provided as either whole protein milk or juice drinks were considered. Those which provide calories alone were not included.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-11-10 11:05:58 +0000" MODIFIED_BY="Nikki Jahnke">
<P>
<BR/>
</P>
<CRIT_OUTCOMES_PRIMARY MODIFIED="2008-11-10 11:05:58 +0000" MODIFIED_BY="Nikki Jahnke">
<OL>
<LI>Change in nutritional indices</LI>
<OL>
<LI>weight</LI>
<LI>height</LI>
<LI>body mass index</LI>
<LI>z score</LI>
<LI>other indices of nutrition (including blood biochemistry if appropriate) or growth, including anthropometric measures of body composition</LI>
</OL>
<LI>Calorie and nutritional intake from food measured by diet diary or weighed food intake daily, weekly or over some other time interval</LI>
<OL>
<LI>total energy intake</LI>
<LI>total fat intake</LI>
<LI>total protein intake</LI>
</OL>
<LI>Calorie and nutritional intake from oral protein calorie supplements measured by diet diary or weighed food intake daily, weekly or over some other time interval</LI>
<OL>
<LI>total energy intake</LI>
<LI>total fat intake</LI>
<LI>total protein intake</LI>
</OL>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2008-11-04 14:52:28 +0000" MODIFIED_BY="Nikki Jahnke">
<OL>
<LI>Measures of eating behaviour</LI>
<LI>Severity scores for individual chronic diseases (e.g. FEV<SUB>1</SUB>)</LI>
<LI>Measures of quality of life</LI>
<LI>Measures of compliance to dietary treatment</LI>
<LI>Adverse effects including diarrhoea, vomiting, reduced appetite and abdominal bloating. Other adverse effects, if reported, would also be examined</LI>
<LI>Number of deaths or age at death in each group</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2015-05-20 11:55:37 +0100" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2015-05-20 11:55:37 +0100" MODIFIED_BY="[Empty name]">
<P>Publications describing RCTs of the use of oral protein calorie supplements in children with chronic diseases were identified from the different trials registers held at the editorial base of the Cochrane Cystic Fibrosis and Genetic Disorders Group.</P>
<P>The search terms used to search this Register were:</P>
<P>CF: nutrition AND supplements AND (protein OR calorie supplements)  </P>
<P>HAEM &amp; COAG: (nutritional OR dietary) supplements</P>
<P>OTHERS: (diet* OR calorie* OR protein* OR nutrition*) AND supplement* (ti/abstr)</P>
<P>These registers are compiled from electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL) (updated each new issue of <I>The Cochrane Library</I>), weekly searches of MEDLINE, a search of Embase to 1995 and the prospective handsearching of two journals - <I>Pediatric Pulmonology</I> and the <I>Journal of Cystic Fibrosis</I>. Unpublished work is identified by searching through the abstract books of three major cystic fibrosis conferences:- the International Cystic Fibrosis Conference; the European Cystic Fibrosis Conference and the North American Cystic Fibrosis Conference. For full details of all searching activities for the register, please see the relevant sections of the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/CF/frame.html">Cystic Fibrosis and Genetic Disorders Group Module</A>. Date of the most recent search of the Group's trials registers: 24 February 2015.</P>
<P>Detailed computerised searches of MEDLINE from 1966 to October 2013 (using the search strategy described in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I>) and of the Cochrane Central Register of Controlled Trials (Issue 9 of 12 2013) were also undertaken for this review. For the full search strategies employed, please see the additional tables attached to this review (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>; <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>).</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2008-04-15 15:41:39 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Unpublished work was identified through the searching of the abstract books of the conferences of the European Society of Parenteral and Enteral Nutrition (ESPEN), 1983 to 1999, the American Society of Parenteral and Enteral Nutrition (ASPEN), 1983 and 1985 to 1999, and the British Association of Parenteral and Enteral Nutrition (BAPEN), 1995, 1997, 1998. Additional RCTs were identified from reference lists. The companies which manufacture oral protein calorie supplements were contacted to ask whether they have data on RCTs of oral protein calorie supplements for children with chronic diseases on file.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2015-05-20 12:12:22 +0100" MODIFIED_BY="[Empty name]">
<P>
<BR/>
</P>
<STUDY_SELECTION MODIFIED="2015-05-20 11:56:34 +0100" MODIFIED_BY="[Empty name]">
<P>For the original review and up until November 2008, the three authors (VP, RS and RW) independently selected the studies to be included in the review according to criteria set out above and ensured they obtained the full reports of these studies if they were published. As from the 2015 update, two authors (JS and DF) independently decided on which studies to include based on the pre-stated criteria. In both iterations the authors resolved any disagreements by discussion.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2015-05-20 11:57:43 +0100" MODIFIED_BY="[Empty name]">
<P>For the reviews up to 2009, two authors (VP and RS) independently extracted data and one author (VP) extracted and analysed the individual patient data from one study by calculating mean change from baseline with standard deviations (SDs) for relevant outcomes (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>); the authors used a standard data extraction form adapted to suit this review. From the 2015 update, two authors (JS and DF) carried out data extraction and management. The authors resolved any disagreements regarding extracted data or how it should be handled by discussion.</P>
<P>The authors grouped outcome data into those measured at one, three, six, 12 months and annually thereafter. If study investigators had recorded outcome data at other time periods, then the authors considered examining these as well.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2015-05-20 11:58:59 +0100" MODIFIED_BY="[Empty name]">
<P>The authors assessed the risk of bias (low, high or unclear) for each study using the 'Risk of bias' assessment tool as documented in chapter 8 of the <I>Cochrane Handbook for Systematic Reviews of Interventions </I>(<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). They considered the following items:</P>
<OL>
<LI>sequence generation;</LI>
<LI>allocation concealment;</LI>
<LI>blinding (or masking) of participants, personnel and outcome assessors;</LI>
<LI>incomplete outcome data;</LI>
<LI>selective outcome reporting;</LI>
<LI>other potential sources of bias.</LI>
</OL>
<P>Again, the authors resolved any differences by discussion.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2015-05-20 12:12:22 +0100" MODIFIED_BY="[Empty name]">
<P>For binary outcome measures, the authors calculated a pooled estimate of the treatment effect for each outcome across studies using the Peto odds ratio (OR) (the odds of an outcome among treatment allocated participants to the corresponding odds among controls).</P>
<P>For continuous outcomes, the authors recorded either the mean change from baseline for each group or the mean post-treatment or intervention values and SD or standard error for each group. They also calculated a pooled estimate of treatment effect by calculating the mean difference (MD). If trial reports had presented standard errors instead of SDs, the authors planned to convert these to SDs in order to enter data into RevMan (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>).</P>
<P>For all outcome measures the authors also reported the relevant 95% confidence intervals (CIs).</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2015-05-20 12:00:55 +0100" MODIFIED_BY="[Empty name]">
<P>If the authors include any cross-over studies in a future update, ideally they will combine the results in a meta-analysis using the inverse variance methods that are recommended by Elbourne (<LINK REF="REF-Elbourne-2002" TYPE="REFERENCE">Elbourne 2002</LINK>). If there are restrictions on the data available on the included trials, they will either use first-arm data only or treat the cross-over study as if it was a parallel study (assuming a correlation of zero as the most conservative estimate). Elbourne says that this approach produces conservative results as it does not take into account within-patient correlation (<LINK REF="REF-Elbourne-2002" TYPE="REFERENCE">Elbourne 2002</LINK>). Also each participant appears in both the treatment and control group, so the two groups are not independent. In order to combine these results with the data entered from already included parallel studies, the authors will use the methods recommended by Curtin (<LINK REF="REF-Curtin-2002a" TYPE="REFERENCE">Curtin 2002a</LINK>; <LINK REF="REF-Curtin-2002b" TYPE="REFERENCE">Curtin 2002b</LINK>; <LINK REF="REF-Curtin-2002c" TYPE="REFERENCE">Curtin 2002c</LINK>).</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2011-11-10 14:23:58 +0000" MODIFIED_BY="Nikki Jahnke">
<P>The authors planned to seek data on the number of participants with each outcome event, irrespective of compliance and whether or not the participant was later thought to be ineligible or otherwise excluded from treatment or follow up. Where outcome data or details of the study methodology were missing from the papers, the authors contacted the primary investigators for further details. If the primary investigators had not responded, the authors had planned to contact the co-investigators.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2015-05-20 12:01:19 +0100" MODIFIED_BY="[Empty name]">
<P>Heterogeneity was tested using a standard Chi<SUP>2</SUP> test, to assess whether observed differences in results are compatible with chance alone. The authors used the I<SUP>2</SUP> test was used to assess the impact of heterogeneity on the meta-analysis. It shows the percentage of variability in effect estimates that are due to heterogeneity rather than to chance. Values over 50% indicate a high level of heterogeneity (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<P>If a high level of heterogeneity existed, the authors planned to discuss this narratively.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2015-01-14 11:38:40 +0000" MODIFIED_BY="Nikki Jahnke">
<P>In this update, it was the authors intention to investigate publication bias through use of the funnel plot. However, the review did not include the minimum number of studies (n = 10) for any analysis. Furthermore, while funnel plot asymmetry may indicate publication bias, this is not inevitably the case (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>). This issue will be considered for a future version of this review provided there is a sufficient number of included studies.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2015-05-20 12:01:43 +0100" MODIFIED_BY="[Empty name]">
<P>The authors have presented data using MDs and 95% CIs at the pre-specified time-points. They have used a fixed-effect model for the majority of the analyses; however, they analysed data on change in total dietary fat intake using a random-effects model due to evidence of significant heterogeneity. If the authors are able to add further trials to the meta-analysis in the future and there is significant heterogeneity between studies, they will use a random-effects model.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2011-11-10 14:28:03 +0000" MODIFIED_BY="Nikki Jahnke">
<P>To investigate any heterogeneity, if the authors identify sufficient studies (at least four), they plan to perform subgroup analyses stratifying according to type of control group(s) used, age and severity of nutritional status, disease type and type of supplement.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2014-11-04 22:20:28 +0000" MODIFIED_BY="[Empty name]">
<P>If, in future, the authors are able to include sufficient studies (at least four) in the review and combine these in a meta-analysis; they will test the robustness of their results with a sensitivity analysis based on the risk of bias in the studies from randomisation (e.g. randomised controlled trials compared to quasi-randomised controlled trials).</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2015-05-20 12:16:04 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2015-05-20 12:13:35 +0100" MODIFIED_BY="[Empty name]">
<P>The included studies are described below. </P>
<SEARCH_RESULTS MODIFIED="2015-05-20 12:02:42 +0100" MODIFIED_BY="[Empty name]">
<P>The original search identified 2105 titles of publications associated with nutrition. From the titles, studies which clearly did not include either children or a nutritional intervention were excluded, leaving 130 publications for which the abstracts were obtained. Two authors then independently selected 39 papers referring to 28 studies, for which the full reports were obtained. These publications were independently checked by both authors to assess eligibility for inclusion in the review. All these references to studies can be obtained from the former lead reviewer (VP).</P>
<P>The same process has been repeated for the additional studies identified in the searches carried out for the annual updates of this review. For the 2015 update of this review, 4891 titles of publication were reviewed (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>) Titles for studies which did not meet the inclusion criteria (children, nutritional intervention) were excluded, as a result 58 abstracts were obtained for further review. Two authors then independently reviewed these abstracts and identified only two studies as needing to obtain full papers.</P>
<P>For the 2015 update, three new studies were identified in the searches which are now listed in the review (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>; <LINK REF="STD-Botr_x00e1_n-2011" TYPE="STUDY">Botrán 2011</LINK>; <LINK REF="STD-Cox-2014" TYPE="STUDY">Cox 2014</LINK>). One of these has been included in the updated review (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>) and one has been excluded with reasons (<LINK REF="STD-Botr_x00e1_n-2011" TYPE="STUDY">Botrán 2011</LINK>). The third new study is still ongoing and the authors have been contacted to ascertain when the published data will be available (<LINK REF="STD-Cox-2014" TYPE="STUDY">Cox 2014</LINK>). Also, one reference that was previously listed as 'Awaiting classification' has now been included under the main study ID with confirmation of the paediatric data from the authors (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>). Five further studies that were previously listed as 'Awaiting classification' have now been excluded (<LINK REF="STD-Jain-2006" TYPE="STUDY">Jain 2006</LINK>; <LINK REF="STD-Johnson-2006" TYPE="STUDY">Johnson 2006</LINK>; <LINK REF="STD-Nielson-2007" TYPE="STUDY">Nielson 2007</LINK>; <LINK REF="STD-Powers-2006" TYPE="STUDY">Powers 2006</LINK>; <LINK REF="STD-Rollins-2007" TYPE="STUDY">Rollins 2007</LINK>). One study that was previously listed as 'Awaiting classification' has been identified as part of an already excluded study (<LINK REF="STD-Rickard-1989" TYPE="STUDY">Rickard 1989</LINK>).</P>
<P>There are currently a total of 106 studies excluded from the review.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2015-05-20 12:10:21 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Study Design</HEADING>
<P>Four studies of parallel design fulfilled the criteria for inclusion in this review (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>; <LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>; <LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). The study by Hanning, which was an explanatory study, aimed to investigate the relationship between nutritional status and skeletal muscle strength (<LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>). Three studies were single centre (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>; <LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>; <LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>) and one was multicentre (<LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). Two studies were conducted in Canada (<LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>; <LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>), one in the UK (the 'CALICO' trial) (<LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>) and one in Turkey (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>). One study explicitly stated an open-label design (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>); however, the remaining three studies compared a supplement to dietary advice alone, so the participants could not be blinded (<LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>; <LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). The duration of the trials ranged from three months (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>) to 12 months (<LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Participants</HEADING>
<P>Three studies were in children with cystic fibrosis (<LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>; <LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>); one study included children with paediatric malignant disease (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>). The four studies included a total of 187 participants (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>; <LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>; <LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). The number of participants in each study ranged from 13 (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>) to 126 (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>). In the Hanning study, the treatment group appeared to be in better clinical condition at baseline (<LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>). Three of the studies included only children (<LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>; <LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>) and one study included both children and adults - for this study, we obtained the individual patient data on those participants who were 16 years or less at the start of the study from the authors (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Interventions</HEADING>
<P>All four studies compared oral protein calorie supplements in addition to a normal diet to a control group. Three of these specified that the supplements were in the form of drinks (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK> <LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>) and one used drink powders, milk shakes or tinned puddings (<LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>). Two studies used dietary counselling in the control group (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>) and two did not have any additional intervention in the control group (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>; <LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>). One study included follow up of intervention group by a nurse specialized in nutrition to check whether supplement was taken regularly (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Outcomes</HEADING>
<P>The Bayram study included relevant primary and secondary outcomes for inclusion in the review, including loss in body weight, body mass index (BMI) and negative deviation from normal weight percentile; however, the authors only reported on percentage change of each outcome comparing treatment and control groups (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>). All efforts made by the review authors to obtain individual patient data or reanalyzed results were unsuccessful.</P>
<P>The Hanning study examined a number of outcome measures relevant to the review (<LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>). Mean change in weight from baseline for treatment and comparison groups was recorded, but results for all other outcomes were expressed as mean post-treatment values. Since the groups were not similar at baseline, we have not included these results. We have attempted, as yet unsuccessfully, to obtain further information from the authors.</P>
<P>The Kalnins study did not report the results as mean change from baseline. From the individual patient data provided by the authors, we have calculated the mean change in weight, height, BMI, with z scores and percentiles, and mean change in percentage ideal weight for height (% WFH), nutritional intake and forced expiratory volume at one second (FEV<SUB>1</SUB>) (% predicted) from baseline (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>).</P>
<P>Poustie reported on nutritional parameters, energy and macronutrient intake, lung function, eating behaviour and activity levels (<LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>).</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2015-05-20 12:13:35 +0100" MODIFIED_BY="[Empty name]">
<P>In summary, a total of 106 studies were excluded from the review. Of these, the authors identified 69 studies which were not of oral protein calorie supplements, 19 studies were not of RCT design, 10 were not in children with chronic diseases, three of the studies were of short intervention duration and five were not within a specified age range.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2015-05-20 12:10:56 +0100" MODIFIED_BY="[Empty name]">
<ALLOCATION MODIFIED="2015-03-12 14:19:58 +0000" MODIFIED_BY="Nikki Jahnke">
<SUBSECTION>
<HEADING LEVEL="4">Generation of sequence</HEADING>
<P>Generation of allocation sequence was assessed as having a high risk of bias in one study, which was described as randomised in the published manuscript, but no details of this were provided to appraise the generation of allocation sequence (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>). We have since been informed by the author of the published manuscript that although generation of allocation sequence was adequate for the first participant, alternation was used for subsequent participants. The study was therefore assessed as being at high risk of bias.</P>
<P>The Bayram study was judged to have an unclear risk of bias as it was reported that the participants were consecutively selected but no further details provided as to how this consecutive sequence was generated (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>).</P>
<P>Generation of the allocation sequence was assessed as having a low risk of bias in the remaining two studies (<LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). In these studies the allocation sequence was determined by random number tables (<LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). However, in one of the studies, the treated group appeared to be in better clinical condition at baseline (<LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>). To overcome this, we decided not to include any of the data from outcomes which were expressed as mean post-treatment values in the analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Allocation concealment</HEADING>
<P>Concealment of allocation was assessed as having a high risk of bias in two studies (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>; <LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>). The Bayram study was an open-label design and therefore did not maintain concealment of allocation. The Kalnins study provided no details of the concealment of the allocation sequence. We have since been informed by the author of the published manuscript that although generation of allocation sequence was adequate for the first participant, alternation was used for subsequent participants. The person undertaking the randomisation was not blinded to the sequence of allocation.</P>
<P>Concealment of allocation was assessed as having a low risk of bias in the other two studies (<LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). In these studies allocation concealment was achieved using sealed envelopes (<LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>).</P>
</SUBSECTION>
</ALLOCATION>
<BLINDING MODIFIED="2015-02-17 14:13:00 +0000" MODIFIED_BY="Nikki Jahnke">
<P>In none of the studies were the participants able to be blinded to the treatment: one study compared supplements to counselling (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>); two studies compared dietary supplements to no supplements (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>; <LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>); and the final study states that participants were not blinded as there was no satisfactory placebo available (<LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). With regards to the study investigators, in the Poustie study the research assistant was not masked to allocation group; however, a masked investigator used a computerised growth package when converting weight and height to body mass index centile (<LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). One study comparing supplements to counselling stated investigators were blinded to treatment allocation (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>).</P>
<P>We classified all four studies as being at low risk of bias despite different levels of blinding as blinding was not deemed to interfere with the outcomes assessed in the studies.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2015-03-12 14:22:59 +0000" MODIFIED_BY="Nikki Jahnke">
<P>Intention-to-treat analysis was not described in one study where four out of 20 participants were lost to follow up (the time demands for testing or the travelling distance were found to be excessive).and no final data were collected (<LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>). Although intention-to-treat analysis was not directly mentioned in the trial publication for two of the studies, the data show that none of the children were lost to follow up and that the number of participants randomised to each group was the same at the start and at the end of the study (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>; <LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>). Statistical analysis of the CALICO Trial was by intention to treat, and no participants were lost to follow up (<LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). We consider the risk of bias for all four studies to be low.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2015-05-20 12:10:56 +0100" MODIFIED_BY="[Empty name]">
<P>All four studies appear to report on all the outcome measures they state they have taken in the 'Methods' section of their individual papers (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>; <LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>; <LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). In three of the studies, we were unable to compare the published study reports with the original study protocols to identify if any planned outcome measures are not reported in the full papers (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>; <LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>; <LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>); however, Dr Kalnins has confirmed that all outcomes measured in the trial were reported. In the CALICO Trial, a number of secondary outcome measures were assessed but not recorded in the key trial publication (<LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). These were assessment of eating behaviour, activity levels and lipase intake. The authors have confirmed that this was due to the poor quality of the available data on these outcomes which precluded the reporting of these data. Tricep skin-fold measurement and mid-upper arm circumference were assessed, but not reported, but were used to calculate mid-arm muscle circumference which was reported. Where possible, data on these outcomes have been provided by the authors and included in this review. We consider the risk of bias for all four studies to be low (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>; <LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>; <LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>).</P>
</SELECTIVE_REPORTING>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2015-05-20 12:16:04 +0100" MODIFIED_BY="[Empty name]">
<P>It should be noted that for studies with such small numbers, it may not be appropriate to use the Review Manager software to analyse the data due to the high variability associated with such small numbers (<LINK REF="REF-RevMan-2014" TYPE="REFERENCE">RevMan 2014</LINK>). As such, caution should be given to significant results from these findings.</P>
<SUBSECTION>
<HEADING LEVEL="3">Primary Outcomes</HEADING>
<P>We have listed the outcomes for which we have data to report. Summary statistics for significant results only are provided here.</P>
<SUBSECTION>
<HEADING LEVEL="4">1. Change nutritional indices</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">a. Weight</HEADING>
<P>Three studies reported change in weight (kg) (<LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>; <LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>) (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>) and two studies reported change in weight (z score) (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>) (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). Two studies reported change in weight percentile, but as this measure represents the same information as z score but uses different units, and as z score is more commonly used internationally, data on percentile have not been presented (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). Additionally, the Bayram study reported the proportion of participants with weight loss, which was significantly higher among the usual dietary intake group compared to the treatment group at six months (P = 0.03) (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>). This was the only study to report a significant difference between the treatment and control arms for this outcome, and did not supply data we were able to analyse.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">b. Height</HEADING>
<P>Two studies reported both change in height (cm) and change in height (z score) (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). One study reported change in percentile, but as this measure represents the same information as z score but uses different units, and as z score is more commonly used internationally, data on percentile have not been presented (<LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). No significant differences between the treatment and control arms were identified for this outcome (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>; <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">c. BMI</HEADING>
<P>Two studies reported change in BMI and change in BMI z score or percentile, or both (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). Bayram reported a significantly higher loss in BMI among the usual dietary intake group compared to the treatment group at three months (P = 0.002), but again did not provide data we could analyse (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>). For the Poutsie study, no significant difference between the treatment and control arms were identified for this outcome (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>; <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>).</P>
<P>
<B>e. Mid-arm muscle circumference</B>
</P>
<P>One study reported on mid-arm muscle circumference (calculated from mid-upper arm circumference and tricep skin-fold measurements) (<LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). No significant difference between the treatment and control arms were identified for this outcome (<LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Calorie and nutritional intake from food</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">a. Total energy intake</HEADING>
<P>Two studies reported on total energy intake (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). A significant difference in mean total energy intake at six months, MD 304.86 kcal/day (95% confidence interval (CI) 5.62 to 604.10) and at 12 months, MD 265.70 kcal/day (95% CI 42.94 to 485.46) was found to favour the treatment group (<LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>). However, the data for these outcomes came from only one study (<LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">b. Total fat intake</HEADING>
<P>Two studies reported on total fat intake (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). No significant difference between the treatment and control arms were identified for this outcome (<LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">c. Total protein intake</HEADING>
<P>Two studies reported on total protein intake (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). No significant difference between the treatment and control arms were identified for this outcome (<LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Secondary Outcomes</HEADING>
<P>Data were reported for just two of these outcomes.</P>
<SUBSECTION>
<HEADING LEVEL="4">2. Severity scores for individual chronic diseases</HEADING>
<P>We have decided to use lung function data to indicate disease severity in the studies including children with cystic fibrosis. Three studies reported lung function data: Hanning and Kalnins reported absolute forced expiratory volume at one second (FEV<SUB>1</SUB>) % predicted (<LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>; <LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>); and the CALICO study reported change in FEV<SUB>1</SUB> % predicted and change in forced vital capacity (FVC) % predicted (<LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). No significant difference between the treatment and control arms were identified for this outcome apart from change in FEV<SUB>1</SUB> % predicted at three months in one study with 69 participants, MD -7.92 (95% -13.89 to -1.95) (<LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>) (<LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>).</P>
<P>In the study by Bayram, the remission rates were significantly lower in the usual dietary care group compared to the treatment group (P = 0.036) (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>). There were no significant differences between the usual dietary care group and the treatment group in the distribution of the febrile neutropenia attacks when assessing both the frequency and the per cent of participants who suffer these attacks (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5. Adverse effects</HEADING>
<P>One study reported a gastrointestinal symptom score (<LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). No significant difference between the treatment and control arms were identified for this outcome (<LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>). Poustie also reported that there was no significant difference between the treatment and control arms for headache, OR 0.30 (95% CI 0.04 to 2.58) (<LINK REF="CMP-001.14" TYPE="ANALYSIS">Analysis 1.14</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2015-05-20 13:03:12 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2015-05-20 12:23:46 +0100" MODIFIED_BY="[Empty name]">
<P>The 2015 updated version of this review screened 4883 studies (abstract and titles) of which just one was included (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>); one is still ongoing and may be included in a future update (<LINK REF="STD-Cox-2014" TYPE="STUDY">Cox 2014</LINK>). Overall four studies with 187 participants in total and ranging in date from 1996 to 2009, are currently included in this review (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>; <LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>; <LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). The main outcomes of interest are summarized below. One study was not included in any of the meta-analyses as the primary outcomes were reported in dissimilar units to the other studies (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="3">Change in weight</HEADING>
<P>Three studies reported on change in weight (kg) (<LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>; <LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>); combined data from all threes studies at six months showed a mean difference in weight of 0.42 kg in the supplemented group compared to the control group, but this was not significant (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>).</P>
<P>Only two studies reported change in weight z score at six months and they found no significant difference in scores between the supplemented group and the control group (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). Although the data from Bayram were not included in the meta-analyses, the study reported that overall, loss in body weight was 6.1% in the supplemented group compared to 47.4% in the control group. Similarly, negative deviation in weight percentile was significantly lower in the supplemented group compared to the control group (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Change in height </HEADING>
<P>Change in height (cm) was reported by two studies at three months (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>) and six months (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>) and by just one study at 12 months (<LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). There was no significant difference in change in height between the supplemented group and the control group at any time-point (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>).</P>
<P>The same two studies reported mean difference in height z score at six months (109 participants); there was no significant difference in the mean change between groups, though the effect estimate favoured the usual diet group (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Change in body mass index (BMI)</HEADING>
<P>Similarly, two studies reported analysable data on the mean difference for the change in BMI at six months (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>); the analysis showed no significant difference between the supplemented and usual diet group (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>). The Bayram study reported that the loss in BMI was 12.1% in the supplemented group and 52.6% in the control group (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>).</P>
<P>Analysable data for the change in BMI z score was also reported by the same two studies at three months (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). They reported that there was no significant difference in the change in BMI z score between the supplemented and control group (<LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>).</P>
</SUBSECTION>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2015-05-20 13:03:12 +0100" MODIFIED_BY="[Empty name]">
<P>Oral protein calorie supplements are widely used in an attempt to improve nutritional status in people with a number of chronic diseases, at some considerable cost. It is therefore concerning that their effectiveness has been assessed by adequate clinical trials in very few chronic diseases of childhood .</P>
<P>In this review, just two chronic diseases were addressed in four clinical trials, which highlights the paucity of evidence for rigorous clinical trials addressing appropriate nutritional interventions for children with chronic diseases. The chronic diseases addressed in the trials included cystic fibrosis (<LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>; <LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>) and paediatric malignant disease (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>).</P>
<P>There is a link between cystic fibrosis and nutritional status and the role of nutritional management has long been recognized (<LINK REF="REF-Corey-1988" TYPE="REFERENCE">Corey 1988</LINK>). Meeting the demand of increased caloric needs in children with cystic fibrosis and cancer may be important in alleviating the increased malnutrition seen in children suffering from these diseases (<LINK REF="REF-Florescu-2014" TYPE="REFERENCE">Florescu 2014</LINK>). From its comprehensive search of the literature, this review included an explanatory study which aimed to assess the effect of supplementation on skeletal muscle strength, rather than clinical outcomes, although these were also addressed (<LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>). Two other studies were pragmatic in approach to mimic the clinical practice setting (<LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). In the 2015 update of this review, only one additional study was included in the synthesis which addressed the potential role of oral protein and energy dense supplements in cancer-related weight loss in children (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>). The interventions differed between studies. In the study by Hanning, the participants in the treatment group appear to have been in better clinical condition than the control group, despite the employment of adequate randomisation methods. This is in contrast to the other studies in which both treatment and control groups were similar at baseline. It would appear, that over the last decade there have been few studies addressing the objectives of the review and fitting the inclusion criteria. Furthermore, other potentially eligible studies were run in an older age group and or focused on metabolic outcomes (such as nitrogen balance) as oppose to clinical endpoints (<LINK REF="STD-Botr_x00e1_n-2011" TYPE="STUDY">Botrán 2011</LINK>; <LINK REF="STD-Rollins-2007" TYPE="STUDY">Rollins 2007</LINK>).</P>
<P>No studies were identified in any other conditions (e.g. cholestatic liver disease) for which oral protein calorie supplements are routinely prescribed. The CALICO study resulted from the previous publication of the Cochrane review 'Oral calorie supplements for cystic fibrosis' (<LINK REF="REF-Smyth-2014" TYPE="REFERENCE">Smyth 2014</LINK>). The search identified many large studies of protein and calorie supplementation for children in the developing world who are malnourished as a result of persistently low nutritional intakes. However, it would not be appropriate to extrapolate data from these studies to children in whom nutritional status is compromised as a consequence of their chronic disease. Although, knowledge of the methods used in these studies may be useful for those planning to investigate supplementation in children with chronic disease.</P>
<P>For reasons of heterogeneity (diversity of outcome measures) only three studies were included in the meta-analyses (<LINK REF="STD-Hanning-1993" TYPE="STUDY">Hanning 1993</LINK>; <LINK REF="STD-Kalnins-1996" TYPE="STUDY">Kalnins 1996</LINK>; <LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). Analyses showed no significant effect of oral protein supplementation on weight or height change in children with cystic fibrosis. These studies ranged from three months to one year of follow up. Disease severity remained unchanged but there were moderate increases in nutrient intake in those receiving oral protein calorie supplements. In contrast, the study among children with paediatric malignancies found oral protein supplements to be effective in preventing weight loss and negative deviation in weight percentiles (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>). The relative inefficacy of oral protein supplements on the reported outcomes in cystic fibrosis may be related to clinical concomitant complications of this chronic disease and methodological issues of the trials. The complex nature of cystic fibrosis affects multiple organs and especially the nutritional status of individuals through the gastrointestinal tract, which usually results in malnutrition as disease progression worsens. The mechanism of the intervention may have been affected by gastrointestinal complications such as diarrhoea, increased metabolic rate, vomiting, fever, and other underlying nutrient deficiencies as a result of malnourished status.</P>
<P>This raises the question of whether prevention of weight loss or correcting nutrient deficiencies related to growth would have been a more sensitive measure of the efficacy of oral protein calorie supplements. Also, none of the studies reported on the appropriateness of the supplements in terms of palatability. None of the three studies of children with cystic fibrosis measured compliance of consumption, but the study in paediatric malignancies reported having a specialised nurse check whether supplements were taken regularly (<LINK REF="STD-Bayram-2009" TYPE="STUDY">Bayram 2009</LINK>).</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2015-05-20 12:24:30 +0100" MODIFIED_BY="[Empty name]">
<P>There were very few published studies that examined the effect of oral protein calorie supplementation on growth in children between one and 16 years of age with chronic diseases. The four included studies only addressed two chronic diseases, malignant disease and cystic fibrosis, highlighting a current gap in the research evidence. The evidence covered in this review marks a slow but important area of work being investigated.</P>
<P>Judgements on the quality of the evidence for the change in weight and height was assessed to be moderate (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>). Three randomised controlled trials (RCTs) (125 participants) assessed the change in weight and overall there was a greater weight change in the intervention groups as compared to the control groups. The quality of the evidence for this outcome was moderate, due to the number of studies included and the number of participants who were involved in these studies. For the change in height, two RCTs (109 participants) were assessed and, based on these results, those participants in the intervention group were shorter than those in the control arms. The quality of evidence for this outcome was also moderate due to the number of studies and participants included. For the outcome measure of BMI, only BMI z score was reported in two RCTs (109 participants). Those participants in the intervention group had a higher BMI than those in the control groups; however, the quality of evidence for this outcome was moderate due to the number of studies included and the number of participants assessed.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2015-05-20 12:58:42 +0100" MODIFIED_BY="[Empty name]">
<P>In order to reduce bias careful attention was paid to standard systematic review methodology. For example, at least two review authors were involved in every aspect of identifying potential studies, deciding on inclusion and exclusion of studies, extracting data, and conducting analyses. However, a few potential sources of bias may remain.</P>
<SUBSECTION>
<HEADING LEVEL="3">Publication bias</HEADING>
<P>A comprehensive search of both published and unpublished sources were undertaken to find relevant studies, including making contact with companies which manufacture oral protein calorie supplements for data on RCTs of these products for children with chronic diseases which they might have had on file. It is, however, still possible that some studies were missed. Furthermore, handsearching of relevant journals was also carried out. We attempted to obtain individual patient data from one study, but were unsuccessful.</P>
<P>Due to the fact that this is an update of a previously conducted review, any potential bias (if it exists) included in the initial review such as screening or selection of included studies could not have been corrected.</P>
<P>The original review was only able to access the study protocol for just one study in order to completely assess the risk of bias of included studies (<LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>). However, from the reported available publications risk of bias was assessed as appropriate for all four studies (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).</P>
</SUBSECTION>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2015-01-15 10:32:02 +0000" MODIFIED_BY="Nikki Jahnke">
<P>There are very few studies addressing the efficacy of oral protein calorie supplements in children with chronic diseases and we found no existing review with which to compare our findings.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2015-01-15 10:33:41 +0000" MODIFIED_BY="Nikki Jahnke">
<IMPLICATIONS_PRACTICE MODIFIED="2015-01-15 10:33:41 +0000" MODIFIED_BY="Nikki Jahnke">
<P>There is still insufficient rigorous evidence on which to base concrete conclusions about the use of oral protein calorie supplements in children with chronic diseases. This does not mean that these products may or may not be efficacious and clinicians must balance potential benefits against possible adverse effects of treatment in making decisions about individual children with chronic disease. A series of large clinical trials to evaluate the effectiveness of this intervention in the different disease areas where these products are commonly used, is urgently needed (see below). Therefore, we would urge caution in their use until this information is available and also since using oral protein calorie supplements in children now may exclude them from participation in a future RCT. The CALICO study of oral protein calorie supplements for children with cystic fibrosis was sufficiently powered to identify a significant effect of this intervention in this population, if one existed. The results of this study have shown that when children with sub-optimal nutrition receive regular dietary advice, their nutritional status is similar whether or not they have supplements. However, this finding can not be extrapolated to the use of these products in children with other chronic diseases.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2008-09-12 16:48:09 +0100" MODIFIED_BY="[Empty name]">
<P>This systematic review has clearly identified the need for a series of well-designed, adequately-powered, multicentre RCTs assessing the effectiveness and possible adverse effects of the use of oral protein calorie supplements for children with chronic disease. A number of studies would be required to assess the effectiveness of these products in children with diseases associated with growth and poor nutritional status which lead to the prescription of these products. The CALICO study has contributed important information on the use of these products for children with cystic fibrosis but further research is required in other chronic diseases of childhood. The CALICO trial would be a useful model upon which such studies could be based.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2014-11-04 22:20:40 +0000" MODIFIED_BY="[Empty name]">
<P>We would like to thank Professor Berthold Koletzko, University of Munich, Germany, for agreeing to provide us with additional data from his study once the report has been accepted for publication, and Daina Kalnins for providing us with the individual patient data from her study.</P>
<P>The new author team (DKF, TS, JS, RW) would like to thank Professor Rosalind Smyth and Dr Vanessa Poustie for their previous input into this review as detailed below.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2015-05-21 10:26:33 +0100" MODIFIED_BY="Nikki Jahnke">
<SUBSECTION>
<HEADING LEVEL="2">Original review and updates to 2009</HEADING>
<P>Two of the authors are dietitians (VP, RW) who have received travel expenses to attend conferences from the manufacturers of oral protein calorie supplements.</P>
<P>All three of the authors of this review were involved in the CALICO trial (<LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Subsequent updates</HEADING>
<P>Ruth Watling is a dietitian who has received sponsorship to attend meetings and conferences and honorarium to present lectures at conferences and study days from companies who produce oral protein calorie supplements. She declares that this does not influence the use of such products in her clinical practice where the clinical condition, age and nutritional status of the child in conjunction with the scientific evidence is paramount to her decision making. Ruth Watling was also involved in the CALICO trial (<LINK REF="STD-Poustie-2006" TYPE="STUDY">Poustie 2006</LINK>).</P>
<P>The remaining authors declare no conflict of interest.<BR/>
</P>
</SUBSECTION>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2015-05-20 13:00:05 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="2">Original review and updates to 2009</HEADING>
<P>Vanessa Poustie, Ruth Watling and Rosalind Smyth wrote the protocol, independently assessed studies for inclusion in this review and extracted the data. Vanessa Poustie and Rosalind Smyth wrote the remainder of the text.</P>
<P>Vanessa Poustie wrote the updates with comments from Rosalind Smyth and Ruth Watling and she acted as guarantor of the review.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Subsequent updates</HEADING>
<P>Damian Francis and Joanne Smith wrote the updates with comments from Ruth Watling. Joanne Smith acts as guarantor of the review.</P>
</SUBSECTION>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES MODIFIED="2015-05-20 13:04:10 +0100" MODIFIED_BY="[Empty name]">
<P>Please refer to 'Oral calorie supplements for cystic fibrosis' Cochrane review, which assesses the effectiveness of this intervention for children and adults with cystic fibrosis (<LINK REF="REF-Smyth-2014" TYPE="REFERENCE">Smyth 2014</LINK>).</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2017-06-29 10:31:10 +0100" MODIFIED_BY="Nikki Jahnke">
<STUDIES MODIFIED="2015-03-09 18:10:35 +0000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2015-01-14 12:03:02 +0000" MODIFIED_BY="Nikki Jahnke">
<STUDY DATA_SOURCE="PUB" ID="STD-Bayram-2009" MODIFIED="2015-01-14 12:03:02 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Bayram 2009" YEAR="2009">
<REFERENCE MODIFIED="2015-01-14 12:03:02 +0000" MODIFIED_BY="Nikki Jahnke" NOTES="&lt;p&gt;Journal Article; Randomized Controlled Trial&lt;/p&gt;" NOTES_MODIFIED="2015-01-14 12:03:02 +0000" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bayram I, Erbey F, Celik N, Nelson J L, Tanyeli A</AU>
<TI>The use of a protein and energy dense eicosapentaenoic acid containing supplement for malignancy-related weight loss in children</TI>
<SO>Pediatric Blood &amp; Cancer</SO>
<YR>2009</YR>
<VL>52</VL>
<NO>5</NO>
<PG>571-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621015"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621014"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hanning-1993" NAME="Hanning 1993" YEAR="1993">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hanning RM, Blimkie CJ, Bar-Or O, Lands LC, Moss LA, Wilson WM</AU>
<TI>Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1993</YR>
<VL>57</VL>
<NO>4</NO>
<PG>580-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621017"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lands LC, Heigenhauser GJF, Bar-Or O, Blimkie C, Hanning R, Wilson WM, et al</AU>
<TI>The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF)</TI>
<SO>American Review of Respiratory Disease</SO>
<YR>1992</YR>
<VL>145</VL>
<PG>115</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621018"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621016"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kalnins-1996" MODIFIED="2010-08-09 15:22:34 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Kalnins 1996" YEAR="1996">
<REFERENCE MODIFIED="2010-08-09 15:22:34 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kalnins D, Corey M, Ellis L, Pencharz PB, Tullis E, Durie PR</AU>
<TI>Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis</TI>
<SO>Journal of Pediatrics</SO>
<YR>2005</YR>
<VL>147</VL>
<NO>3</NO>
<PG>399-401</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621020"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kalnins D, Durie PR, Corey M, Ellis L, Pencharz P, Tullis E</AU>
<TI>Are oral dietary supplements effective in the nutritional management of adolescents and adults with cystic fibrosis</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1996</YR>
<VL>Suppl 11</VL>
<PG>314-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621021"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kalnins D, Durie PR</AU>
<TI>Oral supplements vs normal food intake in children and adults</TI>
<SO>Israel Journal of Medical Science</SO>
<YR>1996</YR>
<VL>32</VL>
<PG>S120-1</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621022"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621019"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Poustie-2006" NAME="Poustie 2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Poustie VJ, Russell JE, Watling RM, Ashby D, Smyth RL</AU>
<TI>Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis</TI>
<SO>Journal of cystic fibrosis</SO>
<YR>2004</YR>
<VL>3</VL>
<NO>Suppl 1</NO>
<PG>S79</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621024"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Poustie VJ, Russell JE, Watling RM, Ashby D, Smyth RL</AU>
<TI>Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial</TI>
<SO>BMJ</SO>
<YR>2006</YR>
<VL>332</VL>
<NO>7542</NO>
<PG>632-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621025"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Poustie VJ, Russell JE, Watling RM, Ashby D, Smyth RL</AU>
<TI>Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis</TI>
<SO>Journal of cystic fibrosis</SO>
<YR>2004</YR>
<VL>3</VL>
<NO>Suppl 1</NO>
<PG>S76</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621026"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Poustie VJ, Russell JE, Watling RM, Ashby D, Smyth RS</AU>
<TI>The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2004</YR>
<VL>38</VL>
<NO>Suppl 27</NO>
<PG>333</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621027"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621023"/></IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2015-02-03 20:34:53 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Abdulhamid-2008" MODIFIED="2015-01-15 10:42:51 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Abdulhamid 2008" YEAR="2008">
<REFERENCE MODIFIED="2008-04-16 10:18:48 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Abdulhamid I, Beck FW, Millard S, Chen X, Prasad A</AU>
<TI>Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2008</YR>
<VL>43</VL>
<NO>3</NO>
<PG>281-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621029"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-01-15 10:42:51 +0000" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abdulhamid I, Millard S, Beck F, Chen X, Van Wagnen C, Prasad A</AU>
<TI>Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2005</YR>
<VL>40</VL>
<NO>Suppl 28</NO>
<PG>348</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621030"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621028"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Agtmaal-1990" MODIFIED="2008-11-11 11:41:46 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Agtmaal 1990" YEAR="1990">
<REFERENCE MODIFIED="2008-11-11 11:41:46 +0000" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Agtmaal VE, Egger RJ, Bloem MW</AU>
<TI>Effects of nutritional supplementation on the protein composition of tear fluid of marginally nourished preschool children</TI>
<SO>Documenta Ophthalmologica</SO>
<YR>1990</YR>
<VL>76</VL>
<PG>178</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621032"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621031"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Akobeng-2000" NAME="Akobeng 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Akobeng AK, Miller V, Stanton J, Elbadri AM, Thomas AG</AU>
<TI>Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease</TI>
<SO>Journal of Pediatric Gastroenterology and Nutrition</SO>
<YR>2000</YR>
<VL>30</VL>
<NO>1</NO>
<PG>78-84</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621034"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621033"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Akobeng-2007" MODIFIED="2008-09-17 20:13:11 +0100" MODIFIED_BY="[Empty name]" NAME="Akobeng 2007" YEAR="2007">
<REFERENCE MODIFIED="2008-09-17 20:13:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Akobeng AK, Richmond K, Miller V, Thomas AG</AU>
<TI>Effect of exclusive enteral nutritional treatment on plasma antioxidant concentrations in childhood Crohn's disease</TI>
<SO>Clinical Nutrition</SO>
<YR>2007</YR>
<VL>26</VL>
<NO>1</NO>
<PG>51-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621036"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621035"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Alexander-1980" MODIFIED="2008-11-11 11:42:00 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Alexander 1980" YEAR="1980">
<REFERENCE MODIFIED="2008-11-11 11:42:00 +0000" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alexander JW, MacMillan BG, Stinnett JD, Ogle CK, Bozian RC, Fischer JE, et al</AU>
<TI>Beneficial effects of aggressive protein feeding in severely burned children</TI>
<SO>Annals of Surgery</SO>
<YR>1980</YR>
<VL>192</VL>
<NO>4</NO>
<PG>505-17</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621038"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621037"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Arora-1998" NAME="Arora 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Arora NK, Anand NK, Bhan MK, Jailkhani B, Aggarwal A, Meenu R, et al</AU>
<TI>Nutrient absorption from a fat-enriched diet in young malnourished children: a randomised controlled trial</TI>
<SO>Acta Paediatrica</SO>
<YR>1998</YR>
<VL>87</VL>
<NO>2</NO>
<PG>143-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621040"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621039"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Attard_x002d_Montalto-1998" NAME="Attard-Montalto 1998" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Attard-Montalto SP, Hadley J, Kingston JE, Eden OB, Saha V</AU>
<TI>Ongoing assessment of nutritional status in children with malignant disease</TI>
<SO>Pediatric Hematology and Oncology</SO>
<YR>1998</YR>
<VL>15</VL>
<NO>5</NO>
<PG>393-403</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621042"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621041"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Badaloo-1999" NAME="Badaloo 1999" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Badaloo A, Boyne M, Reid M, Persaud C, Forrester T, Millward DJ, et al</AU>
<TI>Dietary protein, growth and urea kinetics in severely malnourished children and during recovery</TI>
<SO>Journal of Nutrition</SO>
<YR>1999</YR>
<VL>129</VL>
<NO>5</NO>
<PG>969-79</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621044"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621043"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ball-1989" NAME="Ball 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Ball C, Punchard NA, Howell S, Thompson RPH</AU>
<TI>Essential fatty acid supplementation in children with cystic fibrosis [abstract]</TI>
<SO>Proceedings of the 16th Annual Meeting of the European Working Group for Cystic Fibrosis</SO>
<YR>1989</YR>
<PG>84</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621046"/><IDENTIFIER TYPE="MEDLINE" VALUE="27"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621045"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barbosa-1999" NAME="Barbosa 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barbosa E, Moreira EA, Goes JE, Faintuch J</AU>
<TI>Pilot study with a glutamine-supplemented enteral formula in critically ill infants</TI>
<SO>Revista do Hospital das Clinicas</SO>
<YR>1999</YR>
<VL>54</VL>
<NO>1</NO>
<PG>21-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621048"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621047"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bengoa-1985" MODIFIED="2015-01-15 10:47:22 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Bengoa 1985" YEAR="1985">
<REFERENCE MODIFIED="2015-01-15 10:47:22 +0000" MODIFIED_BY="Nikki Jahnke" NOTES="&lt;p&gt;No reference to last author found, asked reviewer.&lt;/p&gt;" NOTES_MODIFIED="2015-01-15 10:47:22 +0000" NOTES_MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bengoa JM, Griessen M, Kahn JM, Vadas L, Infante F, and LE</AU>
<TI>Glycemic response and hydrogen production in blenderized and polymeric enteral nutrition formulas [abstract]</TI>
<SO>Clinical Nutrition</SO>
<YR>1985</YR>
<VL>4</VL>
<NO>Spec Suppl</NO>
<PG>112</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621050"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621049"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bennett-1999" NAME="Bennett 1999" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bennett VA, Morales E, Gonzalez J, Peerson JM, Lopez DR, Brown KH</AU>
<TI>Effects of dietary viscosity and energy density on total daily energy consumption by young Peruvian children</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1999</YR>
<VL>70</VL>
<NO>2</NO>
<PG>285-91</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621052"/><IDENTIFIER TYPE="MEDLINE" VALUE="53"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621051"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bernstein-1999" NAME="Bernstein 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bernstein ML, Baruchel S, Devine S, Markoglou N, Wainer IW, Williams M, et al</AU>
<TI>Phase I and pharmacokinetic study of CI-980 in recurrent pediatric solid tumor cases: a Pediatric Oncology Group study</TI>
<SO>Journal of the American Society of Pediatric Hematology/Oncology</SO>
<YR>1999</YR>
<VL>21</VL>
<NO>6</NO>
<PG>494-500</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621054"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621053"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Berry-1975" NAME="Berry 1975" YEAR="1975">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Berry HK, Kellogg FW, Hunt MM, Ingberg RL, Gutjahr C</AU>
<TI>Dietary supplement and nutrition in children with cystic fibrosis</TI>
<SO>American Journal of Diseases of Childhood</SO>
<YR>1975</YR>
<VL>129</VL>
<PG>165-71</PG>
<EN>129</EN>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621056"/><IDENTIFIER TYPE="MEDLINE" VALUE="41"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621055"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Borrelli-2006" MODIFIED="2008-09-17 20:12:06 +0100" MODIFIED_BY="[Empty name]" NAME="Borrelli 2006" YEAR="2006">
<REFERENCE MODIFIED="2008-09-17 20:12:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Borrelli O, Cordischi L, Cirulli M, Paganelli M, Labalestra V, Uccini S, Russo PM, Cucchiara S</AU>
<TI>Polymeric diet alone versus corticosteroids in the treatment of active Crohn's disease: a randomised controlled open-label trial</TI>
<SO>Clinical Gastroenterology &amp; Hepatology</SO>
<YR>2006</YR>
<VL>4</VL>
<NO>6</NO>
<PG>744-53</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621058"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621057"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Botr_x00e1_n-2011" MODIFIED="2015-01-06 19:07:05 +0000" MODIFIED_BY="[Empty name]" NAME="Botrán 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-01-06 19:07:05 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't&lt;/p&gt;" NOTES_MODIFIED="2015-01-06 19:07:05 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Botrán M, López-Herce J, Mencía S, Urbano J, Solana M J, García A</AU>
<TI>Enteral nutrition in the critically ill child: comparison of standard and protein-enriched diets</TI>
<SO>The Journal of Pediatrics</SO>
<YR>2011</YR>
<PG>27-32.e1</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621060"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621059"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Braga-1999" NAME="Braga 1999" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Braga M, Gianotti L, Radaelli G, Vignali A, Mari G, Gentilini O, et al</AU>
<TI>Perioperative immunonutrition in patients undergoing cancer surgery: results of a randomized double-blind phase 3 trial</TI>
<SO>Archives of Surgery</SO>
<YR>1999</YR>
<VL>134</VL>
<NO>4</NO>
<PG>428-33</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621062"/><IDENTIFIER TYPE="MEDLINE" VALUE="119"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621061"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bruzzese-2007" MODIFIED="2008-04-16 10:15:50 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Bruzzese 2007" YEAR="2007">
<REFERENCE MODIFIED="2008-04-16 10:15:50 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bruzzese E, Raia V, Spagnuolo MI, Volpicelli M, De Marco G, Maiuri L, et al</AU>
<TI>Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study</TI>
<SO>Clinical Nutrition</SO>
<YR>2007</YR>
<VL>26</VL>
<NO>3</NO>
<PG>322-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621064"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621063"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cassidy-1999" NAME="Cassidy 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cassidy JT</AU>
<TI>Medical management of children with juvenile rheumatoid arthritis</TI>
<SO>Drugs</SO>
<YR>1999</YR>
<VL>58</VL>
<NO>5</NO>
<PG>831-50</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621066"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621065"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chan-1990" NAME="Chan 1990" YEAR="1990">
<REFERENCE PRIMARY="YES" TYPE="OTHER">
<AU>Chan JC, Greifer I, Boineau FG, Mendoza SA, McEnery PT, Strife CF, et al</AU>
<TI>Rational of the growth failure in children with renal diseases study</TI>
<SO>Journal of Pediatrics</SO>
<YR>1990</YR>
<VL>116</VL>
<PG>S11-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621068"/><IDENTIFIER TYPE="MEDLINE" VALUE="195"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Massie MD, Strife CF, Foreman JW, Chan JC</AU>
<TI>Quality control of the nutritional component of the growth failure in children with renal diseases study</TI>
<SO>Journal of Pediatrics</SO>
<YR>1990</YR>
<VL>116</VL>
<NO>2</NO>
<PG>S40-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621069"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621067"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chawla-1983" NAME="Chawla 1983" YEAR="1983">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chawla P, Puri R</AU>
<TI>An evaluation of the pre-school supplementary feeding programme in Chandigarh</TI>
<SO>Indian Pediatrics</SO>
<YR>1983</YR>
<VL>20</VL>
<NO>5</NO>
<PG>357-61</PG>
<EN>20</EN>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621071"/><IDENTIFIER TYPE="MEDLINE" VALUE="36"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621070"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Coghlin_x002d_Dickson-2000" NAME="Coghlin-Dickson 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Coghlin-Dickson TM, Wong RM, Offrin RS, Shizuru JA, Johnston LJ, Hu WW, et al</AU>
<TI>Effect of oral glutamine supplementation during bone marrow transplantation</TI>
<SO>Journal of Parenteral and Enteral Nutrition</SO>
<YR>2000</YR>
<VL>24</VL>
<NO>2</NO>
<PG>61-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621073"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621072"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dartois-1995" NAME="Dartois 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dartois AM, Terzi F, Kleinknecht C, Niaudet P</AU>
<TI>Comparison of two protein diets in infants with chronic renal failure</TI>
<SO>Journal of Renal Nutrition</SO>
<YR>1995</YR>
<VL>5</VL>
<PG>52-61</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621075"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621074"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dhanraj-1997" NAME="Dhanraj 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dhanraj P, Chacko A, Mammen M, Bharathi R</AU>
<TI>Hospital-made diet versus commercial supplement in postburn nutritional support</TI>
<SO>Burns</SO>
<YR>1997</YR>
<VL>23</VL>
<NO>6</NO>
<PG>512-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621077"/><IDENTIFIER TYPE="MEDLINE" VALUE="3"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621076"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dykman-1998" NAME="Dykman 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dykman KD, Dykman RA</AU>
<TI>Effect of nutritional supplements on attentional-deficit hyperactivity disorder</TI>
<SO>Integrative Physiological and Behavioral Science : the official journal of the Pavlovian Society</SO>
<YR>1998</YR>
<VL>33</VL>
<NO>1</NO>
<PG>49-60</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621079"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621078"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dziechciarz-2007" MODIFIED="2008-09-17 20:15:06 +0100" MODIFIED_BY="[Empty name]" NAME="Dziechciarz 2007" YEAR="2007">
<REFERENCE MODIFIED="2008-09-17 20:15:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dziechciarz P, Horvath A, Shamir R, Szajewska H</AU>
<TI>Meta-analysis: enteral nutrition in active Crohn's disease in children</TI>
<SO>Alimentary Pharmacology &amp; Theraputics</SO>
<YR>2007</YR>
<VL>26</VL>
<NO>6</NO>
<PG>795-806</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621081"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621080"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Edefonti-1999" NAME="Edefonti 1999" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Edefonti A, Picca M, Damiani B, Loi S, Ghio L, Giani M, et al</AU>
<TI>Dietary prescription based on estimated nitrogen balance during peritoneal dialysis</TI>
<SO>Pediatric Nephrology</SO>
<YR>1999</YR>
<VL>13</VL>
<NO>3</NO>
<PG>253-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621083"/><IDENTIFIER TYPE="MEDLINE" VALUE="82"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621082"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Elhasid-1999" NAME="Elhasid 1999" YEAR="">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Elhasid R, Laor A, Lischinsky S, Postovsky S, Weyl BA</AU>
<TI>Nutritional status of children with solid tumors</TI>
<SO>Cancer</SO>
<YR>1999</YR>
<VL>86</VL>
<NO>1</NO>
<PG>119-25</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621085"/><IDENTIFIER TYPE="MEDLINE" VALUE="88"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="OTHER">
<AU>Massie MD, Strife CF, Foreman JW, Chan JC</AU>
<TI>Quality control of the nutritional component of the growth failure in children with renal diseases study</TI>
<SO>Journal of Pediatrics</SO>
<YR>1990</YR>
<VL>116</VL>
<NO>2</NO>
<PG>S40-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621086"/><IDENTIFIER TYPE="MEDLINE" VALUE="194"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621084"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-English-1997" NAME="English 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>English RM, Badcock JC, Giay T, Ngu T, Waters AM, Bennett SA</AU>
<TI>Effect of nutrition improvement project on morbidity from infectious diseases in preschool children in Vietnam: comparison with control commune</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7116</NO>
<PG>1122-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621088"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621087"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fauveau-1992" NAME="Fauveau 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="OTHER">
<AU>Fauveau C, Siddiqui M, Briend A, Silimperi DR, Begum N, Fauveau V</AU>
<TI>Limited impact of a targeted food supplementation programme in Bangladeshi urban slum children</TI>
<SO>Annals of Tropical Paediatrics</SO>
<YR>1992</YR>
<VL>12</VL>
<NO>1</NO>
<PG>41-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621090"/><IDENTIFIER TYPE="MEDLINE" VALUE="23"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621089"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fell-2000" NAME="Fell 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fell JM, Paintin M, Arnaud BF, Beattie RM, Hollis A, Kitching P, et al</AU>
<TI>Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease</TI>
<SO>Alimentary Pharmacology &amp; Therapeutics</SO>
<YR>2000</YR>
<VL>14</VL>
<NO>3</NO>
<PG>281-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621092"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621091"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gianotti-1999" NAME="Gianotti 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gianotti L, Braga M, Fortis C, Soldini L, Vignali A, Colombo S, et al</AU>
<TI>A prospective, randomized clinical trial on perioperative feeding with an arginine-, omega-3 fatty acid-, and RNA-enriched enteral diet: effect on host response and nutritional status</TI>
<SO>Journal of Parenteral and Enteral Nutrition</SO>
<YR>1999</YR>
<VL>23</VL>
<NO>6</NO>
<PG>314-20</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621094"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621093"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gibson-1998" NAME="Gibson 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Gibson RA, Makrides M, Neumann MA, and SK</AU>
<TI>Dietary long chain polyunsaturated fatty acids (LCPUFA) do not influence growth of term infants: a randomised clinical trial [abstract]</TI>
<SO>Proceedings of the Nutrition Society of Australia</SO>
<YR>1998</YR>
<VL>22</VL>
<PG>95</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621096"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621095"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gottrand-1999" NAME="Gottrand 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gottrand F, Hankard R, Michaud L, Ategbo S, Dabadie A, Druon D, et al</AU>
<TI>Effect of glucose to fat ratio on energy substrate disposal in children with cystic fibrosis fed enterally</TI>
<SO>Clinical Nutrition</SO>
<YR>1999</YR>
<VL>18</VL>
<NO>5</NO>
<PG>297-300</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621098"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621097"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Granados-1998" NAME="Granados 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Granados EA</AU>
<TI>Which treatment should children with recurrent urinary infections, without anatomical anomalies, receive?</TI>
<SO>Archivos Espanoles de Urologia</SO>
<YR>1998</YR>
<VL>51</VL>
<NO>4</NO>
<PG>354-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621100"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621099"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haffejee-1980" NAME="Haffejee 1980" YEAR="1980">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Haffejee A, Angorn IB, Baker LW</AU>
<TI>Nutritional support in high-output fistulas of the alimentary tract</TI>
<SO>South African Medical Journal</SO>
<YR>1980</YR>
<VL>57</VL>
<NO>7</NO>
<PG>227-31</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621102"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621101"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hanafy-1967" NAME="Hanafy 1967" YEAR="1967">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hanafy MM, Aref MK, Seddik Y, Zein MS, el-Kashlan KM</AU>
<TI>Effect of supplementary feeding on the nutritional status of preschool children</TI>
<SO>Journal of Tropical Medicine and Hygeine</SO>
<YR>1967</YR>
<VL>70</VL>
<NO>10</NO>
<PG>238-42</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621104"/><IDENTIFIER TYPE="MEDLINE" VALUE="43"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621103"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hansen-1996" NAME="Hansen 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hansen GV, Nielson L, Kluger E, Thysen M, Emmertsen H, Stengaard-Pedersen K, et al</AU>
<TI>Nutritional status of Danish rheumatoid arthritis patients and effects of a diet adjusted in energy intake, fish-meal and antioxidants</TI>
<SO>Scandinavian Journal of Rheumatology</SO>
<YR>1996</YR>
<VL>25</VL>
<NO>5</NO>
<PG>325-30</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621106"/><IDENTIFIER TYPE="MEDLINE" VALUE="5"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621105"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Heikens-1989" NAME="Heikens 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Heikens GT, Schofield WN, Dawson S, and-Grantham MS</AU>
<TI>The Kingston project. I. Growth of malnourished children during rehabilitation in the community, given a high energy supplement</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>1989</YR>
<VL>43</VL>
<NO>3</NO>
<PG>145-60</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621108"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621107"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hopman-1997" MODIFIED="2008-04-16 11:14:04 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Hopman 1997" YEAR="1997">
<REFERENCE MODIFIED="2008-04-16 11:14:04 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hopman GD, Pena EG, Broekhof WJ</AU>
<TI>Nutritional support for children who undergo bone marrow transplantation: enteral or parenteral?</TI>
<SO>Tijdschrift voor Kindergeneeskunde</SO>
<YR>1997</YR>
<VL>65</VL>
<PG>39</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621110"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621109"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hopman-1998" NAME="Hopman 1998" YEAR="1998">
<REFERENCE NOTES="&lt;p&gt;(23) Hopman E, Pe&amp;#177;a E, Broekhof S, le Cessie S, de Hullu A, van Weel M et al. Nutritional support in children undergoing bone marrow transplantation: enteral or parenteral? [abstract]. Eur J Gastroenterol Hepatol 1998; 10:A.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hopman E, Pena E, Broekhof S, le Cessie S, de Hullu A, van Weel M, et al</AU>
<TI>Nutritional support in children undergoing bone marrow transplantation: enteral or parenteral? [abstract]</TI>
<SO>European Journal of Gastroenterology &amp; Hepatology</SO>
<YR>1998</YR>
<VL>10</VL>
<PG>A</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621112"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621111"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-INCAP-Study" MODIFIED="2008-11-11 11:43:12 +0000" MODIFIED_BY="Nikki Jahnke" NAME="INCAP Study" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Caulfield LE, Himes JH, Rivera JA</AU>
<TI>Nutritional supplementation during early childhood and bone mineralization during adolescence</TI>
<SO>Journal of Nutrition</SO>
<YR>1995</YR>
<VL>125</VL>
<NO>Suppl 4</NO>
<PG>1104S-10S</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621114"/><IDENTIFIER TYPE="MEDLINE" VALUE="14"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Haas JD, Martinez EJ, Murdoch S, Conlisk E, Rivera JA, Martorell R</AU>
<TI>Nutritional supplementation during the preschool years and physical work capacity in adolescent and young adult Guatemalans</TI>
<SO>Journal of Nutrition</SO>
<YR>1995</YR>
<VL>125</VL>
<NO>Suppl 4</NO>
<PG>1078S-89S</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621115"/><IDENTIFIER TYPE="MEDLINE" VALUE="15"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Habicht JP, Martorell R, Rivera JA</AU>
<TI>Nutritional impact of supplementation in the INCAP longitudinal study: analytic strategies and interences</TI>
<SO>Journal of Nutrition</SO>
<YR>1995</YR>
<VL>125</VL>
<NO>Suppl 4</NO>
<PG>1042S-50S</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621116"/><IDENTIFIER TYPE="MEDLINE" VALUE="13"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-11-11 11:43:12 +0000" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martorell R, Habicht JP, Rivera JA</AU>
<TI>History and design of the INCAP longitudinal study (1969-77) and its follow-up (1988-89)</TI>
<SO>Journal of Nutrition</SO>
<YR>1995</YR>
<VL>125</VL>
<NO>Suppl 4</NO>
<PG>1027S-41S</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621117"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martorell R</AU>
<TI>Results and implications of the INCAP follow-up study</TI>
<SO>Journal of Nutrition</SO>
<YR>1995</YR>
<VL>125</VL>
<NO>Suppl 4</NO>
<PG>1127S-38S</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621118"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pickett KE, Haas JD, Rivera JA, Martorell R</AU>
<TI>Early nutritional supplementation and skeletal maturation in Guatemalan adolescents</TI>
<SO>Journal of Nutrition</SO>
<YR>1995</YR>
<VL>125</VL>
<NO>Suppl 4</NO>
<PG>1097S-103S</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621119"/><IDENTIFIER TYPE="MEDLINE" VALUE="11"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rivera JA, Habicht JP, Robson DS</AU>
<TI>Effect of supplementary feeding on recovery from mild to moderate wasting in preschool children</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1991</YR>
<VL>54</VL>
<NO>1</NO>
<PG>62-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621120"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rivera JA, Habicht JP</AU>
<TI>The recovery of Guatemalan children with mild to moderate wasting: factors enhancing the impact of supplementary feeding</TI>
<SO>American Journal of Public Health</SO>
<YR>1996</YR>
<VL>86</VL>
<NO>10</NO>
<PG>1430-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621121"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rivera JA, Martorell R, Ruel MT, Habicht JP, Haas JD</AU>
<TI>Nutritional supplementation during the preschool years influences body size and composition of Guatemalan adolescents</TI>
<SO>Journal of Nutrition</SO>
<YR>1995</YR>
<VL>125</VL>
<NO>Suppl 4</NO>
<PG>1068S-77S</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621122"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schroeder DG, Martorell R, Rivera JA, Ruel MT</AU>
<TI>Age differences in the impact of nutritional supplementation on growth</TI>
<SO>Journal of Nutrition</SO>
<YR>1995</YR>
<VL>125</VL>
<NO>Suppl 4</NO>
<PG>1051S-9S</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621123"/><IDENTIFIER TYPE="MEDLINE" VALUE="10"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621113"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Iyengar-1979" NAME="Iyengar 1979" YEAR="1979">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Iyengar AK, Rao BS, Reddy V</AU>
<TI>Effect of varying protein and energy intakes on nitrogen balance in Indian preschool children</TI>
<SO>British Journal of Nutrition</SO>
<YR>1979</YR>
<VL>42</VL>
<NO>3</NO>
<PG>417-23</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621125"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621124"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jackson-1990" NAME="Jackson 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jackson AA, Doherty J, de Benoist MH, Hibbert J, Persaud C</AU>
<TI>The effect of the level of dietary protein, carbohydrate and fat on urea kinetics in young children during rapid catch-up weight gain</TI>
<SO>British Journal of Nutrition</SO>
<YR>1990</YR>
<VL>64</VL>
<NO>2</NO>
<PG>371-85</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621127"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621126"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jain-2006" MODIFIED="2014-04-25 21:04:01 +0100" MODIFIED_BY="[Empty name]" NAME="Jain 2006" YEAR="2006">
<REFERENCE MODIFIED="2014-04-25 21:04:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jain MK, Heyland D, Dhaliwal R, Day AG, Drover J, Keefe L, Gelula M</AU>
<TI>Dissemination of the Canadian clinical practice guidelines for nutrition support: results of a cluster randomized controlled trial</TI>
<SO>Critical Care Medicine</SO>
<YR>2006</YR>
<VL>34</VL>
<NO>9</NO>
<PG>2362-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621129"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621128"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jamaican-Study-1996" NAME="Jamaican Study 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grantham-McGregor SM, Powell CA, Walker SP, Himes JH</AU>
<TI>Nutritional supplementation, psychosocial stimulation, and mental development of stunted children: the Jamaica study</TI>
<SO>Lancet</SO>
<YR>1991</YR>
<VL>338</VL>
<NO>8758</NO>
<PG>1-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621131"/><IDENTIFIER TYPE="MEDLINE" VALUE="26"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grantham-McGregor SM, Powell CA, Walker SP</AU>
<TI>Nutritional supplements, stunting and child development (letter)</TI>
<SO>Lancet</SO>
<YR>1989</YR>
<VL>2</VL>
<PG>809-10</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621132"/><IDENTIFIER TYPE="MEDLINE" VALUE="29"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meeks-Gardner J, Grantham-McGregor SM, Chang SM, Himes JH, Powell CA</AU>
<TI>Activity and behavioural development in stunted and non-stunted children and response to nutritional supplementation</TI>
<SO>Child Development</SO>
<YR>1995</YR>
<VL>66</VL>
<NO>6</NO>
<PG>1785-97</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621133"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Walker SP, Grantham-McGregor SM, Himes JH, Powell CA, Chang SM</AU>
<TI>Early childhood supplementation does not benefit the long-term growth of stunted children in Jamaica</TI>
<SO>Journal of Nutrition</SO>
<YR>1996</YR>
<VL>126</VL>
<NO>12</NO>
<PG>3017-24</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621134"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Walker SP, Powell CA, Grantham-McGregor SM, Himes JH, Chang SM</AU>
<TI>Nutritional supplementation, psychosocial stimulation, and growth of stunted children: the Jamaica study</TI>
<SO>American Journal of Clincial Nutrition</SO>
<YR>1991</YR>
<VL>54</VL>
<NO>4</NO>
<PG>642-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621135"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621130"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Johnson-2006" MODIFIED="2014-04-25 21:04:01 +0100" MODIFIED_BY="[Empty name]" NAME="Johnson 2006" YEAR="2006">
<REFERENCE MODIFIED="2014-04-25 21:04:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Johnson T, MacDonald S, Hill SM, Thomas A, Murphy MS</AU>
<TI>Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial</TI>
<SO>Gut</SO>
<YR>2006</YR>
<VL>55</VL>
<NO>3</NO>
<PG>356-61</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621137"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621136"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kabir-1994" NAME="Kabir 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kabir I, Malek MA, Rahman MM, Khaled MA, Mahalanabis D</AU>
<TI>Changes in body composition of malnourished children after dietary supplementation as measured by bioelectrical impedance</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1994</YR>
<VL>59</VL>
<NO>1</NO>
<PG>5-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621139"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621138"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karkos-2007" MODIFIED="2008-09-17 20:12:18 +0100" MODIFIED_BY="[Empty name]" NAME="Karkos 2007" YEAR="2007">
<REFERENCE MODIFIED="2008-09-17 20:12:18 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Karkos PD, Leong SC, Arya AK, Papouliakos SM, Apostolidou MT, Issing WJ</AU>
<TI>Complementry ENT: A systematic review of commonly used supplements</TI>
<SO>Journal of Laryngology &amp; Otology</SO>
<YR>2007</YR>
<VL>121</VL>
<NO>8</NO>
<PG>779-82</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621141"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621140"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kashirskaja-1996" NAME="Kashirskaja 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kashirskaja N, Hill CM, Ilangovan P, Kapranov N, Simonova O, Shabalova L, Rolles CJ</AU>
<TI>The relative contribution of optimal nutritional support in cystic fibrosis</TI>
<SO>Journal of the Royal Society of Medicine</SO>
<YR>1996</YR>
<VL>89</VL>
<NO>Suppl 27</NO>
<PG>48-50</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621143"/><IDENTIFIER TYPE="MEDLINE" VALUE="8"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621142"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kaur-1979" NAME="Kaur 1979" YEAR="1979">
<REFERENCE PRIMARY="NO" TYPE="OTHER">
<AU>Kaur P, Bhatt CM</AU>
<TI>Effect of supplementary feeding on the nutritional status of pre-school children</TI>
<SO>Indian Pediatrics</SO>
<YR>1979</YR>
<VL>16</VL>
<NO>12</NO>
<PG>1091-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621145"/><IDENTIFIER TYPE="MEDLINE" VALUE="40"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621144"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Keele-1995" NAME="Keele 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Keele AM, Bray MJ, Emery PW, Silk DBA</AU>
<TI>Two-phase randomised controlled clinical trial of oral dietary supplements in surgical patients [abstract]</TI>
<SO>Proceedings of the 17th European Society of Parenteral &amp; Enteral Nutrition Conference</SO>
<YR>1995</YR>
<PG>8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621147"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621146"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kendell-1982" NAME="Kendell 1982" YEAR="1982">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kendell BD, Fonseca RJ, Lee M</AU>
<TI>Postoperative nutritional supplementation for the orthognathic surgery patient</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>1982</YR>
<VL>40</VL>
<NO>4</NO>
<PG>205-13</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621149"/><IDENTIFIER TYPE="MEDLINE" VALUE="38"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621148"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kingston-Project-_x0027_93" NAME="Kingston Project '93" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Heikens GT, Schofield WN, Christie CD, Gernay J, Dawson S</AU>
<TI>The Kingston Project III. The effects of high energy supplement and metronidazole on malnourished children rehabilitated in the community: morbidity and growth</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>1993</YR>
<VL>47</VL>
<NO>3</NO>
<PG>174-91</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621151"/><IDENTIFIER TYPE="MEDLINE" VALUE="21"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Heikens GT, Schofield WN, Dawson S, Grantham-McGregor SM</AU>
<TI>The Kingston Project I. Growth of malnourished children during rehabilitation in the community, given a high energy supplement</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>1989</YR>
<VL>43</VL>
<NO>3</NO>
<PG>145-60</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621152"/><IDENTIFIER TYPE="MEDLINE" VALUE="30"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Heikens GT, Schofield WN, Dawson S</AU>
<TI>The Kingston Project II. The effects of high energy supplement and metronidazole on malnourished children rehabilitated in the community: anthropometry</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>1993</YR>
<VL>47</VL>
<NO>3</NO>
<PG>160-73</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621153"/><IDENTIFIER TYPE="MEDLINE" VALUE="20"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621150"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Knops-1999" NAME="Knops 1999" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Knops N, Wulffraat N, Lodder S, Houwen R, de Meer K</AU>
<TI>Resting energy expenditure and nutritional status in children with juvenile rheumatoid arthritis</TI>
<SO>Journal of Rheumatology</SO>
<YR>1999</YR>
<VL>26</VL>
<NO>9</NO>
<PG>2039-43</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621155"/><IDENTIFIER TYPE="MEDLINE" VALUE="190"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621154"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kobayashi-1998" NAME="Kobayashi 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kobayashi K, Katsumata T, Yokoyama K, Takahashi H, Igarashi M, Saigenji K</AU>
<TI>A randomized controlled study of total parenteral nutrition and enteral nutrition by elemental and polymeric diet as primary therapy in active phase of Crohn's disease</TI>
<SO>Nippon Shokakibyo Gakkai Zasshi [Japanese Journal of Gastroenterology]</SO>
<YR>1998</YR>
<VL>95</VL>
<NO>11</NO>
<PG>1212-21</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621157"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621156"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Koletzko-1992" NAME="Koletzko 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Koletzko B, Ruhl-Bagheri I, Thiel I, Steinkamp G</AU>
<TI>Effects of a formula supplement rich in linoleic acid on the essential fatty acid status of cystic fibrosis patients [abstract]</TI>
<SO>Clinical Nutrition</SO>
<YR>1992</YR>
<VL>11</VL>
<PG>39</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621159"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Steinkamp G, Demmelmair H, Ruhl-Bagheri I, von der Hardt H, Koletzko B</AU>
<TI>Energy supplements rich in linoleic acid improve body weight and essential fatty acid status of cystic fibrosis patients</TI>
<SO>Journal of Gastroenterology and Nutrition</SO>
<YR>2000</YR>
<VL>31</VL>
<NO>4</NO>
<PG>418-23</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621160"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621158"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Koretz-2007" MODIFIED="2008-09-17 20:16:09 +0100" MODIFIED_BY="[Empty name]" NAME="Koretz 2007" YEAR="2007">
<REFERENCE MODIFIED="2008-09-17 20:16:08 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Koretz RL, Avenell A, Lipman TO, Braunschweig CL, Milne AC</AU>
<TI>Does enteral nutrition affect clinical outcome? A systematic review of the randomised trials</TI>
<SO>American Journal of Gastroenterology</SO>
<YR>2007</YR>
<VL>102</VL>
<NO>2</NO>
<PG>412-429</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621162"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621161"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kossmann-2000" NAME="Kossmann 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kossmann J, Nestel P, Herrera MG, El Amin A, Fawzi WW</AU>
<TI>Undernutrition in relation to childhood infections: a prospective study in the Sudan</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2000</YR>
<VL>54</VL>
<NO>6</NO>
<PG>463-72</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621164"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621163"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ladas-2006" MODIFIED="2008-09-17 20:16:44 +0100" MODIFIED_BY="[Empty name]" NAME="Ladas 2006" YEAR="2006">
<REFERENCE MODIFIED="2008-09-17 20:16:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ladas EJ, Sacks N, Brophy P, Rogers PC</AU>
<TI>Standards of nutritional care in pediatric oncology: results from a nationwide survey on the standards of practice in pediatric oncology. A children's oncology groups study</TI>
<SO>Pediatric blood &amp; cancer</SO>
<YR>2006</YR>
<VL>46</VL>
<NO>3</NO>
<PG>339-44</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621166"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621165"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lagstrom-1999" NAME="Lagstrom 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lagstrom H, Seppanen R, Jokinen E, Niinikoski H, Ronnemaa T, Viikari J, et al</AU>
<TI>Influence of dietary fat on the nutrient intake and growth of children from 1 to 5 y of age: the Special Turku Coronary Risk Factor Intervention Project</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1999</YR>
<VL>69</VL>
<NO>3</NO>
<PG>516-23</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621168"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621167"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lambert-1995" NAME="Lambert 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Lambert B, MacDonald A, Booth IW</AU>
<TI>An open prospective randomised comparison of a newly available high energy enteral feed, with a conventional formula designed for children 1-6 years [abstract]</TI>
<SO>Proceedings of the 5th The British Association for Parenteral and Enteral Nutrition Conference</SO>
<YR>1995</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621170"/><IDENTIFIER TYPE="MEDLINE" VALUE="46"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621169"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lepage-2002" NAME="Lepage 2002" YEAR="2002">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lepage G, Yesair DW, Ronco N, Champagne J, Bureau N, Chemtob S, et al</AU>
<TI>Effect of an organized lipid matrix on lipid absorption and clinical outcomes in patients with cystic fibrosis</TI>
<SO>Journal of Pediatrics</SO>
<YR>2002</YR>
<VL>141</VL>
<NO>2</NO>
<PG>178-85</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621172"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621171"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Linday-2004" MODIFIED="2008-09-17 20:12:28 +0100" MODIFIED_BY="[Empty name]" NAME="Linday 2004" YEAR="2006">
<REFERENCE MODIFIED="2008-09-17 20:12:28 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Linday LA, Shindledecker RD, Tapia-Mendoza J, Dolitsky JN</AU>
<TI>Effect of daily cod liver oil and a multivitamin-mineral supplement with selenium on upper respiratory tract pediatric visits by young, inner-city, Latino children: randomized pediatric sites.</TI>
<SO>The Annals of otology, rhinology, and laryngology</SO>
<YR>2004</YR>
<VL>113</VL>
<NO>11</NO>
<PG>891-901</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621174"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-09-17 20:12:28 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Linday LA</AU>
<TI>Nutritional supplements and pediatric upper respiratory tract illnesses [letter]</TI>
<SO>Journal of Allergy &amp; Clinical Immunology</SO>
<YR>2006</YR>
<VL>117</VL>
<NO>4</NO>
<PG>953-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621175"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621173"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lloyd_x002d_Still-2006" MODIFIED="2015-01-15 10:50:17 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Lloyd-Still 2006" YEAR="2006">
<REFERENCE MODIFIED="2015-01-15 10:50:17 +0000" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lloyd-Still J, Powers CA, Hoffman DR, Boyd-Trull K, Lester LA, Benisek DC, et al</AU>
<TI>A randomized, controlled study examining the bioavailability and safety of an algal docosahexaenoic acid (DHA) triacylglycerol in cystic fibrosis (CF) patients [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2004</YR>
<VL>38</VL>
<NO>Suppl 27</NO>
<PG>331</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621177"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-04-16 11:02:26 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lloyd-Still JD, Powers CA, Hoffman DR, Arterburn LM, Benisek DC, Lester LA.</AU>
<TI>Bioavailability and safety of an algal docosahexaenoic acid (DHA) triglyceride in cystic fibrosis (CF) [abstract]</TI>
<SO>Pediatric Research</SO>
<YR>2001</YR>
<VL>49</VL>
<NO>4 Suppl</NO>
<PG>455a</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621178"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-04-16 11:04:15 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lloyd-Still JD, Powers CA, Hoffman DR, Boyd-Trull K, Arterburn LM, Benisek DC, et al.</AU>
<TI>Blood and tissue essential fatty acids after docosahexaenoic acid supplementation in cystic fibrosis [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>2001</YR>
<VL>32</VL>
<NO>Suppl 22</NO>
<PG>263</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621179"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-04-16 11:05:46 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lloyd-Still JD, Powers CA, Hoffman DR, Boyd-Trull K, Lester LA, Benisek DC, et al</AU>
<TI>Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study</TI>
<SO>Nutrition</SO>
<YR>2006</YR>
<VL>22</VL>
<NO>1</NO>
<PG>36-46</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621180"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-04-16 11:05:17 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Powers CA, Lloyd-Still JD, Hoffman DR, Arterburn LM, Benisek DC, Lester LA</AU>
<TI>Lipid soluble antioxidant status during supplementation with algal docosahexaenoic acid triglyceride in CF [abstract]</TI>
<SO>Proceedings of 24th European Cystic Fibrosis Conference; 2001 June 6-9; Vienna, Austria</SO>
<YR>2001</YR>
<PG>P133</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621181"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621176"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lutter-2008" MODIFIED="2008-09-17 20:31:56 +0100" MODIFIED_BY="[Empty name]" NAME="Lutter 2008" YEAR="2008">
<REFERENCE MODIFIED="2008-09-17 20:31:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lutter CK, Rodriguez A, Fuenmayor G, Avila L, Sempertegui F, Escobar J</AU>
<TI>Growth and micronutrient status in children receiving a fortified complementary food</TI>
<SO>Journal of nutrition</SO>
<YR>2008</YR>
<VL>138</VL>
<NO>2</NO>
<PG>379-88</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621183"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621182"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maes-1997" NAME="Maes 1997" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maes M, Sokal E, Otte JB</AU>
<TI>Growth factors in children with end-stage liver disease before and after liver transplantation: a review</TI>
<SO>Pediatric Transplantation</SO>
<YR>1997</YR>
<VL>1</VL>
<NO>2</NO>
<PG>171-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621185"/><IDENTIFIER TYPE="MEDLINE" VALUE="136"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621184"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mahlungulu-2007" MODIFIED="2011-11-10 13:10:08 +0000" MODIFIED_BY="[Empty name]" NAME="Mahlungulu 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-11-10 13:10:08 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="COCHRANE_REVIEW">
<AU>Mahlungulu S, Grobler LA, Visser ME, Volmink J</AU>
<TI>Nutritional interventions for reducing morbidity and mortality in people with HIV</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2011-11-10 13:10:08 +0000" MODIFIED_BY="Nikki Jahnke"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621187"/><IDENTIFIER MODIFIED="2011-11-10 13:10:08 +0000" MODIFIED_BY="Nikki Jahnke" TYPE="DOI" VALUE="10.1002/14651858.CD004536.pub2"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621186"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Manguso-2005" MODIFIED="2008-04-16 08:57:56 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Manguso 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-04-16 08:57:56 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Manguso F, D'Ambra G, Menchise A, Sollazzo R, D'Agostino L</AU>
<TI>Effects of an appropriate oral diet on the nutritional status of patients with HCV-related liver cirrhosis: A prospective study</TI>
<SO>Clinical Nutrition</SO>
<YR>2005</YR>
<VL>24</VL>
<NO>5</NO>
<PG>751-9</PG>
<IDENTIFIERS MODIFIED="2008-04-16 08:57:56 +0100" MODIFIED_BY="Nikki Jahnke"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621189"/><IDENTIFIER MODIFIED="2008-04-16 08:57:53 +0100" MODIFIED_BY="Nikki Jahnke" TYPE="PUBMED" VALUE="16182039"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621188"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marques-2004" MODIFIED="2008-04-16 08:59:10 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Marques 2004" YEAR="2004">
<REFERENCE MODIFIED="2008-04-16 08:59:10 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marques IL, De Barros Almeida Peres SP, Bettiol H, Barbieri MA, Andrea M, De Souza L</AU>
<TI>Growth of children with isolated Robin sequence treated by nasopharyngeal intubation: Importance of a hypercaloric diet</TI>
<SO>Cleft Palete-Craniofacial Journal</SO>
<YR>2004</YR>
<VL>41</VL>
<NO>1</NO>
<PG>53-8</PG>
<IDENTIFIERS MODIFIED="2008-04-16 08:59:10 +0100" MODIFIED_BY="Nikki Jahnke"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621191"/><IDENTIFIER MODIFIED="2008-04-16 08:59:10 +0100" MODIFIED_BY="Nikki Jahnke" TYPE="PUBMED" VALUE="14697069"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621190"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Martorell-1995" NAME="Martorell 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martorell R, Habicht JP, Rivera JA</AU>
<TI>History and design of the INCAP longitudinal study (1969-77) and its follow-up (1988-89)</TI>
<SO>Journal of Nutrition</SO>
<YR>1995</YR>
<VL>125</VL>
<PG>1027S-41S</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621193"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621192"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mathisen-1999" NAME="Mathisen 1999" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mathisen B, Worrall L, Masel J, Wall C, Shepherd RW</AU>
<TI>Feeding problems in infants with gastro-oesophageal reflux disease: a controlled study</TI>
<SO>Journal of Paediatrics and Child Health</SO>
<YR>1999</YR>
<VL>35</VL>
<NO>2</NO>
<PG>163-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621195"/><IDENTIFIER TYPE="MEDLINE" VALUE="77"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621194"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McCargar-1998" NAME="McCargar 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McCargar LJ, Innis SM, Bowron E, Leichter J, Dawson K, Toth E, et al</AU>
<TI>Effect of enteral nutritional products differing in carbohydrate and fat on indices of carbohydrate and lipid metabolism in patients with NIDDM</TI>
<SO>Molecular &amp; Cellular Biochemistry</SO>
<YR>1998</YR>
<VL>188</VL>
<NO>1-2</NO>
<PG>81-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621197"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621196"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McClure-2000" NAME="McClure 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McClure RJ, Newell SJ</AU>
<TI>Randomised controlled study of clinical outcome following trophic feeding</TI>
<SO>Archives of Disease in Childhood. Fetal and Neonatal Edition</SO>
<YR>2000</YR>
<VL>82</VL>
<NO>1</NO>
<PG>F29-33</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621199"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621198"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McWhirter-1994" NAME="McWhirter 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>McWhirter JP, Pennington CR</AU>
<TI>A comparison between oral and nasogastric nutritional supplements in malnourished patients [abstract]</TI>
<SO>Proceedings of the 5th British Association of Parenteral and Enteral Nutrition Conference</SO>
<YR>1995</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621201"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621200"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mok-2006" MODIFIED="2008-11-11 11:43:30 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Mok 2006" YEAR="2006">
<REFERENCE MODIFIED="2008-11-11 11:43:30 +0000" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mok E, Eleouet-Da VC, Daubrosse C, Gottrand F, Rigal O, Fontan JE, Cuisset JM, Guilhot J, Hankard R</AU>
<TI>Oral glutamine and amino acid supplementation inhibit whole-body protein degradation in children with Duchenne muscular dystrophy</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2006</YR>
<VL>83</VL>
<NO>4</NO>
<PG>823-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621203"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621202"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mora-1981" NAME="Mora 1981" YEAR="1981">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mora JO, Herrera MG, Suescun J, De Navarro L, Wagner M</AU>
<TI>The effects of nutritional supplementation on physical growth of children at risk of malnutrition</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1981</YR>
<VL>34</VL>
<NO>9</NO>
<PG>1885-92</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621205"/><IDENTIFIER TYPE="MEDLINE" VALUE="39"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621204"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ndekha-2005" MODIFIED="2008-11-11 11:43:53 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Ndekha 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-11-11 11:43:53 +0000" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ndekha MJ, Manary MJ, Ashorn P, Briend A</AU>
<TI>Home-based therapy with ready-to-use therapeutic food is of benefit to malnourished, HIV-infected Malawian children</TI>
<SO>Acta Paediatrica</SO>
<YR>2005</YR>
<VL>94</VL>
<NO>2</NO>
<PG>222-5</PG>
<IDENTIFIERS MODIFIED="2008-04-16 09:00:24 +0100" MODIFIED_BY="Nikki Jahnke"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621207"/><IDENTIFIER MODIFIED="2008-04-16 09:00:24 +0100" MODIFIED_BY="Nikki Jahnke" TYPE="PUBMED" VALUE="15981758"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621206"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Newby-2007" MODIFIED="2011-11-10 13:10:44 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Newby 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-11-10 13:10:44 +0000" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="COCHRANE_REVIEW">
<AU>Newby EA, Sawczenko A, Thomas AG, Wilson D</AU>
<TI>Interventions for growth failure in childhood Crohn's disease</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2011-11-10 13:10:44 +0000" MODIFIED_BY="Nikki Jahnke"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621209"/><IDENTIFIER MODIFIED="2011-11-10 13:10:44 +0000" MODIFIED_BY="Nikki Jahnke" TYPE="DOI" VALUE="10.1002/14651858.CD003873.pub2"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621208"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nielson-2007" MODIFIED="2015-02-03 20:23:47 +0000" MODIFIED_BY="[Empty name]" NAME="Nielson 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-02-03 20:23:47 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nielsen AA, Nielsen JN, Gronbaek H, Eivindson M, Vind I, Munkholm P, Brandslund I</AU>
<TI>Impact of enteral supplements enriched with omega-3 fatty acid and/or omega-6 fatty acids, arginine and ribonucleic acid compounds on leptin levels and nutritional status in active Crohn's disease treated with prednisolone</TI>
<SO>Digestion</SO>
<YR>2007</YR>
<VL>75</VL>
<NO>1</NO>
<PG>10-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621211"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621210"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Oudshoorn-2007" MODIFIED="2008-04-16 10:15:59 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Oudshoorn 2007" YEAR="2007">
<REFERENCE MODIFIED="2008-04-16 10:15:59 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Oudshoorn JH, Klijn PH, Hofman Z, Voorbij HA, van der Ent CK, Berger R, et al</AU>
<TI>Dietary supplementation with multiple micronutrients: no beneficial effects in pediatric cystic fibrosis patients</TI>
<SO>Journal of Cystic Fibrosis</SO>
<YR>2007</YR>
<VL>6</VL>
<NO>1</NO>
<PG>35-40</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621213"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621212"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Papadopoulou-1998" NAME="Papadopoulou 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Papadopoulou A</AU>
<TI>Nutritional considerations in children undergoing bone marrow transplantation</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>1998</YR>
<VL>52</VL>
<NO>12</NO>
<PG>863-71</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621215"/><IDENTIFIER TYPE="MEDLINE" VALUE="149"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621214"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Papas-2007" MODIFIED="2008-04-16 10:16:05 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Papas 2007" YEAR="2007">
<REFERENCE MODIFIED="2008-04-16 10:16:05 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Papas K, Kalbfleisch J, Mohon R</AU>
<TI>Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients</TI>
<SO>Digestive Diseases and Sciences</SO>
<YR>2007</YR>
<VL>52</VL>
<NO>2</NO>
<PG>347-52</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621217"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621216"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pelekanos-1990" MODIFIED="2008-11-11 11:44:07 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Pelekanos 1990" YEAR="1990">
<REFERENCE MODIFIED="2008-11-11 11:44:07 +0000" MODIFIED_BY="Nikki Jahnke" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Pelekanos JT, Holt TL, Ward LC, Cleghorn GJ, Shepherd RW</AU>
<TI>Protein turnover in malnourished patients with cystic fibrosis: Effects of elemental and non elemental nutritional supplements</TI>
<SO>Journal of Pediatric Gastroenterology &amp; Nutrition</SO>
<YR>1990</YR>
<VL>10</VL>
<NO>3</NO>
<PG>339-43</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621219"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621218"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Powers-1999" NAME="Powers 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Powers SW, Schindler T, Schwarber L, Deeks CM, Byars KC, Arthur S, et al</AU>
<TI>Behavioral treatment to improve nutrition in toddlers with cystic fibrosis [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1999</YR>
<VL>Suppl 19</VL>
<PG>329</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621221"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621220"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Powers-2006" MODIFIED="2014-08-25 20:02:19 +0100" MODIFIED_BY="[Empty name]" NAME="Powers 2006" YEAR="2006">
<REFERENCE MODIFIED="2014-08-25 20:02:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Powers SW, Piazza-Waggoner C, Jones JS, Ferguson KS, Daines C, Acton JD</AU>
<TI>Examining clinical trial results with single-subject analysis: an example involving behavioural and nutrition treatment for young children with cystic fibrosis</TI>
<SO>Journal of Pediatric Psychology</SO>
<YR>2006</YR>
<VL>31</VL>
<NO>6</NO>
<PG>574-81</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621223"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621222"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Raynor-1999" NAME="Raynor 1999" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Raynor P, Rudolf MC, Cooper K, Marchant P, Cottrell D</AU>
<TI>A randomised controlled trial of specialist health visitor intervention for failure to thrive</TI>
<SO>Archives of Disease in Childhood</SO>
<YR>1999</YR>
<VL>80</VL>
<NO>6</NO>
<PG>500-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621225"/><IDENTIFIER TYPE="MEDLINE" VALUE="191"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621224"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reifsnider-1998" MODIFIED="2008-04-16 10:53:49 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Reifsnider 1998" YEAR="1998">
<REFERENCE MODIFIED="2008-04-16 10:53:45 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reifsnider E</AU>
<TI>Follow-up study of children with growth deficiency</TI>
<SO>Western Journal of Nursing Research</SO>
<YR>1998</YR>
<VL>20</VL>
<NO>1</NO>
<PG>14-29</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621227"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reifsnider E</AU>
<TI>Reversing growth deficiency in children: the effect of a community-based intervention</TI>
<SO>Journal of Pediatric Health Care</SO>
<YR>1998</YR>
<VL>12</VL>
<NO>6 Pt 1</NO>
<PG>305-12</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621228"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621226"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rettammel-1995" NAME="Rettammel 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rettammel AL, Marcus MS, Farrell PM, Sondel SA, Koscil RE, Mischler EH</AU>
<TI>Oral supplementation with a high-fat, high-energy product improves nutritional status and alters serum lipids in patients with cystic fibrosis</TI>
<SO>Journal of the American Dietetic Association</SO>
<YR>1996</YR>
<VL>95</VL>
<PG>454-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621230"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621229"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rickard-1983" NAME="Rickard 1983" YEAR="1983">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rickard KA, Foland BB, Detamore CM, Coates TD, Grosfeld JL, White NM, et al</AU>
<TI>Effectiveness of central parenteral nutrition versus peripheral parenteral nutrition plus enteral nutrition in reversing protein- energy malnutrition in children with advanced neuroblastoma and Wilm's tumor: A prospective randomized study</TI>
<SO>The American Journal of Clinical Nutrition</SO>
<YR>1983</YR>
<VL>38</VL>
<PG>445-56</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621232"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621231"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rickard-1984" NAME="Rickard 1984" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Rickard KA, Loghani ES, Grosfeld JL, Detamore CM, White NM, Foland BB, et al</AU>
<TI>Effectiveness of enteral and parenteral nutrition in preventing and/or reversing PEM in children with advanced neuroblastoma: a prospective randomized study [abstract]</TI>
<SO>Proceedings of the Annual Meeting of the American Society of Clinical Oncologists</SO>
<YR>1984</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621234"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621233"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rickard-1989" MODIFIED="2008-11-11 11:44:36 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Rickard 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Godshall BJ, Rickard KA, Loghmani ES, Coates TD, Grosfeld JL, Weetman RM, et al</AU>
<TI>Intergration of nutritional support into oncologic treatment protocols for high and low nutritional risk children with Wilm's tumor: a prospective randomized study [abstract]</TI>
<SO>Proceedings of the Annual Meeting of the American Society of Clinical Oncologists</SO>
<YR>1987</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621236"/><IDENTIFIER TYPE="MEDLINE" VALUE="33"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rickard KA, Detamore CM, Coates TD, Grosfeld JL, Weetman RM, White NM, et al</AU>
<TI>Effect of nutrition staging on treatment delays and outcome in Stage IV neuroblastoma</TI>
<SO>Cancer</SO>
<YR>1983</YR>
<VL>52</VL>
<PG>587-98</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621237"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rickard KA, Godshall BJ, Loghmani ES, Coates TD, Grosfeld JL, Weetman RM, et al</AU>
<TI>Integration of nutrition support into oncologic treatment protocols for high and low nutritional risk children with Wilm's tumour. A prospective randomized study</TI>
<SO>Cancer</SO>
<YR>1989</YR>
<VL>64</VL>
<NO>2</NO>
<PG>491-509</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621238"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Rickard KA, Grosfeld JL, Kirksey A, Ballantine TVN, Baehner RL</AU>
<TI>Reversal of protein energy malnutrition in children during treatment of advanced neoplastic disease</TI>
<SO>Annals of Surgery</SO>
<YR>1979</YR>
<VL>190</VL>
<NO>6</NO>
<PG>771-81</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621239"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-11-11 11:44:36 +0000" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Rickard KA, Loghmani ES, Grosfeld JL, Detamore CM, White NM, Foland BB, et al</AU>
<TI>Effectiveness of enteral and parenteral nutrition in preventing and/or reversing PEM in children with advanced neuroblastoma: a prospective randomised study [abstract]</TI>
<SO>Proceedings of the Annual Meeting of the American Society of Clinical Oncologists</SO>
<YR>1984</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621240"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rickard KA, Loghmani ES, Grosfeld JL, Lingard CD, White NM, Foland BB, et al</AU>
<TI>Short- and long-term effectiveness of enteral and parenteral nutrition in reversing or preventing protein-energy malnutrition in advanced neuroblastoma A prospective randomised study</TI>
<SO>Cancer</SO>
<YR>1985</YR>
<VL>56</VL>
<NO>12</NO>
<PG>2881-97</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621241"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621235"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rock-1999" NAME="Rock 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rock MJ, Davis L, Marcus M, Lai HC, Douglas J, Kosorok M, et al</AU>
<TI>Early nutritional intervention in infants with CF [abstract]</TI>
<SO>Pediatric Pulmonology</SO>
<YR>1999</YR>
<VL>Suppl 19</VL>
<PG>102-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621243"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621242"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rollins-2007" MODIFIED="2015-02-03 20:34:53 +0000" MODIFIED_BY="[Empty name]" NAME="Rollins 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-02-03 20:34:52 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rollins NC, van den Broeck J, Kindra G, Pent M, Kasambira T, Bennish ML</AU>
<TI>The effect of nutritional support on weight gain of HIV-infected children with prolonged diarrhoea</TI>
<SO>Acta Paediatrica</SO>
<YR>2007</YR>
<VL>96</VL>
<NO>1</NO>
<PG>62-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621245"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621244"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Saiyed-2000" NAME="Saiyed 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Saiyed F, Seshadri S</AU>
<TI>Impact of the integrated package of nutrition and health services</TI>
<SO>Indian Journal of Pediatrics</SO>
<YR>2000</YR>
<VL>67</VL>
<NO>5</NO>
<PG>322-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621247"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621246"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shaw-1999" NAME="Shaw 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shaw WC, Bannister RP, Roberts CT</AU>
<TI>Assisted feeding is more reliable for infants with clefts-a randomized trial</TI>
<SO>The Cleft Palate-Craniofacial Journal</SO>
<YR>1999</YR>
<VL>36</VL>
<NO>3</NO>
<PG>262-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621249"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621248"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shepherd-1988" NAME="Shepherd 1988" YEAR="1988">
<REFERENCE PRIMARY="YES" TYPE="CONFERENCE_PROC">
<AU>Shepherd RW, Holt TL, Cleghorn G, Ward LC, Isles A, Francis P</AU>
<TI>Nutritional supplementation during management of pulmonary exacerbations in CF: a controlled study including effects on protein turnover [abstract]</TI>
<SO>Proceedings of the 10th International Cystic Fibrosis Congress</SO>
<YR>1988</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621251"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shepherd RW, Holt TL, Cleghorn G, Ward LC, Isles A, Francis P</AU>
<TI>Short-term nutritional supplementation during management of pulmonary exacerbations in cystic fibrosis: a controlled study, including effects on protein turnover</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1988</YR>
<VL>48</VL>
<NO>2</NO>
<PG>235-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621252"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621250"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sirisinha-1973" NAME="Sirisinha 1973" YEAR="1973">
<REFERENCE PRIMARY="NO" TYPE="OTHER">
<AU>Sirisinha S, Edelman R, Suskind R, Charupatana C, Olsen RE</AU>
<TI>Complement and C3-proactive levels in children with protein-calorie malnutrition and effect of dietary treatment</TI>
<SO>Lancet</SO>
<YR>1973</YR>
<VL>1</VL>
<NO>7811</NO>
<PG>1016-20</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621254"/><IDENTIFIER TYPE="MEDLINE" VALUE="42"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621253"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Soliman-2004" MODIFIED="2008-04-16 10:15:08 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Soliman 2004" YEAR="2004">
<REFERENCE MODIFIED="2008-04-16 10:15:08 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Soliman AT, El-Matary W, Abdel Fattah MM, Nasr IS, El Alaily RK, Alaa Thabet M</AU>
<TI>The effect of high-calorie diet on nutritional parameters of children with beta-thalassaemia major</TI>
<SO>Clinical Nutrition</SO>
<YR>2004</YR>
<VL>23</VL>
<NO>5</NO>
<PG>1153-8</PG>
<IDENTIFIERS MODIFIED="2008-04-16 10:15:08 +0100" MODIFIED_BY="Nikki Jahnke"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621256"/><IDENTIFIER MODIFIED="2008-04-16 10:15:08 +0100" MODIFIED_BY="Nikki Jahnke" TYPE="PUBMED" VALUE="15380908 "/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621255"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sondel-1987" NAME="Sondel 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sondel SA, Parrell SW, Becker D, Mischler EH</AU>
<TI>Oral nutritional supplements in cystic fibrosis</TI>
<SO>Nutrition Support Services</SO>
<YR>1987</YR>
<VL>7</VL>
<NO>4</NO>
<PG>20-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621258"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621257"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stark-2005" MODIFIED="2008-04-16 09:09:24 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Stark 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-04-16 09:09:14 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stark LJ, Hommel KA, Mackner LM, Janicke DM, Davis AM, Pfefferkorn M, et al</AU>
<TI>Randomized trial comparing two methods of increasing dietary calcium intake in children with inflammatory bowel disease</TI>
<SO>Journal of Pediatric Gastroenterology &amp; Nutrition</SO>
<YR>2005</YR>
<VL>40</VL>
<NO>4</NO>
<PG>501-7</PG>
<IDENTIFIERS MODIFIED="2008-04-16 09:09:14 +0100" MODIFIED_BY="Nikki Jahnke"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621260"/><IDENTIFIER MODIFIED="2008-04-16 09:09:14 +0100" MODIFIED_BY="Nikki Jahnke" TYPE="MEDLINE" VALUE="15795602"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621259"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Taylor-1999" NAME="Taylor 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Taylor SJ, Fettes SB, Jewkes C, Nelson RJ</AU>
<TI>Prospective, randomized, controlled trial to determine the effect of early enhanced enteral nutrition on clinical outcome in mechanically ventilated patients suffering head injury [see comments]</TI>
<SO>Critical Care Medicine</SO>
<YR>1999</YR>
<VL>27</VL>
<NO>11</NO>
<PG>2525-31</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621262"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621261"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Teixido_x002d_Planas-2005" MODIFIED="2008-04-16 09:12:13 +0100" MODIFIED_BY="Nikki Jahnke" NAME="Teixido-Planas 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-04-16 09:11:03 +0100" MODIFIED_BY="Nikki Jahnke" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Teixido-Planas J, Ortiz A, Coronel F, Montenegro J, Lopez-Menchero R, Ortiz R, et al</AU>
<TI>Oral protein-energy supplements in peritoneal dialysis: A multicentre study</TI>
<SO>Peritoneal Dialysis International</SO>
<YR>2005</YR>
<VL>25</VL>
<NO>2</NO>
<PG>163-72</PG>
<IDENTIFIERS MODIFIED="2008-04-16 09:11:03 +0100" MODIFIED_BY="Nikki Jahnke"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621264"/><IDENTIFIER MODIFIED="2008-04-16 09:11:03 +0100" MODIFIED_BY="Nikki Jahnke" TYPE="PUBMED" VALUE="15796145"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621263"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-van-Eys-1982" NAME="van Eys 1982" YEAR="1982">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Eys J, Cangir AC</AU>
<TI>Effect of nutritional supportive therapy on children with advanced cancer</TI>
<SO>Cancer Research</SO>
<YR>1982</YR>
<VL>42</VL>
<NO>2 Suppl</NO>
<PG>713-4s</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621266"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621265"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Walker-2000" NAME="Walker 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Walker SP, Grantham-Mcgregor SM, Powell CA, Chang SM</AU>
<TI>Effects of growth restriction in early childhood on growth, IQ, and cognition at age 11 to 12 years and the benefits of nutritional supplementation and psychosocial stimulation</TI>
<SO>Journal of Pediatrics</SO>
<YR>2000</YR>
<VL>137</VL>
<NO>1</NO>
<PG>36-41</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621268"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621267"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yamamoto-2007" MODIFIED="2008-09-17 20:13:02 +0100" MODIFIED_BY="[Empty name]" NAME="Yamamoto 2007" YEAR="2007">
<REFERENCE MODIFIED="2008-09-17 20:13:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yamamoto T, Nakahigashi M, Umegae S, Kitagawa T, Matsumoto K</AU>
<TI>Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn's disease: A prospective, non-randomised, parallel, controlled study</TI>
<SO>Alimentary Pharmacology &amp; Theraputics</SO>
<YR>2007</YR>
<VL>25</VL>
<NO>1</NO>
<PG>67-72</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621270"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621269"/></IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2015-03-09 16:49:47 +0000" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES MODIFIED="2015-03-09 18:10:35 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Cox-2014" MODIFIED="2015-03-09 18:10:35 +0000" MODIFIED_BY="[Empty name]" NAME="Cox 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-03-09 18:10:35 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cox SE, Makani J, Walter G, Mtunguja S, Kamala BA, Ellins E, et al</AU>
<TI>Ready-to-use supplementary food supplements improve endothelial function, hemoglobin and growth in Tanzanian children with sickle cell anaemia: the vascular function intervention study (V-FIT), a random order crossover trial [abstract]</TI>
<SO>56th ASH Annual Meeting and Exposition; 2014 Dec 6-9; San Francisco, California</SO>
<YR>2014</YR>
<VL>1</VL>
<PG>Abstract no: 4087</PG>
<IDENTIFIERS><IDENTIFIER TYPE="CENTRAL" VALUE="1017322"/><IDENTIFIER OTHERTYPE="CFGD Register" TYPE="OTHER" VALUE="SC262 "/><IDENTIFIER OTHERTYPE="CRS" TYPE="OTHER" VALUE="5500131000000279"/><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2621272"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2621271"/></IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2015-05-20 13:03:49 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2015-05-20 13:03:49 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Corey-1988" MODIFIED="2008-11-11 11:08:06 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Corey 1988" TYPE="JOURNAL_ARTICLE">
<AU>Corey M, McLaughlin FJ, Williams M, Levison H</AU>
<TI>A comparison of survival, growth and pulmonary function in patients with cystic fibrosis in Boston and Toronto</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>1988</YR>
<VL>41</VL>
<NO>6</NO>
<PG>583-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-CPS-1994" MODIFIED="2008-11-11 11:08:06 +0000" MODIFIED_BY="Nikki Jahnke" NAME="CPS 1994" TYPE="JOURNAL_ARTICLE">
<AU>Canadian Paediatric Society Nutrition Committee</AU>
<TI>Undernutrition in children with a neurodevelopmental disability</TI>
<SO>Canadian Medical Association Journal</SO>
<YR>1994</YR>
<VL>151</VL>
<NO>6</NO>
<PG>753-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Curtin-2002a" MODIFIED="2008-11-11 11:08:06 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Curtin 2002a" TYPE="JOURNAL_ARTICLE">
<AU>Curtin F, Elbourne D, Altman DG</AU>
<TI>Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes</TI>
<SO>Statistics in medicine</SO>
<YR>2002</YR>
<VL>21</VL>
<NO>15</NO>
<PG>2131-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Curtin-2002b" MODIFIED="2008-11-11 11:08:06 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Curtin 2002b" TYPE="JOURNAL_ARTICLE">
<AU>Curtin F, Elbourne D, Altman DG</AU>
<TI>Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomes</TI>
<SO>Statistics in medicine</SO>
<YR>2002</YR>
<VL>21</VL>
<NO>15</NO>
<PG>2145-59</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Curtin-2002c" MODIFIED="2008-11-11 11:08:06 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Curtin 2002c" TYPE="JOURNAL_ARTICLE">
<AU>Curtin F, Elbourne D, Altman DG</AU>
<TI>Meta-analysis combining parallel and cross-over clinical trials. III: The issue of carry-over</TI>
<SO>Statistics in medicine</SO>
<YR>2002</YR>
<VL>21</VL>
<NO>15</NO>
<PG>2161-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" MODIFIED="2014-05-08 18:32:28 +0100" MODIFIED_BY="[Empty name]" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey Smith G, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by a simple, graphical test</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7109</NO>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Elbourne-2002" MODIFIED="2008-11-11 11:08:06 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Elbourne 2002" TYPE="JOURNAL_ARTICLE">
<AU>Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A</AU>
<TI>Meta-analyses involving cross-over trials: methodological issues</TI>
<SO>International Journal of Epidemiology</SO>
<YR>2002</YR>
<VL>31</VL>
<NO>1</NO>
<PG>140-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Florescu-2014" MODIFIED="2015-01-15 10:20:37 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Florescu 2014" TYPE="JOURNAL_ARTICLE">
<AU>Florescu L, Paduraru DT, Mîndru DE, Temneanu OR, Petrariu FD, Matei MC</AU>
<TI>Epidemiological evaluation regarding the role of cystic fibrosis as a risk factor for child malnutrition.</TI>
<SO>Revista Medico-chirurgicala a Societatii de Medici Si Naturalisti Din Iasi</SO>
<YR>2014</YR>
<VL>118</VL>
<NO>2</NO>
<PG>450-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hendricks-1995" MODIFIED="2008-11-11 11:08:06 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Hendricks 1995" TYPE="JOURNAL_ARTICLE">
<AU>Hendricks KM, Duggan C, Gallagher L, Carlin AC, Richardson DS, Collier SB, et al</AU>
<TI>Malnutrition in hospitalised pediatric patients: current perspective</TI>
<SO>Arhives of Pediatrics and Adolescent Medicine</SO>
<YR>1995</YR>
<VL>149</VL>
<NO>10</NO>
<PG>1118-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hendrickse-1997" MODIFIED="2008-11-11 11:08:06 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Hendrickse 1997" TYPE="JOURNAL_ARTICLE">
<AU>Hendrickse WK, Reilly JJ, Weaver LT</AU>
<TI>Malnutrition in a children's hospital</TI>
<SO>Clinical Nutrition</SO>
<YR>1997</YR>
<VL>16</VL>
<PG>13-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2015-01-06 19:23:54 +0000" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="BOOK_SECTION">
<AU>Higgins JPT, Altman DG, Sterne JAC (editors)</AU>
<TI>Chapter 8: Assessing the risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<YR>2011</YR>
<PB>Wiley Publishers</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Johansson-1986" MODIFIED="2008-11-11 11:08:06 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Johansson 1986" TYPE="JOURNAL_ARTICLE">
<AU>Johansson U, Portinsson S, Akesson A, Svantesson H, Ockerman PA, Akesson B</AU>
<TI>Nutritional status in girls with juvenile chronic arthritis</TI>
<SO>Human Nutrition: Clinical Nutrition</SO>
<YR>1986</YR>
<VL>40</VL>
<NO>1</NO>
<PG>57-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Joosten-2010" MODIFIED="2015-01-06 19:08:02 +0000" MODIFIED_BY="[Empty name]" NAME="Joosten 2010" TYPE="JOURNAL_ARTICLE">
<AU>Joosten K F, Zwart H, Hop W C, Hulst J M</AU>
<TI>National malnutrition screening days in hospitalised children in The Netherlands</TI>
<SO>Arch Dis Child</SO>
<YR>2010</YR>
<VL>95</VL>
<PG>141-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Koscik-2004" MODIFIED="2008-11-11 11:08:06 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Koscik 2004" TYPE="JOURNAL_ARTICLE">
<AU>Koscik RL, Farrell PM, Kosorok MR, Zaremba KM, Laxova A, Lai HC, et al</AU>
<TI>Cognitive function of children with cystic fibrosis: deleterious effect of early malnutrition</TI>
<SO>Pediatrics</SO>
<YR>2004</YR>
<VL>113</VL>
<NO>6</NO>
<PG>1549-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moy-1990" MODIFIED="2008-11-11 11:08:06 +0000" MODIFIED_BY="Nikki Jahnke" NAME="Moy 1990" TYPE="JOURNAL_ARTICLE">
<AU>Moy RJD, Smallman S, Booth IW</AU>
<TI>Malnutrition in a UK Children's Hospital</TI>
<SO>Journal of Human Nutrition and Dietetics</SO>
<YR>1990</YR>
<VL>3</VL>
<PG>93-100</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pawellek-2008" MODIFIED="2015-01-06 19:08:10 +0000" MODIFIED_BY="[Empty name]" NAME="Pawellek 2008" TYPE="JOURNAL_ARTICLE">
<AU>Pawellek I, Dokoupil K, Koletzko B</AU>
<TI>Prevalence of malnutrition in paediatric hospital patients</TI>
<SO>Clin Nutr</SO>
<YR>2008</YR>
<VL>27</VL>
<PG>72-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2014" MODIFIED="2015-05-20 12:12:27 +0100" MODIFIED_BY="[Empty name]" NAME="RevMan 2014" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2014</YR>
<EN>5.3</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Smyth-2014" MODIFIED="2015-05-20 13:03:49 +0100" MODIFIED_BY="[Empty name]" NAME="Smyth 2014" TYPE="COCHRANE_REVIEW">
<AU>Smyth RL, Rayner O</AU>
<TI>Oral calorie supplements for cystic fibrosis</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2014</YR>
<NO>11</NO>
<IDENTIFIERS MODIFIED="2015-05-20 13:03:49 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2015-05-20 13:03:49 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000406.pub4"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Spagnuolo-2013" MODIFIED="2015-01-06 19:08:16 +0000" MODIFIED_BY="[Empty name]" NAME="Spagnuolo 2013" TYPE="JOURNAL_ARTICLE">
<AU>Spagnuolo M I, Liguoro I, Chiatto F, Mambretti D, Guarino A</AU>
<TI>Application of a score system to evaluate the risk of malnutrition in a multiple hospital setting</TI>
<SO>Ital J Pediatr</SO>
<YR>2013</YR>
<VL>39</VL>
<PG>81</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2015-05-20 11:26:24 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Poustie-2009" MODIFIED="2015-05-20 11:26:24 +0100" MODIFIED_BY="[Empty name]" NAME="Poustie 2009" TYPE="COCHRANE_REVIEW">
<AU>Poustie VJ, Smyth RL, Watling RM</AU>
<TI>Oral protein calorie supplementation for children with chronic disease</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2015-05-20 11:26:24 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2015-05-20 11:26:24 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001914"/></IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2015-03-09 16:49:29 +0000" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2015-05-20 13:06:16 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2015-05-20 13:06:16 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2015-05-20 13:05:06 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bayram-2009">
<CHAR_METHODS MODIFIED="2015-01-14 12:20:32 +0000" MODIFIED_BY="Nikki Jahnke">
<P>Randomized (2:1 randomization) controlled open-label study.</P>
<P>Duration: 3 months (follow up of a subset of participants for a further 3 months).</P>
<P>Parallel design.</P>
<P>Single centre.</P>
<P>Location: Turkey.</P>
<P>No intention-to-treat analysis.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-01-14 14:10:20 +0000" MODIFIED_BY="Nikki Jahnke">
<P>52 children (31 boys, 21 girls) with paediatric malignant disease receiving intensive chemotherapy.</P>
<P>Mean (SD) age 7.5 (3.0) years.</P>
<P>
<B>Treatment group</B> n = 33: 18 children were diagnosed with leukaemia (12 acute lymphoblastic leukaemia, 6 acute myeloid leukaemia) and 15 had a solid tumour (4 non-Hodgkin lymphoma, 3 neuroblastoma, 2 Wilm&#8217;s tumour, 2 brain tumour, 2 malignant bone tumour, 1 soft tissue tumour, and 1 hepatoblastoma). </P>
<P>
<B>Control group</B> n = 19: 11 children were diagnosed with leukaemia (7 acute lymphoblastic leukaemia, 4 acute myeloid leukaemia) and 8 had a solid tumour (3 neuroblastoma, 2 soft tissue tumour, 1 brain tumour, 1 malignant bone tumour, and 1 retinoblastoma).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-05-20 13:05:06 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Treatment</B>: usual dietary intake plus 2x daily (morning and evening) oral supplement (ProSure&#8482;) containing protein and energy dense EPA (banana and vanilla flavoured); each 240 ml container contained 300 kcal, 16 g protein, 1.09 g EPA (derived from deodorized sardine oil). Children supervised by a nurse specialized in nutrition who monitored compliance with supplement.</P>
<P>
<B>Control</B>: usual dietary care.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-02-03 21:07:18 +0000" MODIFIED_BY="[Empty name]">
<P>Body weight, BMI, weight percentiles, status of primary disease, attacks of febrile neutropenia and clinical status.</P>
<P>Measured monthly for 3 months. Subgroup of 23 children followed for further 3 months (6 months total).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-01-14 12:21:43 +0000" MODIFIED_BY="Nikki Jahnke"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-01-14 14:09:05 +0000" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Hanning-1993">
<CHAR_METHODS MODIFIED="2015-01-14 12:53:28 +0000" MODIFIED_BY="Nikki Jahnke">
<P>Randomised controlled study.</P>
<P>Duration: 6 months (follow up of a subset of participants for a further 3 months).</P>
<P>Parallel design.</P>
<P>Single centre.</P>
<P>Location: Canada.</P>
<P>No intention-to-treat analysis.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-01-14 14:09:05 +0000" MODIFIED_BY="Nikki Jahnke">
<P>20 children with CF and mild to moderate lung disease aged 7 - 15 years.<BR/>
<B>Randomised</B> n = 20 (10 treatment group, 10 control group).<BR/>Gender split: treatment group 7 males, 3 females; control group 5 male, 5 female.</P>
<P>Mean (SD) age: treatment group 10.7 (2.4) years; control group 10.0 (2.8) years.</P>
<P>
<B>Studied</B> n = 16 (9 treatment group, 7 control group).</P>
<P>Gender split: treatment group 6 male, 3 females; control group 4 males, 3 females.</P>
<P>Mean (SD) age: treatment group 10.6 (2.5) years; control group 9.5 (2.9) years.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-01-14 12:54:40 +0000" MODIFIED_BY="Nikki Jahnke">
<P>
<B>Treatment</B>: dietary supplements, drink powders, milk shakes, tinned puddings, to achieve 25% of normal energy recommendations in addition to normal diet.<BR/>
<B>Control</B>: no intervention.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Skeletal muscle strength and power, pulmonary function and respiratory muscle strength, height, weight and anthropometric measurements, habitual physical activity, body composition, dietary energy and nutrient intake, energy and nutrient intake from supplements. Laboratory measures of nutritional status (e.g. albumin, amino acids).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-01-14 13:11:28 +0000" MODIFIED_BY="Nikki Jahnke">
<P>Number enrolled was slightly less than the sample size of 24 investigators had estimated they needed.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-02-17 15:50:47 +0000" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Kalnins-1996">
<CHAR_METHODS MODIFIED="2015-01-14 13:24:31 +0000" MODIFIED_BY="Nikki Jahnke">
<P>Quasi-randomised study.</P>
<P>Duration: 3 months.<BR/>Parallel design.</P>
<P>Single centre.</P>
<P>Location: Canada.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-01-14 13:29:27 +0000" MODIFIED_BY="Nikki Jahnke">
<P>Adolescents and adults (over 10 years of age) with CF. Most recent published report states 13 completed the trial (2 drop-outs).<BR/>Mean (SD) age: treatment group 19.5 (11.3) years; control group 16.4 (6.7) years.</P>
<P>Gender split: 3 males, 10 females.<BR/>Less than 90% ideal WFH or 5% reduction in ideal WFH over 3 months.</P>
<P>All participants pancreatic insufficient, except 1 in treatment group.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-01-14 13:27:36 +0000" MODIFIED_BY="Nikki Jahnke">
<P>
<B>Treatment</B>: high-calorie drink to increase energy intake by 20% of predicted energy needs.<BR/>
<B>Control: </B>nutritional counselling to increase energy intake by 20% of predicted energy needs by eating high calorie foods.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-02-17 15:50:12 +0000" MODIFIED_BY="Nikki Jahnke">
<P>Z scores for weight* and height*, WFH*<BR/>Anthropometric measures*<BR/>Pulmonary function (FEV<SUB>1</SUB> % predicted)*<BR/>Energy* and nutrient* intake<BR/>Faecal balance studies.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-02-17 15:50:47 +0000" MODIFIED_BY="Nikki Jahnke">
<P>Information from lead author:</P>
<P>A modified randomization process was used:</P>
<P>1. males and females were segregated in 2 groups</P>
<P>2. within each gender, participants were separated into groups by age: 10 - 14 years, 15 - 18 years and &gt; 18 years</P>
<P>3. if a participant within his/her age group were to select a sealed envelope card containing supplement, as the arm, then the next patient of the same group would be automatically assigned to diet counselling.</P>
<P>If there was a drop out, then the next participant of that gender and age would replace the drop out in that group.</P>
<P>The above was done because of the relatively small number of participants in each group.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-02-17 15:51:21 +0000" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Poustie-2006">
<CHAR_METHODS MODIFIED="2015-01-14 13:50:42 +0000" MODIFIED_BY="Nikki Jahnke">
<P>Randomised controlled study.</P>
<P>Duration: 12 months.<BR/>Parallel design.</P>
<P>Multicentre (7 specialist paediatric CF centres and their associated shared care clinics and 7 smaller paediatric CF clinics).</P>
<P>Location: UK.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-02-17 15:51:21 +0000" MODIFIED_BY="Nikki Jahnke">
<P>102 children aged 2 - 15 years with CF and at least one of following criteria: BMI &lt; 25th centile but &gt; 0.4th centile; or no increase in weight over the previous 3 months; or 5% decrease in weight from baseline over a period of &lt; 6 months.</P>
<P>
<B>Treatment</B> group (n = 50).</P>
<P>Age (mean (SD)): 8.75 (3.72) years.</P>
<P>Gender split: 27 males, 23 females.</P>
<P>BMI centile (mean (SD)):34.27 (23.96).<BR/>Weight centile (mean (SD)): 25.07 (20.37).<BR/>Height centile (mean (SD)):26.69 (24.83).<BR/>Energy intake (% EAR) (mean (SD)): 118.43 (28.71).<BR/>FEV1 (% predicted) (mean (SD)): 81.34 (16.16).</P>
<P>
<B>Control</B> group (n = 52).</P>
<P>Age (mean (SD)): 8.79 (3.67) years.</P>
<P>Gender split: 27 males, 25 females.</P>
<P>BMI centile (mean (SD)): 31.52 (25.36).<BR/>Weight centile (mean (SD)): 24.69 (22.79).<BR/>Height centile (mean (SD)): 28.15 (26.93).<BR/>Energy intake (% EAR) (mean (SD)): 116.24 (29.59).<BR/>FEV1 (% predicted) (mean (SD)): 73.67 (18.58).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-01-14 14:07:30 +0000" MODIFIED_BY="Nikki Jahnke">
<P>
<B>Treatment</B>: oral calorie supplements (chosen by the children) in the form of drinks sufficient to increase usual energy intake by 20% plus routine dietetic advice.</P>
<P>
<B>Control</B>: dietary advice alone.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-01-14 13:53:43 +0000" MODIFIED_BY="Nikki Jahnke">
<P>Change in BMI*<BR/>Change in BMI percentile and z score*<BR/>Change in weight*<BR/>Change in height*<BR/>Change in weight percentile*<BR/>Change in height percentile*</P>
<P>Mid-upper arm circumference*</P>
<P>Tricep skinfold<BR/>Mid-arm muscle circumference<BR/>Energy* and macro-nutrient* intake<BR/>FEV1 &amp; FVC expressed as % predicted for age, sex and height*<BR/>Gastrointestinal symptoms*</P>
<P>Eating behaviour</P>
<P>Activity levels</P>
<P>Lipase intake<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-01-14 14:07:54 +0000" MODIFIED_BY="Nikki Jahnke">
<P>Sample size calculation undertaken: with a 5% significance level and 90% power, using a conservatively estimated SD for 1 year change in BMI centile of 15 points, authors needed 47 children in each arm or 94 in total.</P>
<P>The children selected the supplements that they liked, and we recommended a daily amount sufficient to increase usual energy intake by 20%. Excluded supplements that provided only energy or protein alone.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>BMI: body mass index<BR/>CF: cystic fibrosis<BR/>EAR: estimated average requirement for age and sex<BR/>EPA: eicosapentaenoic acid<BR/>FEV1: forced expiratory volume in 1 second<BR/>FVC: forced vital capacity<BR/>SD: standard deviation<BR/>WFH : weight for height<BR/>*: outcomes included in review</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2015-02-03 20:35:43 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2008-04-16 10:21:17 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Abdulhamid-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-04-16 10:21:17 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Intervention is zinc supplements, not an oral calorie supplement.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Agtmaal-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease / not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Akobeng-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-09-18 11:49:10 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Akobeng-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-09-18 11:49:10 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Alexander-1980">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease / not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Arora-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease / not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Attard_x002d_Montalto-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Badaloo-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ball-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Barbosa-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bengoa-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bennett-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bernstein-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Berry-1975">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-09-17 20:19:43 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Borrelli-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-09-17 20:19:43 +0100" MODIFIED_BY="[Empty name]">
<P>Not OPCS</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-04-25 21:03:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Botr_x00e1_n-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-04-25 21:03:17 +0100" MODIFIED_BY="[Empty name]">
<P>Interevntion duration less than one month</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Braga-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Adult study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-04-16 10:22:04 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Bruzzese-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-04-16 10:22:04 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cassidy-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Chan-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Chawla-1983">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease / not OPCS / unclear if RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Coghlin_x002d_Dickson-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Dartois-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Dhanraj-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease / not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Dykman-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease / not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-09-17 20:20:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dziechciarz-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-09-17 20:20:02 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Edefonti-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT / not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Elhasid-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-English-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease / not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Fauveau-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Fell-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gianotti-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease / not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gibson-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gottrand-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Granados-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Haffejee-1980">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hanafy-1967">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hansen-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease / not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Heikens-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hopman-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hopman-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-INCAP-Study">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease / not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Iyengar-1979">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Jackson-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-04-25 21:04:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jain-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-04-25 21:04:19 +0100" MODIFIED_BY="[Empty name]">
<P>Not OPCS</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Jamaican-Study-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-04-25 21:09:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Johnson-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-04-25 21:09:07 +0100" MODIFIED_BY="[Empty name]">
<P> Both groups received supplemental amino acids</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kabir-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease / not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-09-17 20:20:43 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Karkos-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-09-17 20:20:43 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kashirskaja-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT / not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kaur-1979">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease / not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Keele-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Adult study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kendell-1982">
<CHAR_REASON_FOR_EXCLUSION>
<P>Adult study / not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kingston-Project-_x0027_93">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Knops-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kobayashi-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-04 14:57:44 +0000" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Koletzko-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-04 14:57:44 +0000" MODIFIED_BY="Nikki Jahnke">
<P>Quasi-randomised study where treatment &amp; comparison group not comparable.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-09-17 20:21:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Koretz-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-09-17 20:21:01 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kossmann-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease / not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-09-17 20:21:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ladas-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-09-17 20:21:23 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lagstrom-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease / not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lambert-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lepage-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-09-17 20:21:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Linday-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-09-17 20:21:37 +0100" MODIFIED_BY="[Empty name]">
<P>Not OPCS</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-04-16 10:22:47 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Lloyd_x002d_Still-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-04-16 10:22:47 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-09-17 20:32:24 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lutter-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-09-17 20:32:24 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Maes-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-09-18 11:49:40 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Mahlungulu-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-09-18 11:49:40 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-09-18 11:49:41 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Manguso-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-09-18 11:49:41 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not children with chronic disease/Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-09-18 11:49:52 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Marques-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-09-18 11:49:52 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT / Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Martorell-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mathisen-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-09-18 11:49:55 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-McCargar-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-09-18 11:49:55 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not children with chronic disease / Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-McClure-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-10 12:02:50 +0000" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-McWhirter-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-10 12:02:50 +0000" MODIFIED_BY="Nikki Jahnke">
<P>Adult study / OPCS administered for less than 1 month.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-09-17 20:22:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mok-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-09-17 20:22:30 +0100" MODIFIED_BY="[Empty name]">
<P>Not OPCS</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mora-1981">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-04-16 10:23:03 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Ndekha-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-04-16 10:23:03 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-04-16 10:23:11 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Newby-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-04-16 10:23:11 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not RCT - review article.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-03 20:25:54 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nielson-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-03 20:25:54 +0000" MODIFIED_BY="[Empty name]">
<P>The median age of the sample was 36 and 35 years in both groups. lowest age range in one group was 15 years but data was not presented disaggregated according to age. </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-04-16 10:24:05 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Oudshoorn-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-04-16 10:24:05 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Intervention uses micronutrient supplements not oral calorie supplements.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Papadopoulou-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT - review article.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-04-16 10:24:33 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Papas-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-04-16 10:24:33 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Pharmacokinetic trial of different formulations of vitamin E supplementation, not oral calorie supplementation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Pelekanos-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Powers-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-08-25 20:03:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Powers-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-08-25 20:03:53 +0100" MODIFIED_BY="[Empty name]">
<P>Not OPCS. </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Raynor-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Reifsnider-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease / not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Rettammel-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Rickard-1983">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Rickard-1984">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Rickard-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Rock-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-02-03 20:35:43 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rollins-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-02-03 20:35:43 +0000" MODIFIED_BY="[Empty name]">
<P>Oral protein supplement intervention arm only provided to children under 1 year of age. </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Saiyed-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease / not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Shaw-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Shepherd-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sirisinha-1973">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Soliman-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not RCT/Not OPCS</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sondel-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention for less than 1 month.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-04-16 09:11:37 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Stark-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-04-16 09:11:37 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Taylor-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease / not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-04-16 09:11:36 +0100" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Teixido_x002d_Planas-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-04-16 09:11:36 +0100" MODIFIED_BY="Nikki Jahnke">
<P>Not children with chronic disease.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-van-Eys-1982">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Walker-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not children with chronic disease / not OPCS.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-09-17 20:23:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yamamoto-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-09-17 20:23:22 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>OPCS: oral protein calorie supplements<BR/>RCT : randomised controlled trial</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2015-03-09 16:49:47 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES>
<P>CDAI: Crohn&#8217;s Disease Activity Index<BR/>HNR: high nutritional risk<BR/>LNR: low nutritional risk<BR/>RNA: ribonucleic acid</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2015-03-12 14:15:29 +0000" MODIFIED_BY="Nikki Jahnke" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2015-03-12 14:15:29 +0000" MODIFIED_BY="Nikki Jahnke" STUDY_ID="STD-Cox-2014">
<CHAR_STUDY_NAME MODIFIED="2015-03-12 14:12:33 +0000" MODIFIED_BY="Nikki Jahnke">
<P>Ready-to-use supplementary food supplements improve endothelial function, haemoglobin and growth in Tanzanian children with sickle cell anaemia: the vascular function intervention study (V-FIT), a random order crossover trial.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-03-12 14:11:49 +0000" MODIFIED_BY="Nikki Jahnke">
<P>Randomised cross-over trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-03-12 14:12:27 +0000" MODIFIED_BY="Nikki Jahnke">
<P>Tanzanian children (n = 119) with sickle cell anaemia aged 8 - 11.9 years.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-03-12 14:15:11 +0000" MODIFIED_BY="Nikki Jahnke">
<P>Daily ready-to-use supplementary food providing 500 kcal, 1 RDA of vitamins and minerals and 1 mg folate (Nutriset, France), plus weekly anti-malarial prophylactic chloroquine syrup (150/225 mg base) (Wallace Manufacturing Chemicals, UK), or a vascular ready-to-use supplementary food fortified with arginine and citrulline (average 0.2 g/kg/d and 0.1 g/kg/d) plus daily chloroquine syrup (3 mg base/kg/d).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-03-12 14:15:20 +0000" MODIFIED_BY="Nikki Jahnke">
<P>Height, weight and body composition by impedance, endothelium-dependent and -independent vasodilatation.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2015-03-12 14:15:22 +0000" MODIFIED_BY="Nikki Jahnke">
<P>November 2012.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-03-12 14:15:29 +0000" MODIFIED_BY="Nikki Jahnke">
<P>Sharon Cox (sharon.cox@lshtm.ac.uk).</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2015-03-09 16:56:26 +0000" MODIFIED_BY="[Empty name]">
<P>Study author contacted for availability of study findings. </P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES>
<P>RDA: recommended daily allowance</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2015-05-20 13:06:16 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2015-05-20 13:06:16 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-14 12:41:12 +0000" MODIFIED_BY="Nikki Jahnke" RESULT="UNKNOWN" STUDY_ID="STD-Bayram-2009">
<DESCRIPTION>
<P>Children were randomized, using a 2:1 randomization scheme. No further details given.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-04-15 16:24:45 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-Hanning-1993">
<DESCRIPTION>
<P>Paper states that participants were randomly allocated to treatment or control ordered on the basis of a table of random numbers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-20 13:06:16 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kalnins-1996">
<DESCRIPTION>
<P>Paper states "randomized" but gives no further detail on method of randomisation.</P>
<P>Personal communication confirmed that participants split into groups according to age and gender and first participant in each group chose a sealed envelope that contained a card allocating to either supplement or dietary advice group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-04-15 17:14:25 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-Poustie-2006">
<DESCRIPTION>
<P>Paper states that random number tables were used to generate the randomisation code.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2015-02-17 15:47:54 +0000" MODIFIED_BY="Nikki Jahnke" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 15:45:49 +0000" MODIFIED_BY="Nikki Jahnke" RESULT="NO" STUDY_ID="STD-Bayram-2009">
<DESCRIPTION>
<P>Open-label design and therefore did not maintain concealment of allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-04-15 16:24:01 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-Hanning-1993">
<DESCRIPTION>
<P>Paper states that participants selected a card from within a sealed envelope.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-02-17 15:47:54 +0000" MODIFIED_BY="Nikki Jahnke" RESULT="NO" STUDY_ID="STD-Kalnins-1996">
<DESCRIPTION>
<P>Unclear from paper. However communication with lead author confirmed that allocation was concealed from initial participant as the cards were in sealed envelopes - low risk of bias. But other participants were allocated alternately - high risk of bias as clinician can foresee which treatment next participant will receive.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-04-15 17:14:54 +0100" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-Poustie-2006">
<DESCRIPTION>
<P>Sequentially numbered, opaque envelopes, administered by the pharmacy of the lead centre, were used for treatment group allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2015-02-17 15:45:49 +0000" MODIFIED_BY="Nikki Jahnke" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-02-17 15:45:49 +0000" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-Bayram-2009">
<DESCRIPTION>
<P>Not blinded. Outcomes were not affected by blinding due to the fact that they were objective measures.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-02-03 21:12:49 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hanning-1993">
<DESCRIPTION>
<P>Not explicitly discussed in paper. Groups were dietary supplement or no supplement, so participants at least could not be blinded. Outcomes were not affected by blinding. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-02-03 21:04:27 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kalnins-1996">
<DESCRIPTION>
<P>Participants could not be blinded as treatment options were counselling or dietary supplements.</P>
<P>No discussion in paper of whether outcome assessors were blinded to participants' treatment group. However, lead author confirmed that different physicians were used, but she was not sure if patients had discussed their treatment arm during clinic visits therefore we judge that blinding was not present.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2015-02-03 21:11:56 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Poustie-2006">
<DESCRIPTION>
<P>The research assistant was not masked to allocation group, but a masked investigator used a computerised growth package for conversion of weight and height to BMI centile. The children in the trial were not masked, as no satisfactory placebo was available. This however did not influence outcomes due to objectivity of the measures. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2015-01-14 14:03:55 +0000" MODIFIED_BY="Nikki Jahnke" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-01-14 12:44:27 +0000" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-Bayram-2009">
<DESCRIPTION>
<P>There was no loss to follow up.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-01-14 12:52:40 +0000" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-Hanning-1993">
<DESCRIPTION>
<P>Reasons for 4 participants not completing trial given (the time demands for testing or the travelling distance found to be excessive).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-01-14 13:37:28 +0000" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-Kalnins-1996">
<DESCRIPTION>
<P>Two participants dropped out (one from each group) after baseline measurements. Reasons given (feeling unwell, change of mind).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-01-14 14:03:55 +0000" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-Poustie-2006">
<DESCRIPTION>
<P>Paper states that investigators made every effort to obtain full outcome data on all participants, but replaced any missing data with routinely collected data where appropriate. Full reasons given for any drop outs or missing data (unable to collect interim data on 2 children from the treatment group (owing to parental choice or illness) and 1 child from the standard care group (illness)).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2015-01-14 12:44:59 +0000" MODIFIED_BY="Nikki Jahnke" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-01-14 12:44:59 +0000" MODIFIED_BY="Nikki Jahnke" RESULT="YES" STUDY_ID="STD-Bayram-2009">
<DESCRIPTION>
<P>Outcomes all reported in the Results as outlined in the Methods.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-17 15:40:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hanning-1993">
<DESCRIPTION>
<P>Paper appears to address all the outcomes measured in the 'Resuts' section. No access to study protocol to double check. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-11-06 08:37:31 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kalnins-1996">
<DESCRIPTION>
<P>Paper appears to address all the outcomes measured in the 'Resuts' section. No access to study protocol to double check, however the lead author has confirmed that all planned outcome measures were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-07-17 16:18:50 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Poustie-2006">
<DESCRIPTION>
<P>Paper appears to address all the outcomes measured in the 'Results' section. The investigators of the study have confirmed that assessment of eating behaviour was planned and undertaken, however due to concerns of the validity and reliability of the tools used to assess this outcome in the three age groups of participants, the data were not reported. Lipase intake was also assessed within the dietary diaries however data were not reported on this outcome in the key publication as the diaries were only returned by approximately half of the study participants. 
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2008-04-24 09:35:35 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2015-05-20 13:07:10 +0100" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2015-05-20 13:07:10 +0100" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2014-10-10 22:04:38 +0100" MODIFIED_BY="GDT">Oral protein calorie supplements compared with no intervention, placebo or additional nutritional advice compared to placebo for children with chronic disease</TITLE>
<TABLE COLS="7" ROWS="14">
<TR>
<TD COLSPAN="7">
<P>
<B>Oral protein calorie supplements compared with no intervention, placebo or additional nutritional advice compared to placebo for children with chronic disease</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population: </B>children with chronic disease<BR/>
<B>Settings: </B>
<BR/>
<B>Intervention: </B>oral protein calorie supplements<BR/>
<B>Comparison: </B>no intervention, placebo or additional nutritional advice</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Control (<B>no intervention, placebo or additional nutritional advice)</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Oral protein calorie supplements</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Change in weight in kg at 6 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean change in weight in kg at 6 months ranged across control groups from 1.33 to 6.55 kg</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean change in weight in kg at 6 months in the intervention group was 0.42 higher (0.12 lower to 0.96 higher)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>125<BR/>(3 RCTs)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;<BR/>MODERATE</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Change in weight Z score at 6 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean change in weight Z score at 6 months ranged across control groups from 0.06 to 0.83 kg</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean change in weight Z score at 6 months in the intervention group was 0.03 higher (0.1 lower to 0.16 higher)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>109<BR/>(2 RCTs)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>HIGH</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Change in height in cm at 6 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean change in height in cm at 6 months ranged across control groups from 3.46 to 6.58 cm</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean change in height in cm at 6 months in the intervention group was 0.4 lower (1.23 lower to 0.42 higher)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>109<BR/>(2 RCTs)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>HIGH</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Change in BMI at 6 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean change in BMI at 6 months ranged across control groups from 0.14 to 1.12 kg/m<SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean change in BMI at 6 months in the intervention group was 0.18 higher (0.12 lower to 0.47 higher)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>109<BR/>(2 RCTs)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>HIGH</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Change in total energy intake (kcal/day) at 3 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean change in total energy intake (kcal/day) at 3 months ranged across control groups from -56.75 to 190.54 kcal</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean change in total energy intake (kcal/day) at 3 months in the intervention group was 133.43 higher (102.94 lower to 369.79 higher)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>53<BR/>(2 RCTs)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>HIGH</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Change in total protein intake (g/day) at 3 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean change in total protein intake (g/day) at 3 months ranged across control groups from -1.95 to 7.87 g</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean change in total protein intake (g/day) at 3 months in the intervention group was 3.45 higher (5.87 lower to 12.76 higher)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>53<BR/>(2 RCTs)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>HIGH</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Disease severity score: change in FEV1 % predicted at 12 months</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean disease severity score: change in FEV1 % predicted at 12 months in the control group was -1.5 %</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean disease severity score: change in FEV1 % predicted at 12 months in the intervention group was 4.91 higher (1.75 lower to 11.57 higher)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>70<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>HIGH</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality: </B>Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality: </B>Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality: </B>Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality: </B>We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>BMI: body mass index<BR/>CI: confidence interval<BR/>FEV<SUB>1</SUB>: forced expiratory volume at one second<BR/>RCT: randomised controlled trial</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2008-04-24 12:45:20 +0100" MODIFIED_BY="Nikki Jahnke"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2015-03-09 17:53:34 +0000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2015-03-09 17:53:34 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Oral protein calorie supplements compared with no intervention, placebo or additional nutritional advice</NAME>
<CONT_OUTCOME CHI2="5.675675678352942" CI_END="0.595249262120229" CI_START="-0.021084852188709424" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="MD" EFFECT_SIZE="0.2870822049657598" ESTIMABLE="YES" I2="11.904761946317205" I2_Q="0.0" ID="CMP-001.01" MODIFIED="2014-10-09 23:10:39 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.339066732576637" P_Q="0.8232993567613627" P_Z="0.06787092279382612" Q="0.38887096630452056" RANDOM="NO" SCALE="1.6806185280910815" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="165" TOTAL_2="169" UNITS="" WEIGHT="300.0" Z="1.8258628535145323">
<NAME>Change in weight in kg</NAME>
<GROUP_LABEL_1>Supplements</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours supplements</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.2467215036176063" CI_END="0.655582257035251" CI_START="-0.183309315462152" DF="1" EFFECT_SIZE="0.23613647078654948" ESTIMABLE="YES" I2="19.789624459167147" ID="CMP-001.01.01" NO="1" P_CHI2="0.26417966389409353" P_Z="0.2698509294336291" STUDIES="2" TAU2="0.0" TOTAL_1="52" TOTAL_2="55" WEIGHT="100.0" Z="1.103405954598416">
<NAME>3 months</NAME>
<CONT_DATA CI_END="1.5393306182436883" CI_START="-4.439330618243689" EFFECT_SIZE="-1.4500000000000002" ESTIMABLE="YES" MEAN_1="2.15" MEAN_2="3.6" ORDER="40" SD_1="2.75" SD_2="1.32" SE="1.5251967086248253" STUDY_ID="STD-Kalnins-1996" TOTAL_1="4" TOTAL_2="4" WEIGHT="1.9688098379913135"/>
<CONT_DATA CI_END="0.6936368188428667" CI_START="-0.1536368188428664" EFFECT_SIZE="0.27000000000000013" ESTIMABLE="YES" MEAN_1="1.11" MEAN_2="0.84" ORDER="41" SD_1="1.25" SD_2="0.85" SE="0.21614520582238228" STUDY_ID="STD-Poustie-2006" TOTAL_1="48" TOTAL_2="51" WEIGHT="98.03119016200868"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.040083208430815" CI_END="0.9624350434843073" CI_START="-0.11596142394615627" DF="2" EFFECT_SIZE="0.4232368097690755" ESTIMABLE="YES" I2="50.49606909515093" ID="CMP-001.01.02" NO="2" P_CHI2="0.13265017790575329" P_Z="0.1239389052292819" STUDIES="3" TAU2="0.0" TOTAL_1="63" TOTAL_2="62" WEIGHT="100.0" Z="1.538448852777807">
<NAME>6 months</NAME>
<CONT_DATA CI_END="2.5148277747423737" CI_START="-0.13482777474237406" EFFECT_SIZE="1.19" ESTIMABLE="YES" MEAN_1="2.52" MEAN_2="1.33" ORDER="42" SD_1="1.33" SD_2="1.35" SE="0.6759449587811033" STUDY_ID="STD-Hanning-1993" TOTAL_1="9" TOTAL_2="7" WEIGHT="16.564490147571117"/>
<CONT_DATA CI_END="1.2297613201132473" CI_START="-8.369761320113247" EFFECT_SIZE="-3.57" ESTIMABLE="YES" MEAN_1="2.98" MEAN_2="6.55" ORDER="43" SD_1="2.27" SD_2="4.34" SE="2.44890281554822" STUDY_ID="STD-Kalnins-1996" TOTAL_1="4" TOTAL_2="4" WEIGHT="1.2619950128214352"/>
<CONT_DATA CI_END="0.9248158451639686" CI_START="-0.26481584516396894" EFFECT_SIZE="0.32999999999999985" ESTIMABLE="YES" MEAN_1="2.05" MEAN_2="1.72" ORDER="44" SD_1="1.8" SD_2="1.18" SE="0.3034830485946682" STUDY_ID="STD-Poustie-2006" TOTAL_1="50" TOTAL_2="51" WEIGHT="82.17351483960745"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.0032007714199513" CI_START="-0.683200771419952" DF="0" EFFECT_SIZE="0.1599999999999997" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.03" NO="3" P_CHI2="1.0" P_Z="0.7099603559200456" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="52" WEIGHT="100.0" Z="0.37190933423639405">
<NAME>12 months</NAME>
<CONT_DATA CI_END="1.0032007714199513" CI_START="-0.683200771419952" EFFECT_SIZE="0.1599999999999997" ESTIMABLE="YES" MEAN_1="3.13" MEAN_2="2.97" ORDER="45" SD_1="2.35" SD_2="1.97" SE="0.43021238046770843" STUDY_ID="STD-Poustie-2006" TOTAL_1="50" TOTAL_2="52" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.75107289102276" CI_END="0.10426377528138796" CI_START="-0.05238767918454902" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="0.025938048048419468" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.02" MODIFIED="2008-04-16 14:47:31 +0100" MODIFIED_BY="Nikki Jahnke" NO="2" P_CHI2="0.7814206416208662" P_Q="0.5964271499805036" P_Z="0.516303366192384" Q="1.033596615715284" RANDOM="NO" SCALE="6.290128827303924" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="156" TOTAL_2="162" UNITS="" WEIGHT="300.0" Z="0.6490541716001235">
<NAME>Change in weight Z score</NAME>
<GROUP_LABEL_1>Supplements</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours supplements</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.3265742796489924" CI_END="0.1098204791573227" CI_START="-0.1519966852877317" DF="1" EFFECT_SIZE="-0.021088103065204495" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.01" NO="1" P_CHI2="0.5676834152213412" P_Z="0.7522065506651925" STUDIES="2" TAU2="0.0" TOTAL_1="52" TOTAL_2="55" WEIGHT="100.0" Z="0.3157311904868908">
<NAME>3 months</NAME>
<CONT_DATA CI_END="3.233941935375316" CI_START="-5.953941935375315" EFFECT_SIZE="-1.3599999999999999" ESTIMABLE="YES" MEAN_1="-0.79" MEAN_2="0.57" ORDER="46" SD_1="4.68" SD_2="0.27" SE="2.343890995758975" STUDY_ID="STD-Kalnins-1996" TOTAL_1="4" TOTAL_2="4" WEIGHT="0.08120172128391799"/>
<CONT_DATA CI_END="0.11096176462452564" CI_START="-0.15096176462452562" EFFECT_SIZE="-0.019999999999999997" ESTIMABLE="YES" MEAN_1="0.04" MEAN_2="0.06" ORDER="47" SD_1="0.28" SD_2="0.38" SE="0.06681845465403208" STUDY_ID="STD-Poustie-2006" TOTAL_1="48" TOTAL_2="51" WEIGHT="99.91879827871608"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.3909019956584835" CI_END="0.16136793580061579" CI_START="-0.10377036524686409" DF="1" EFFECT_SIZE="0.028798785276875852" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.02" NO="2" P_CHI2="0.5318260266509826" P_Z="0.6702720711337866" STUDIES="2" TAU2="0.0" TOTAL_1="54" TOTAL_2="55" WEIGHT="100.0" Z="0.4257746369964948">
<NAME>6 months</NAME>
<CONT_DATA CI_END="3.20901516260293" CI_START="-6.12901516260293" EFFECT_SIZE="-1.46" ESTIMABLE="YES" MEAN_1="-0.63" MEAN_2="0.83" ORDER="48" SD_1="4.75" SD_2="0.37" SE="2.382194366545266" STUDY_ID="STD-Kalnins-1996" TOTAL_1="4" TOTAL_2="4" WEIGHT="0.08061843779356681"/>
<CONT_DATA CI_END="0.16262262044494838" CI_START="-0.10262262044494838" EFFECT_SIZE="0.03" ESTIMABLE="YES" MEAN_1="0.09" MEAN_2="0.06" ORDER="49" SD_1="0.34" SD_2="0.34" SE="0.06766584564362339" STUDY_ID="STD-Poustie-2006" TOTAL_1="50" TOTAL_2="51" WEIGHT="99.91938156220644"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.224718132912196" CI_START="-0.06471813291219598" DF="0" EFFECT_SIZE="0.08" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.03" NO="3" P_CHI2="1.0" P_Z="0.27860182828292246" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="52" WEIGHT="100.00000000000001" Z="1.0834656003911893">
<NAME>12 months</NAME>
<CONT_DATA CI_END="0.224718132912196" CI_START="-0.06471813291219598" EFFECT_SIZE="0.08" ESTIMABLE="YES" MEAN_1="0.03" MEAN_2="-0.05" ORDER="50" SD_1="0.45" SD_2="0.27" SE="0.07383713887281304" STUDY_ID="STD-Poustie-2006" TOTAL_1="50" TOTAL_2="52" WEIGHT="100.00000000000001"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.0199990913841033" CI_END="0.21579104935841337" CI_START="-0.6681289916509896" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.2261689711462881" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.03" MODIFIED="2008-04-16 14:47:59 +0100" MODIFIED_BY="Nikki Jahnke" NO="3" P_CHI2="0.9067485353714932" P_Q="0.632840747164864" P_Z="0.31586399998770953" Q="0.9150730458317009" RANDOM="NO" SCALE="4.868907114293411" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="156" TOTAL_2="162" UNITS="" WEIGHT="300.0" Z="1.0029935227195235">
<NAME>Change in height in cm</NAME>
<GROUP_LABEL_1>Supplements</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours supplements</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.011651115346803432" CI_END="0.37839115417358704" CI_START="-1.1524564567713287" DF="1" EFFECT_SIZE="-0.3870326512988709" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.01" NO="1" P_CHI2="0.9140430247137488" P_Z="0.3216632236339315" STUDIES="2" TAU2="0.0" TOTAL_1="52" TOTAL_2="55" WEIGHT="100.0" Z="0.9910458127424047">
<NAME>3 months</NAME>
<CONT_DATA CI_END="2.353286701742353" CI_START="-2.853286701742353" EFFECT_SIZE="-0.25" ESTIMABLE="YES" MEAN_1="3.7" MEAN_2="3.95" ORDER="51" SD_1="2.38" SD_2="1.18" SE="1.3282319074619462" STUDY_ID="STD-Kalnins-1996" TOTAL_1="4" TOTAL_2="4" WEIGHT="8.64489913408606"/>
<CONT_DATA CI_END="0.40082120507791263" CI_START="-1.2008212050779123" EFFECT_SIZE="-0.3999999999999999" ESTIMABLE="YES" MEAN_1="1.65" MEAN_2="2.05" ORDER="52" SD_1="0.86" SD_2="2.78" SE="0.40858975542136894" STUDY_ID="STD-Poustie-2006" TOTAL_1="48" TOTAL_2="51" WEIGHT="91.35510086591394"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.09327493020559904" CI_END="0.42053122023127437" CI_START="-1.226845230281533" DF="1" EFFECT_SIZE="-0.40315700502512924" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.02" NO="2" P_CHI2="0.7600543465538461" P_Z="0.33740208613477707" STUDIES="2" TAU2="0.0" TOTAL_1="54" TOTAL_2="55" WEIGHT="99.99999999999999" Z="0.959311042376885">
<NAME>6 months</NAME>
<CONT_DATA CI_END="2.3931623757677216" CI_START="-4.193162375767722" EFFECT_SIZE="-0.9000000000000004" ESTIMABLE="YES" MEAN_1="5.68" MEAN_2="6.58" ORDER="53" SD_1="2.45" SD_2="2.3" SE="1.6802157599546554" STUDY_ID="STD-Kalnins-1996" TOTAL_1="4" TOTAL_2="4" WEIGHT="6.256038683986633"/>
<CONT_DATA CI_END="0.4807289403211613" CI_START="-1.2207289403211616" EFFECT_SIZE="-0.3700000000000001" ESTIMABLE="YES" MEAN_1="3.09" MEAN_2="3.46" ORDER="54" SD_1="1.03" SD_2="2.92" SE="0.43405335354710733" STUDY_ID="STD-Poustie-2006" TOTAL_1="50" TOTAL_2="51" WEIGHT="93.74396131601335"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.7681798754250002" CI_START="-0.6681798754249988" DF="0" EFFECT_SIZE="0.05000000000000071" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.03" NO="3" P_CHI2="1.0" P_Z="0.8914627365082635" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="52" WEIGHT="100.0" Z="0.13645355791821848">
<NAME>12 months</NAME>
<CONT_DATA CI_END="0.7681798754250002" CI_START="-0.6681798754249988" EFFECT_SIZE="0.05000000000000071" ESTIMABLE="YES" MEAN_1="5.9" MEAN_2="5.85" ORDER="55" SD_1="1.85" SD_2="1.85" SE="0.3664250369343063" STUDY_ID="STD-Poustie-2006" TOTAL_1="50" TOTAL_2="52" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.3760624222621516" CI_END="0.05015170306047883" CI_START="-0.0898295757637737" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.019838936351647442" ESTIMABLE="YES" I2="0.0" I2_Q="10.424912599455228" ID="CMP-001.04" MODIFIED="2008-04-16 14:48:38 +0100" MODIFIED_BY="Nikki Jahnke" NO="4" P_CHI2="0.6669574838164469" P_Q="0.3274627703230495" P_Z="0.578515582026109" Q="2.232763660119897" RANDOM="NO" SCALE="0.5060331158771272" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="156" TOTAL_2="162" UNITS="" WEIGHT="300.0" Z="0.555554300795181">
<NAME>Change in height Z score</NAME>
<GROUP_LABEL_1>Supplements</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours supplements</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.13569468695435263" CI_END="0.07746972985958243" CI_START="-0.24883914866726514" DF="1" EFFECT_SIZE="-0.08568470940384136" ESTIMABLE="YES" I2="0.0" ID="CMP-001.04.01" NO="1" P_CHI2="0.712599254555935" P_Z="0.30332699016698683" STUDIES="2" TAU2="0.0" TOTAL_1="52" TOTAL_2="55" WEIGHT="100.0" Z="1.0293250077379805">
<NAME>3 months</NAME>
<CONT_DATA CI_END="0.3656948182583998" CI_START="-0.4056948182583998" EFFECT_SIZE="-0.020000000000000018" ESTIMABLE="YES" MEAN_1="0.53" MEAN_2="0.55" ORDER="56" SD_1="0.35" SD_2="0.18" SE="0.19678668654154427" STUDY_ID="STD-Kalnins-1996" TOTAL_1="4" TOTAL_2="4" WEIGHT="17.894113245198305"/>
<CONT_DATA CI_END="0.08005772020612949" CI_START="-0.28005772020612946" EFFECT_SIZE="-0.09999999999999999" ESTIMABLE="YES" MEAN_1="0.02" MEAN_2="0.12" ORDER="57" SD_1="0.14" SD_2="0.64" SE="0.09186787187234143" STUDY_ID="STD-Poustie-2006" TOTAL_1="48" TOTAL_2="51" WEIGHT="82.1058867548017"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.007604075187902612" CI_END="0.07075055710754194" CI_START="-0.2640944268064951" DF="1" EFFECT_SIZE="-0.09667193484947659" ESTIMABLE="YES" I2="0.0" ID="CMP-001.04.02" NO="2" P_CHI2="0.9305114677491354" P_Z="0.25775689139136815" STUDIES="2" TAU2="0.0" TOTAL_1="54" TOTAL_2="55" WEIGHT="100.0" Z="1.131708818845076">
<NAME>6 months</NAME>
<CONT_DATA CI_END="0.33042413341254356" CI_START="-0.4904241334125437" EFFECT_SIZE="-0.08000000000000007" ESTIMABLE="YES" MEAN_1="0.82" MEAN_2="0.9" ORDER="58" SD_1="0.35" SD_2="0.23" SE="0.20940391591371924" STUDY_ID="STD-Kalnins-1996" TOTAL_1="4" TOTAL_2="4" WEIGHT="16.64032575261707"/>
<CONT_DATA CI_END="0.0833731719452254" CI_START="-0.2833731719452254" EFFECT_SIZE="-0.1" ESTIMABLE="YES" MEAN_1="0.0" MEAN_2="0.1" ORDER="59" SD_1="0.19" SD_2="0.64" SE="0.09355945996541241" STUDY_ID="STD-Poustie-2006" TOTAL_1="50" TOTAL_2="51" WEIGHT="83.35967424738293"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.10740580703742478" CI_START="-0.06740580703742477" DF="0" EFFECT_SIZE="0.019999999999999997" ESTIMABLE="YES" I2="0.0" ID="CMP-001.04.03" NO="3" P_CHI2="1.0" P_Z="0.6538107532035884" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="52" WEIGHT="100.0" Z="0.44847454670851583">
<NAME>12 months</NAME>
<CONT_DATA CI_END="0.10740580703742478" CI_START="-0.06740580703742477" EFFECT_SIZE="0.019999999999999997" ESTIMABLE="YES" MEAN_1="0.03" MEAN_2="0.01" ORDER="60" SD_1="0.23" SD_2="0.22" SE="0.044595618963853736" STUDY_ID="STD-Poustie-2006" TOTAL_1="50" TOTAL_2="52" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.151938561017804" CI_END="0.30634321801102027" CI_START="-0.01630882215256793" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="0.14501719792922618" ESTIMABLE="YES" I2="22.35932256129681" I2_Q="0.0" ID="CMP-001.05" MODIFIED="2014-05-08 18:16:24 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.2720600016963356" P_Q="0.9150606077643741" P_Z="0.07809858685162324" Q="0.1775300490345601" RANDOM="NO" SCALE="2.204716903144654" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="156" TOTAL_2="162" UNITS="" WEIGHT="300.0" Z="1.7618266720774045">
<NAME>Change in body mass index</NAME>
<GROUP_LABEL_1>Supplements</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours supplements</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.3318477288738553" CI_END="0.3826274208240436" CI_START="-0.07708068673891444" DF="1" EFFECT_SIZE="0.15277336704256458" ESTIMABLE="YES" I2="24.91634153661465" ID="CMP-001.05.01" NO="1" P_CHI2="0.24847691685546625" P_Z="0.1926780618794197" STUDIES="2" TAU2="0.0" TOTAL_1="52" TOTAL_2="55" WEIGHT="100.00000000000001" Z="1.3026974824860467">
<NAME>3 months</NAME>
<CONT_DATA CI_END="0.6454783734576302" CI_START="-1.6854783734576302" EFFECT_SIZE="-0.52" ESTIMABLE="YES" MEAN_1="0.2" MEAN_2="0.72" ORDER="61" SD_1="0.88" SD_2="0.8" SE="0.5946427498927402" STUDY_ID="STD-Kalnins-1996" TOTAL_1="4" TOTAL_2="4" WEIGHT="3.8895189939193484"/>
<CONT_DATA CI_END="0.41445893726604993" CI_START="-0.054458937266049945" EFFECT_SIZE="0.18" ESTIMABLE="YES" MEAN_1="0.19" MEAN_2="0.01" ORDER="62" SD_1="0.65" SD_2="0.53" SE="0.1196241048893919" STUDY_ID="STD-Poustie-2006" TOTAL_1="48" TOTAL_2="51" WEIGHT="96.11048100608066"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.6425607831093876" CI_END="0.470491113943157" CI_START="-0.11705037831646437" DF="1" EFFECT_SIZE="0.17672036781334632" ESTIMABLE="YES" I2="72.54678618852385" ID="CMP-001.05.02" NO="2" P_CHI2="0.05632044196410402" P_Z="0.238384850277505" STUDIES="2" TAU2="0.0" TOTAL_1="54" TOTAL_2="55" WEIGHT="100.0" Z="1.1790335178431248">
<NAME>6 months</NAME>
<CONT_DATA CI_END="0.24383284895281299" CI_START="-2.123832848952813" EFFECT_SIZE="-0.9400000000000002" ESTIMABLE="YES" MEAN_1="0.18" MEAN_2="1.12" ORDER="63" SD_1="0.72" SD_2="0.97" SE="0.6040074502851764" STUDY_ID="STD-Kalnins-1996" TOTAL_1="4" TOTAL_2="4" WEIGHT="6.157952284592743"/>
<CONT_DATA CI_END="0.5532562835655239" CI_START="-0.05325628356552392" EFFECT_SIZE="0.25" ESTIMABLE="YES" MEAN_1="0.39" MEAN_2="0.14" ORDER="64" SD_1="0.87" SD_2="0.67" SE="0.15472543677208905" STUDY_ID="STD-Poustie-2006" TOTAL_1="50" TOTAL_2="51" WEIGHT="93.84204771540726"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.43560250485564533" CI_START="-0.2756025048556453" DF="0" EFFECT_SIZE="0.08000000000000002" ESTIMABLE="YES" I2="0.0" ID="CMP-001.05.03" NO="3" P_CHI2="1.0" P_Z="0.6592610161273719" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="52" WEIGHT="100.0" Z="0.44093367347582435">
<NAME>12 months</NAME>
<CONT_DATA CI_END="0.43560250485564533" CI_START="-0.2756025048556453" EFFECT_SIZE="0.08000000000000002" ESTIMABLE="YES" MEAN_1="0.32" MEAN_2="0.24" ORDER="65" SD_1="1.03" SD_2="0.78" SE="0.18143318329346483" STUDY_ID="STD-Poustie-2006" TOTAL_1="50" TOTAL_2="52" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.1056728078432725" CI_END="0.18030285482715352" CI_START="-0.06052725212004619" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="0.05988780135355367" ESTIMABLE="YES" I2="3.402573753951136" I2_Q="2.048320499896194" ID="CMP-001.06" MODIFIED="2008-04-16 14:49:14 +0100" MODIFIED_BY="Nikki Jahnke" NO="6" P_CHI2="0.37561800734078" P_Q="0.36026652757958544" P_Z="0.3296704509534827" Q="2.0418230807342925" RANDOM="NO" SCALE="1.2556429029875467" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="107" TOTAL_2="112" UNITS="" WEIGHT="300.0" Z="0.9747779067505756">
<NAME>Change in body mass index Z score</NAME>
<GROUP_LABEL_1>Supplements</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours supplements</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.06384972710898" CI_END="0.2275260721912624" CI_START="-0.08494813912066282" DF="1" EFFECT_SIZE="0.07128896653529979" ESTIMABLE="YES" I2="6.001761854326183" ID="CMP-001.06.01" NO="1" P_CHI2="0.30233918310342167" P_Z="0.3711581117962879" STUDIES="2" TAU2="0.0" TOTAL_1="52" TOTAL_2="55" WEIGHT="100.00000000000001" Z="0.8943061657321245">
<NAME>3 months</NAME>
<CONT_DATA CI_END="0.4140882478855736" CI_START="-0.9940882478855735" EFFECT_SIZE="-0.29" ESTIMABLE="YES" MEAN_1="0.12" MEAN_2="0.41" ORDER="66" SD_1="0.59" SD_2="0.41" SE="0.35923529893372114" STUDY_ID="STD-Kalnins-1996" TOTAL_1="4" TOTAL_2="4" WEIGHT="4.923956174921112"/>
<CONT_DATA CI_END="0.2502317713563223" CI_START="-0.0702317713563223" EFFECT_SIZE="0.09" ESTIMABLE="YES" MEAN_1="0.04" MEAN_2="-0.05" ORDER="67" SD_1="0.43" SD_2="0.38" SE="0.08175240597286994" STUDY_ID="STD-Poustie-2006" TOTAL_1="48" TOTAL_2="51" WEIGHT="95.0760438250789"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.2639938232358847" CI_START="-1.1839938232358846" DF="0" EFFECT_SIZE="-0.45999999999999996" ESTIMABLE="YES" I2="0.0" ID="CMP-001.06.02" NO="2" P_CHI2="1.0" P_Z="0.21302460305099924" STUDIES="2" TAU2="0.0" TOTAL_1="5" TOTAL_2="5" WEIGHT="100.0" Z="1.2452916087858386">
<NAME>6 months</NAME>
<CONT_DATA CI_END="0.2639938232358847" CI_START="-1.1839938232358846" EFFECT_SIZE="-0.45999999999999996" ESTIMABLE="YES" MEAN_1="0.12" MEAN_2="0.58" ORDER="68" SD_1="0.47" SD_2="0.57" SE="0.36939139134527754" STUDY_ID="STD-Kalnins-1996" TOTAL_1="4" TOTAL_2="4" WEIGHT="100.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="0.0" MEAN_2="0.0" ORDER="69" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Poustie-2006" TOTAL_1="1" TOTAL_2="1" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.9303846782601438E-32" CI_END="0.27577011814174535" CI_START="-0.11577011814174534" DF="0" EFFECT_SIZE="0.08000000000000002" ESTIMABLE="YES" I2="100.0" ID="CMP-001.06.03" NO="3" P_CHI2="0.0" P_Z="0.42317525998812333" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="52" WEIGHT="100.0" Z="0.8009246776348012">
<NAME>12 months</NAME>
<CONT_DATA CI_END="0.27577011814174535" CI_START="-0.11577011814174536" EFFECT_SIZE="0.08" ESTIMABLE="YES" MEAN_1="0.0" MEAN_2="-0.08" ORDER="70" SD_1="0.6" SD_2="0.38" SE="0.0998845487396478" STUDY_ID="STD-Poustie-2006" TOTAL_1="50" TOTAL_2="52" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.29480241416376984" CI_END="0.9124354223631679" CI_START="-8.996389302596398" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-4.041976940116615" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.07" MODIFIED="2013-09-18 14:23:36 +0100" MODIFIED_BY="Nikki Jahnke" NO="7" P_CHI2="0.5871594209783348" P_Q="0.5871594209783348" P_Z="0.1098195324586551" Q="0.29480241416376984" RANDOM="NO" SCALE="13.469926714150821" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="8" TOTAL_2="8" UNITS="" WEIGHT="200.0" Z="1.599004816184657">
<NAME>Change in % ideal weight for height</NAME>
<GROUP_LABEL_1>Supplements</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours supplements</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="4.054187945493133" CI_START="-9.554187945493133" DF="0" EFFECT_SIZE="-2.75" ESTIMABLE="YES" I2="0.0" ID="CMP-001.07.01" NO="1" P_CHI2="1.0" P_Z="0.42827635530258934" STUDIES="1" TAU2="0.0" TOTAL_1="4" TOTAL_2="4" WEIGHT="100.00000000000001" Z="0.7921446321974748">
<NAME>3 months</NAME>
<CONT_DATA CI_END="4.054187945493133" CI_START="-9.554187945493133" EFFECT_SIZE="-2.75" ESTIMABLE="YES" MEAN_1="0.25" MEAN_2="3.0" ORDER="71" SD_1="6.29" SD_2="2.94" SE="3.47158825323511" STUDY_ID="STD-Kalnins-1996" TOTAL_1="4" TOTAL_2="4" WEIGHT="100.00000000000001"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.7282159072234213" CI_START="-12.728215907223422" DF="0" EFFECT_SIZE="-5.5" ESTIMABLE="YES" I2="0.0" ID="CMP-001.07.02" NO="2" P_CHI2="1.0" P_Z="0.1358695510176947" STUDIES="1" TAU2="0.0" TOTAL_1="4" TOTAL_2="4" WEIGHT="100.0" Z="1.4913502935347638">
<NAME>6 months</NAME>
<CONT_DATA CI_END="1.7282159072234213" CI_START="-12.728215907223422" EFFECT_SIZE="-5.5" ESTIMABLE="YES" MEAN_1="-2.0" MEAN_2="3.5" ORDER="72" SD_1="4.97" SD_2="5.45" SE="3.687933025422235" STUDY_ID="STD-Kalnins-1996" TOTAL_1="4" TOTAL_2="4" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.08" MODIFIED="2008-09-17 12:38:48 +0100" MODIFIED_BY="Nikki Jahnke" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="0.75" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="148" TOTAL_2="151" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Change in mid-arm muscle circumference</NAME>
<GROUP_LABEL_1>Supplements</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.08.01" MODIFIED="2008-09-17 12:37:43 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<CONT_DATA CI_END="0.43002748465279034" CI_START="-0.5300274846527904" EFFECT_SIZE="-0.04999999999999999" ESTIMABLE="YES" MEAN_1="0.28" MEAN_2="0.33" MODIFIED="2008-09-17 12:37:43 +0100" MODIFIED_BY="Nikki Jahnke" ORDER="51" SD_1="1.51" SD_2="0.79" SE="0.2449164823635464" STUDY_ID="STD-Poustie-2006" TOTAL_1="48" TOTAL_2="50" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.08.02" MODIFIED="2008-09-17 12:38:19 +0100" MODIFIED_BY="Nikki Jahnke" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>6 months</NAME>
<CONT_DATA CI_END="0.4839760629485214" CI_START="-0.42397606294852136" EFFECT_SIZE="0.030000000000000027" ESTIMABLE="YES" MEAN_1="0.45" MEAN_2="0.42" MODIFIED="2008-09-17 12:38:19 +0100" MODIFIED_BY="Nikki Jahnke" ORDER="52" SD_1="1.4" SD_2="0.85" SE="0.23162469643800937" STUDY_ID="STD-Poustie-2006" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.08.03" MODIFIED="2008-09-17 12:38:48 +0100" MODIFIED_BY="Nikki Jahnke" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="51" WEIGHT="0.0" Z="0.0">
<NAME>12 months</NAME>
<CONT_DATA CI_END="0.6085332466171538" CI_START="-0.32853324661715383" EFFECT_SIZE="0.14" ESTIMABLE="YES" MEAN_1="0.76" MEAN_2="0.62" MODIFIED="2008-09-17 12:38:48 +0100" MODIFIED_BY="Nikki Jahnke" ORDER="53" SD_1="1.37" SD_2="1.0" SE="0.23905196744066948" STUDY_ID="STD-Poustie-2006" TOTAL_1="50" TOTAL_2="51" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.308388435473666" CI_END="330.9020234071713" CI_START="70.46493633950612" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="200.68347987333874" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.09" MODIFIED="2015-02-17 14:26:29 +0000" MODIFIED_BY="Nikki Jahnke" NO="9" P_CHI2="0.5076044748558046" P_Q="0.6283228121354988" P_Z="0.0025231111075404333" Q="1.7388892945311778" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="83" TOTAL_2="84" UNITS="" WEIGHT="400.0" Z="3.020555922142682">
<NAME>Change in total energy intake (kcal/day)</NAME>
<GROUP_LABEL_1>Supplements</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours supplements</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="390.6937638546424" CI_START="-249.69376385464238" DF="0" EFFECT_SIZE="70.5" ESTIMABLE="YES" I2="0.0" ID="CMP-001.09.01" NO="1" P_CHI2="1.0" P_Z="0.6660734054383723" STUDIES="1" TAU2="0.0" TOTAL_1="4" TOTAL_2="4" WEIGHT="100.0" Z="0.4315432607013606">
<NAME>1 month</NAME>
<CONT_DATA CI_END="390.6937638546424" CI_START="-249.69376385464238" EFFECT_SIZE="70.5" ESTIMABLE="YES" MEAN_1="375.5" MEAN_2="305.0" ORDER="73" SD_1="208.26" SD_2="251.76" SE="163.36716714199338" STUDY_ID="STD-Kalnins-1996" TOTAL_1="4" TOTAL_2="4" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.5694991409424879" CI_END="369.7899571310428" CI_START="-102.93961406760738" DF="1" EFFECT_SIZE="133.4251715317177" ESTIMABLE="YES" I2="36.28540634947416" ID="CMP-001.09.02" NO="2" P_CHI2="0.21027980897073162" P_Z="0.26856345171644536" STUDIES="2" TAU2="0.0" TOTAL_1="25" TOTAL_2="28" WEIGHT="100.0" Z="1.106376866461585">
<NAME>3 months</NAME>
<CONT_DATA CI_END="1895.1832336063392" CI_START="-274.6832336063392" EFFECT_SIZE="810.25" ESTIMABLE="YES" MEAN_1="753.5" MEAN_2="-56.75" ORDER="74" SD_1="960.6" SD_2="550.37" SE="553.5475356507334" STUDY_ID="STD-Kalnins-1996" TOTAL_1="4" TOTAL_2="4" WEIGHT="4.746347411402108"/>
<CONT_DATA CI_END="341.8820524088758" CI_START="-142.48205240887572" EFFECT_SIZE="99.70000000000002" ESTIMABLE="YES" MEAN_1="290.24" MEAN_2="190.54" ORDER="75" SD_1="409.33" SD_2="418.27" SE="123.56454216464019" STUDY_ID="STD-Poustie-2006" TOTAL_1="21" TOTAL_2="24" WEIGHT="95.25365258859789"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="604.0970640928513" CI_START="5.622935907148701" DF="0" EFFECT_SIZE="304.86" ESTIMABLE="YES" I2="0.0" ID="CMP-001.09.03" NO="3" P_CHI2="1.0" P_Z="0.04584762150885017" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="21" WEIGHT="100.0" Z="1.9967934859215035">
<NAME>6 months</NAME>
<CONT_DATA CI_END="604.0970640928513" CI_START="5.622935907148701" EFFECT_SIZE="304.86" ESTIMABLE="YES" MEAN_1="365.19" MEAN_2="60.33" ORDER="76" SD_1="585.72" SD_2="471.88" SE="152.6747769107979" STUDY_ID="STD-Poustie-2006" TOTAL_1="27" TOTAL_2="21" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="488.46043344761813" CI_START="42.93956655238196" DF="0" EFFECT_SIZE="265.70000000000005" ESTIMABLE="YES" I2="0.0" ID="CMP-001.09.04" NO="4" P_CHI2="1.0" P_Z="0.019399235740601983" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="31" WEIGHT="100.0" Z="2.3377689773383805">
<NAME>12 months</NAME>
<CONT_DATA CI_END="488.46043344761813" CI_START="42.93956655238196" EFFECT_SIZE="265.70000000000005" ESTIMABLE="YES" MEAN_1="405.22" MEAN_2="139.52" ORDER="77" SD_1="371.2" SD_2="492.18" SE="113.65537081534352" STUDY_ID="STD-Poustie-2006" TOTAL_1="27" TOTAL_2="31" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="7.118656999334475" CI_END="20.328553390879748" CI_START="1.755490115478004" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="11.042021753178876" ESTIMABLE="YES" I2="43.80962588345019" I2_Q="0.0" ID="CMP-001.10" MODIFIED="2015-02-17 14:26:35 +0000" MODIFIED_BY="Nikki Jahnke" NO="10" P_CHI2="0.12974908715892053" P_Q="0.9376106035358217" P_Z="0.019781428613243463" Q="0.41268114211241574" RANDOM="YES" SCALE="114.01" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="68.1348466619618" TOTALS="SUB" TOTAL_1="83" TOTAL_2="84" UNITS="" WEIGHT="400.0" Z="2.3304680150851746">
<NAME>Change in total fat intake (g/day)</NAME>
<GROUP_LABEL_1>Supplements</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours supplements</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.539299922318502E-32" CI_END="43.54187461225788" CI_START="-12.581874612257872" DF="0" EFFECT_SIZE="15.480000000000002" ESTIMABLE="YES" I2="100.0" ID="CMP-001.10.01" NO="1" P_CHI2="0.0" P_Z="0.27961223728393736" STUDIES="1" TAU2="0.0" TOTAL_1="4" TOTAL_2="4" WEIGHT="100.0" Z="1.0811908648265054">
<NAME>1 month</NAME>
<CONT_DATA CI_END="43.54187461225787" CI_START="-12.581874612257874" EFFECT_SIZE="15.48" ESTIMABLE="YES" MEAN_1="14.58" MEAN_2="-0.9" ORDER="83" SD_1="14.07" SD_2="24.94" SE="14.317546053706272" STUDY_ID="STD-Kalnins-1996" TOTAL_1="4" TOTAL_2="4" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="5.608997039889028" CI_END="97.32795574945571" CI_START="-42.71533889819615" DF="1" EFFECT_SIZE="27.30630842562978" ESTIMABLE="YES" I2="82.17150066422954" ID="CMP-001.10.02" NO="2" P_CHI2="0.01786861016624608" P_Z="0.44467286989065447" STUDIES="2" TAU2="2151.2373973214244" TOTAL_1="25" TOTAL_2="28" WEIGHT="100.0" Z="0.7643262206824177">
<NAME>3 months</NAME>
<CONT_DATA CI_END="127.34820822320424" CI_START="11.051791776795774" EFFECT_SIZE="69.2" ESTIMABLE="YES" MEAN_1="24.05" MEAN_2="-45.15" ORDER="84" SD_1="44.34" SD_2="39.43" SE="29.667998331535617" STUDY_ID="STD-Kalnins-1996" TOTAL_1="4" TOTAL_2="4" WEIGHT="42.103798266486706"/>
<CONT_DATA CI_END="11.149707702892725" CI_START="-17.469707702892727" EFFECT_SIZE="-3.16" ESTIMABLE="YES" MEAN_1="11.93" MEAN_2="15.09" ORDER="85" SD_1="23.9" SD_2="25.03" SE="7.301005434674245" STUDY_ID="STD-Poustie-2006" TOTAL_1="21" TOTAL_2="24" WEIGHT="57.8962017335133"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="26.41060143725899" CI_START="-2.9906014372589933" DF="0" EFFECT_SIZE="11.709999999999999" ESTIMABLE="YES" I2="0.0" ID="CMP-001.10.03" NO="3" P_CHI2="1.0" P_Z="0.11846695357046431" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="21" WEIGHT="100.0" Z="1.561240766707257">
<NAME>6 months</NAME>
<CONT_DATA CI_END="26.41060143725899" CI_START="-2.9906014372589933" EFFECT_SIZE="11.709999999999999" ESTIMABLE="YES" MEAN_1="14.03" MEAN_2="2.32" ORDER="86" SD_1="28.27" SD_2="23.66" SE="7.500444678175446" STUDY_ID="STD-Poustie-2006" TOTAL_1="27" TOTAL_2="21" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="22.340840197434858" CI_START="-4.640840197434862" DF="0" EFFECT_SIZE="8.849999999999998" ESTIMABLE="YES" I2="0.0" ID="CMP-001.10.04" NO="4" P_CHI2="1.0" P_Z="0.19853463436100283" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="31" WEIGHT="99.99999999999999" Z="1.285737656760442">
<NAME>12 months</NAME>
<CONT_DATA CI_END="22.340840197434858" CI_START="-4.640840197434862" EFFECT_SIZE="8.849999999999998" ESTIMABLE="YES" MEAN_1="21.08" MEAN_2="12.23" ORDER="87" SD_1="24.56" SD_2="27.86" SE="6.88320821395132" STUDY_ID="STD-Poustie-2006" TOTAL_1="27" TOTAL_2="31" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.5267786035507256" CI_END="11.544089722215546" CI_START="0.7857225107150034" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="6.164906116465275" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.11" MODIFIED="2015-02-17 14:26:35 +0000" MODIFIED_BY="Nikki Jahnke" NO="11" P_CHI2="0.821887745369439" P_Q="0.8906446755816708" P_Z="0.024687966123019007" Q="0.6251795455894227" RANDOM="NO" SCALE="150.89883040939318" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="83" TOTAL_2="84" UNITS="" WEIGHT="400.0" Z="2.2462505171651106">
<NAME>Change in total protein intake (g/day)</NAME>
<GROUP_LABEL_1>Supplements</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours supplements</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="32.92080929366744" CI_START="-24.620809293667435" DF="0" EFFECT_SIZE="4.15" ESTIMABLE="YES" I2="0.0" ID="CMP-001.11.01" NO="1" P_CHI2="1.0" P_Z="0.7773976836923417" STUDIES="1" TAU2="0.0" TOTAL_1="4" TOTAL_2="4" WEIGHT="100.0" Z="0.28271191306500776">
<NAME>1 month</NAME>
<CONT_DATA CI_END="32.92080929366744" CI_START="-24.620809293667435" EFFECT_SIZE="4.15" ESTIMABLE="YES" MEAN_1="13.35" MEAN_2="9.2" ORDER="78" SD_1="25.74" SD_2="14.12" SE="14.679254068242022" STUDY_ID="STD-Kalnins-1996" TOTAL_1="4" TOTAL_2="4" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.9015990579613025" CI_END="12.763670007071152" CI_START="-5.86872804455842" DF="1" EFFECT_SIZE="3.4474709812563655" ESTIMABLE="YES" I2="0.0" ID="CMP-001.11.02" NO="2" P_CHI2="0.3423534282678581" P_Z="0.46827592433161247" STUDIES="2" TAU2="0.0" TOTAL_1="25" TOTAL_2="28" WEIGHT="100.0" Z="0.7252870985566438">
<NAME>3 months</NAME>
<CONT_DATA CI_END="72.416676157116" CI_START="-21.11667615711601" EFFECT_SIZE="25.65" ESTIMABLE="YES" MEAN_1="23.7" MEAN_2="-1.95" ORDER="79" SD_1="44.35" SD_2="17.62" SE="23.860987510997948" STUDY_ID="STD-Kalnins-1996" TOTAL_1="4" TOTAL_2="4" WEIGHT="3.9683000919392954"/>
<CONT_DATA CI_END="12.036736347096735" CI_START="-6.976736347096735" EFFECT_SIZE="2.5300000000000002" ESTIMABLE="YES" MEAN_1="10.4" MEAN_2="7.87" ORDER="80" SD_1="16.51" SD_2="15.91" SE="4.850464815723482" STUDY_ID="STD-Poustie-2006" TOTAL_1="21" TOTAL_2="24" WEIGHT="96.0316999080607"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="18.784476309630154" CI_START="-1.244476309630155" DF="0" EFFECT_SIZE="8.77" ESTIMABLE="YES" I2="0.0" ID="CMP-001.11.03" NO="3" P_CHI2="1.0" P_Z="0.0860881807024291" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="21" WEIGHT="100.0" Z="1.7164036953072663">
<NAME>6 months</NAME>
<CONT_DATA CI_END="18.784476309630154" CI_START="-1.244476309630155" EFFECT_SIZE="8.77" ESTIMABLE="YES" MEAN_1="13.98" MEAN_2="5.21" ORDER="81" SD_1="20.32" SD_2="15.07" SE="5.109520577226451" STUDY_ID="STD-Poustie-2006" TOTAL_1="27" TOTAL_2="21" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="16.00303554798581" CI_START="-2.363035547985808" DF="0" EFFECT_SIZE="6.82" ESTIMABLE="YES" I2="0.0" ID="CMP-001.11.04" NO="4" P_CHI2="1.0" P_Z="0.14549937769948687" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="31" WEIGHT="99.99999999999999" Z="1.455613920333245">
<NAME>12 months</NAME>
<CONT_DATA CI_END="16.00303554798581" CI_START="-2.363035547985808" EFFECT_SIZE="6.82" ESTIMABLE="YES" MEAN_1="12.57" MEAN_2="5.75" ORDER="82" SD_1="16.41" SD_2="19.27" SE="4.6853083119998225" STUDY_ID="STD-Poustie-2006" TOTAL_1="27" TOTAL_2="31" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.12" MODIFIED="2015-03-09 17:53:34 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="40.551446149672536" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="191" TOTAL_2="231" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Disease severity score</NAME>
<GROUP_LABEL_1>Supplements</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours supplements</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.12.01" MODIFIED="2008-04-16 14:29:26 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="4" TOTAL_2="4" WEIGHT="0.0" Z="0.0">
<NAME>FEV1 % predicted at 3 months</NAME>
<CONT_DATA CI_END="6.640678087996488" CI_START="-36.200678087996494" EFFECT_SIZE="-14.780000000000001" ESTIMABLE="YES" MEAN_1="-12.4" MEAN_2="2.38" ORDER="89" SD_1="13.59" SD_2="17.12" SE="10.929118216946874" STUDY_ID="STD-Kalnins-1996" TOTAL_1="4" TOTAL_2="4" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.12.02" MODIFIED="2013-09-18 14:24:05 +0100" MODIFIED_BY="Nikki Jahnke" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="38" WEIGHT="0.0" Z="0.0">
<NAME>Change in FEV1 % predicted at 3 months</NAME>
<CONT_DATA CI_END="-1.9456998101501286" CI_START="-13.894300189849872" EFFECT_SIZE="-7.92" ESTIMABLE="YES" MEAN_1="-2.55" MEAN_2="5.37" MODIFIED="2008-04-16 14:18:40 +0100" MODIFIED_BY="Nikki Jahnke" ORDER="56" SD_1="12.28" SD_2="12.97" SE="3.048168352568919" STUDY_ID="STD-Poustie-2006" TOTAL_1="31" TOTAL_2="38" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.12.03" MODIFIED="2013-09-18 14:24:05 +0100" MODIFIED_BY="Nikki Jahnke" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="38" WEIGHT="0.0" Z="0.0">
<NAME>Change in FEV1 % predicted at 6 months</NAME>
<CONT_DATA CI_END="3.1871676802399187" CI_START="-9.96716768023992" EFFECT_SIZE="-3.39" ESTIMABLE="YES" MEAN_1="-1.78" MEAN_2="1.61" MODIFIED="2008-04-16 14:19:54 +0100" MODIFIED_BY="Nikki Jahnke" ORDER="57" SD_1="11.51" SD_2="16.45" SE="3.3557594589083157" STUDY_ID="STD-Poustie-2006" TOTAL_1="32" TOTAL_2="38" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.12.04" MODIFIED="2013-09-18 14:24:05 +0100" MODIFIED_BY="Nikki Jahnke" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="38" WEIGHT="0.0" Z="0.0">
<NAME>Change in FEV1 % predicted at 12 months</NAME>
<CONT_DATA CI_END="11.56517927100376" CI_START="-1.745179271003761" EFFECT_SIZE="4.91" ESTIMABLE="YES" MEAN_1="3.41" MEAN_2="-1.5" MODIFIED="2008-04-16 14:21:32 +0100" MODIFIED_BY="Nikki Jahnke" ORDER="58" SD_1="13.5" SD_2="14.89" SE="3.3955620223121272" STUDY_ID="STD-Poustie-2006" TOTAL_1="32" TOTAL_2="38" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.12.05" MODIFIED="2013-09-18 14:24:05 +0100" MODIFIED_BY="Nikki Jahnke" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="37" WEIGHT="0.0" Z="0.0">
<NAME>Change in FVC % predicted at 3 months</NAME>
<CONT_DATA CI_END="9.414240770228828" CI_START="-9.17424077022883" EFFECT_SIZE="0.11999999999999988" ESTIMABLE="YES" MEAN_1="1.47" MEAN_2="1.35" MODIFIED="2008-04-16 14:18:59 +0100" MODIFIED_BY="Nikki Jahnke" ORDER="59" SD_1="13.98" SD_2="24.31" SE="4.742046712868508" STUDY_ID="STD-Poustie-2006" TOTAL_1="30" TOTAL_2="37" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.12.06" MODIFIED="2013-09-18 14:24:05 +0100" MODIFIED_BY="Nikki Jahnke" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="38" WEIGHT="0.0" Z="0.0">
<NAME>Change in FVC % predicted at 6 months</NAME>
<CONT_DATA CI_END="8.81159588633236" CI_START="-9.07159588633236" EFFECT_SIZE="-0.1299999999999999" ESTIMABLE="YES" MEAN_1="-3.0" MEAN_2="-2.87" MODIFIED="2008-04-16 14:20:26 +0100" MODIFIED_BY="Nikki Jahnke" ORDER="60" SD_1="17.71" SD_2="20.16" SE="4.562122547588898" STUDY_ID="STD-Poustie-2006" TOTAL_1="31" TOTAL_2="38" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.12.07" MODIFIED="2013-09-18 14:24:05 +0100" MODIFIED_BY="Nikki Jahnke" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="38" WEIGHT="0.0" Z="0.0">
<NAME>Change in FVC % predicted at 12 months</NAME>
<CONT_DATA CI_END="14.206878012071972" CI_START="-3.6668780120719724" EFFECT_SIZE="5.27" ESTIMABLE="YES" MEAN_1="0.06" MEAN_2="-5.21" MODIFIED="2008-04-16 14:57:22 +0100" MODIFIED_BY="Nikki Jahnke" ORDER="61" SD_1="17.82" SD_2="20.02" SE="4.559715424653169" STUDY_ID="STD-Poustie-2006" TOTAL_1="31" TOTAL_2="38" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.13" MODIFIED="2015-03-09 17:53:34 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1.627898996075201" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="27" TOTAL_2="31" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Gastro-intestinal symptom score</NAME>
<GROUP_LABEL_1>Supplements</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.13.01" MODIFIED="2008-04-16 14:42:45 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="31" WEIGHT="0.0" Z="0.0">
<NAME>12 months</NAME>
<CONT_DATA CI_END="1.2528863884223849" CI_START="-0.852886388422385" EFFECT_SIZE="0.2" ESTIMABLE="YES" MEAN_1="-0.42" MEAN_2="-0.62" MODIFIED="2008-04-16 14:42:45 +0100" MODIFIED_BY="Nikki Jahnke" ORDER="63" SD_1="2.05" SD_2="2.03" SE="0.5371968039858989" STUDY_ID="STD-Poustie-2006" TOTAL_1="27" TOTAL_2="31" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-001.14" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2015-03-09 17:53:34 +0000" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="513.71" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>Headache</NAME>
<GROUP_LABEL_1>Supplements</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours supplements</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="3" I2="0.0" ID="CMP-001.14.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2012-06-27 13:51:21 +0100" MODIFIED_BY="Nikki Jahnke" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>3 months</NAME>
<DICH_DATA CI_END="2.5813725030178984" CI_START="0.0360329588627444" EFFECT_SIZE="0.3049827687110593" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.41185067960474514" LOG_CI_START="-1.4433000741249682" LOG_EFFECT_SIZE="-0.5157246972601116" MODIFIED="2012-06-27 13:34:53 +0100" MODIFIED_BY="Nikki Jahnke" ORDER="220" O_E="-1.0" SE="1.0897247358851685" STUDY_ID="STD-Poustie-2006" TOTAL_1="10" TOTAL_2="10" VAR="0.8421052631578947" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2015-05-20 13:06:17 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2015-03-12 14:02:50 +0000" MODIFIED_BY="Nikki Jahnke" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram for 2015 update.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAUkAAAKpCAYAAAAxJt63AAA6+UlEQVR42u2df4RWzf//3yRJkkhu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==
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2015-05-20 13:06:17 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAiMAAADOCAMAAADbsfL2AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2015-05-20 13:06:17 +0100" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAP0AAAGSCAIAAACnglCQAAARFklEQVR42u2dv24bxxPHCQQIUrBQ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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK MODIFIED="2015-05-26 16:42:33 +0100" MODIFIED_BY="Nikki Jahnke"/>
<APPENDICES MODIFIED="2015-01-06 19:03:39 +0000" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2015-01-06 19:03:27 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2010-08-09 15:10:43 +0100" MODIFIED_BY="Nikki Jahnke">Search strategy - Medline [Ovid MEDLINE(R) and Ovid OLDMEDLINE(R)]</TITLE>
<APPENDIX_BODY MODIFIED="2015-01-06 19:03:27 +0000" MODIFIED_BY="[Empty name]">
<TABLE COLS="1" ROWS="2">
<TR>
<TH>
<P>Medline - Ovid MEDLINE(R) and Ovid OLDMEDLINE(R) 1947 to Present with Daily Update (Searched 18/10/2013)</P>
</TH>
</TR>
<TR>
<TD>
<P>1. randomized controlled trial.pt.</P>
<P>2. controlled clinical trial.pt.</P>
<P>3. randomized.ab.</P>
<P>4. placebo.ab.</P>
<P>5. clinical trials as topic.sh.</P>
<P>6. randomly.ab.</P>
<P>7. trial.ti.</P>
<P>8. 1 or 2 or 3 or 4 or 5 or 6 or 7</P>
<P>9. (animals not (humans and animals)).sh.</P>
<P>10. 8 not 9</P>
<P>11. exp Child/</P>
<P>12. ADOLESCENT/</P>
<P>13. exp infant/</P>
<P>14. child hospitalized/</P>
<P>15. adolescent hospitalized/</P>
<P>16. (child$ or infant$ or toddler$ or adolescen$ or teenage$).tw.</P>
<P>17. or/11-16</P>
<P>18. Child Nutrition Sciences/</P>
<P>19. exp Dietary Proteins/</P>
<P>20. Dietary Supplements/</P>
<P>21. Dietetics/</P>
<P>22. or/18-21</P>
<P>23. exp Infant, Newborn/</P>
<P>24. exp Overweight/</P>
<P>25. exp Eating Disorders/</P>
<P>26. Athletes/</P>
<P>27. exp Sports/</P>
<P>28. exp Pregnancy/</P>
<P>29. exp Viruses/</P>
<P>30. (newborn$ or obes$ or eating disorder$ or pregnan$ or childbirth or virus$ or influenza).tw.</P>
<P>31. or/23-30</P>
<P>32. 10 and 17 and 22</P>
<P>33. 32 not 31<BR/>
</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2015-01-06 19:03:39 +0000" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2010-08-09 15:13:04 +0100" MODIFIED_BY="Nikki Jahnke">Search strategy - The Cochrane Library 'Clinical Trials'</TITLE>
<APPENDIX_BODY MODIFIED="2015-01-06 19:03:39 +0000" MODIFIED_BY="[Empty name]">
<TABLE COLS="5" ROWS="12">
<TR>
<TH COLSPAN="5">
<P>The Cochrane Library &#8216;Clinical Trials&#8217; database, Issue 4 of 4 2011 (searched 18/10/2013)</P>
</TH>
</TR>
<TR>
<TH>
<P>
<B>ID</B>
</P>
</TH>
<TH>
<P>
<B>Search</B>
</P>
</TH>
<TH>
<P>
<B>Hits</B>
</P>
</TH>
<TH>
<P>
<B>Edit</B>
</P>
</TH>
<TH>
<P>
<B>Delete</B>
</P>
</TH>
</TR>
<TR>
<TD>
<P>#1</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=1">(child* OR infant* OR toddler* OR adolescent* OR teenage*)</A>
</P>
</TD>
<TD>
<P>126648</P>
</TD>
<TD>
<P>edit</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=deletequery&amp;qnum=1">delete</A>
</P>
</TD>
</TR>
<TR>
<TD>
<P>#2</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=2">(supplement*:ti) OR nutrition*</A>
</P>
</TD>
<TD>
<P>27096</P>
</TD>
<TD>
<P>edit</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=deletequery&amp;qnum=2">delete</A>
</P>
</TD>
</TR>
<TR>
<TD>
<P>#3</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=3">(#1 AND #2)</A>
</P>
</TD>
<TD>
<P>8463</P>
</TD>
<TD>
<P>edit</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=deletequery&amp;qnum=3">delete</A>
</P>
</TD>
</TR>
<TR>
<TD>
<P>#4</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=4">(newborn* OR obes* OR eating disorder* OR preg* OR childbirth* OR virus* OR influenza* OR sport* OR athlete*)</A>
</P>
</TD>
<TD>
<P>67975</P>
</TD>
<TD>
<P>edit</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=deletequery&amp;qnum=4">delete</A>
</P>
</TD>
</TR>
<TR>
<TD>
<P>#5</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=5">(#3 AND NOT #4)</A>
</P>
</TD>
<TD>
<P>5027</P>
</TD>
<TD>
<P>edit</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=deletequery&amp;qnum=5">delete</A>
</P>
</TD>
</TR>
<TR>
<TD>
<P>#6</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=6">"accession number" near pubmed</A>
</P>
</TD>
<TD>
<P>353977</P>
</TD>
<TD>
<P>edit</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=deletequery&amp;qnum=6">delete</A>
</P>
</TD>
</TR>
<TR>
<TD>
<P>#7</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=7">(#5 AND NOT #6)</A>
</P>
</TD>
<TD>
<P>1424</P>
</TD>
<TD>
<P>edit</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=deletequery&amp;qnum=7">delete</A>
</P>
</TD>
</TR>
<TR>
<TD>
<P>#8</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=8">SR-CF</A>
</P>
</TD>
<TD>
<P>3532</P>
</TD>
<TD>
<P>edit</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=deletequery&amp;qnum=8">delete</A>
</P>
</TD>
</TR>
<TR>
<TD>
<P>#9</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=9">(#7 AND NOT #8)</A>
</P>
</TD>
<TD>
<P>1364</P>
</TD>
<TD>
<P>edit</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=deletequery&amp;qnum=9">delete</A>
</P>
</TD>
</TR>
<TR>
<TD>
<P>#10</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=runquery&amp;qnum=10">(#9)</A>
</P>
</TD>
<TD>
<P>984</P>
</TD>
<TD>
<P>edit</P>
</TD>
<TD>
<P>
<A HREF="http://www3.interscience.wiley.com/cochrane/searchHistory?mode=deletequery&amp;qnum=10">delete</A>
</P>
</TD>
</TR>
</TABLE>
<P>
<B>Line #10 restricts search to &#8216;Clinical Trials&#8217; database only</B>
</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;0 studies included in quantitative synthesis (meta-analysis)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;1 study included in qualitative synthesis&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;2 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;51 abstracts were obtained and reviewed&lt;/p&gt;" WIDTH="125">
<FLOWCHARTBOX TEXT="&lt;p&gt;4891 records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;4891 records identified through database searching&lt;/p&gt;" WIDTH="120"/>
<OUT TEXT="&lt;p&gt;4790 of records excluded&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;1 abstract added to ongoing studies&lt;/p&gt;" WIDTH="123"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;1 full-text article excluded, with reasons&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>